:TYPE,:START_ID,:END_ID,publication_year:int,pmid:int,hdac6:boolean,autophagy:boolean,anatabine:boolean,evidence:string,document:string,pmc:string,citation:string,annotation:string,tau:boolean
DIRECTLY_DECREASES,2137,2132,2014,24227736,False,False,False,Increased neurotoxicity of microglia after knockdown of Siglece mRNA was neutralized by the reactive oxygen species scavenger Trolox.,#57:0,PMC3828472,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2014-01-06"", ""ref"": ""24227736"", ""pub_year"": 2014, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Claude J"", ""Linnartz-Gerlach B"", ""Kudin AP"", ""Kunz WS"", ""Neumann H""], ""title"": ""Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst."", ""doi"": ""10.1523/JNEUROSCI.2211-13.2013""}","{""PublicationType"": [""Research""], ""Section"": [""Abstract""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cells, Cultured"", ""Coculture Techniques"", ""Female"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Microglia"", ""Neurons"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Protein Binding"", ""Respiratory Burst"", ""Sialic Acid Binding Ig-like Lectin 3""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cd33 protein, mouse"", ""Neuroprotective Agents"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Siglece protein, mouse""]}",False
DIRECTLY_DECREASES,1920,30128,2013,23737518,False,False,False,"Small molecules in the diaminothiazole class are potent Tau kinase inhibitors that target CDK5 and GSK3β. Lead compounds from the series have IC50 values toward CDK5/p25 and GSK3β in the low nanomolar range and no observed toxicity in the therapeutic dose range. Neuronal protective effects and decreased PHF-1 immunoreactivity were observed in two animal models, 3×Tg-AD and CK-p25. Treatment nearly eliminated Sarkosyl-insoluble Tau with the most prominent effect on the phosphorylation at Ser-404. Treatment also induced the recovery of memory in a fear conditioning assay.",#60:23,PMC3724657,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2013-11-04"", ""ref"": ""23737518"", ""pub_year"": 2013, ""last_author"": ""Kosik KS"", ""type"": ""PubMed"", ""author_list"": [""Zhang X"", ""Hernandez I"", ""Rei D"", ""Mair W"", ""Laha JK"", ""Cornwell ME"", ""Cuny GD"", ""Tsai LH"", ""Steen JA"", ""Kosik KS""], ""title"": ""Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models."", ""doi"": ""10.1074/jbc.M112.436402""}","{""Confidence"": [""Medium""], ""Half_life"": [""30 min""], ""IC50"": [""30 nM""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Blotting, Western"", ""Cyclin-Dependent Kinase 5"", ""Diamines"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Injections, Intraperitoneal"", ""Injections, Intraventricular"", ""Injections, Subcutaneous"", ""Learning"", ""Male"", ""Memory"", ""Mice"", ""Mice, Transgenic"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Tauopathies"", ""Thiazoles"", ""Treatment Outcome"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Diamines"", ""Neuroprotective Agents"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Thiazoles"", ""tau Proteins"", ""Cyclin-Dependent Kinase 5"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3""]}",False
DIRECTLY_DECREASES,11888,19086,2018,27550730,False,False,False,"Here we report the discovery of a new first-in-class small-molecule (CM-414) that acts as a dual inhibitor of PDE5 and HDACs. We have used this compound as a chemical probe to validate this systems therapeutics strategy, where an increase in the activation of cAMP/cGMP-responsive element-binding protein (CREB) induced by PDE5 inhibition, combined with moderate HDAC class I inhibition, leads to efficient histone acetylation. This molecule rescued the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice. Chronic treatment of Tg2576 mice with CM-414 diminished brain Aβ and tau phosphorylation (pTau) levels, increased the inactive form of GSK3β, reverted the decrease in dendritic spine density on hippocampal neurons, and reversed their cognitive deficits, at least in part by inducing the expression of genes related to synaptic transmission.",#60:23,PMC5399234,"{""full_journal_name"": ""Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"", ""pub_date"": ""2018-01-05"", ""ref"": ""27550730"", ""pub_year"": 2018, ""last_author"": ""Garcia-Osta A"", ""type"": ""PubMed"", ""author_list"": [""Cuadrado-Tejedor M"", ""Garcia-Barroso C"", ""S\u00e1nchez-Arias JA"", ""Rabal O"", ""P\u00e9rez-Gonz\u00e1lez M"", ""Mederos S"", ""Ugarte A"", ""Franco R"", ""Segura V"", ""Perea G"", ""Oyarzabal J"", ""Garcia-Osta A""], ""title"": ""A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice."", ""doi"": ""10.1038/npp.2016.163""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Behavior, Animal"", ""Disease Models, Animal"", ""Female"", ""Hippocampus"", ""Histone Deacetylase Inhibitors"", ""Mice"", ""Mice, Transgenic"", ""Motor Activity"", ""Neuronal Plasticity"", ""Phosphodiesterase 5 Inhibitors"", ""Primary Cell Culture"", ""Pyrazoles"", ""Pyrimidinones""], ""substances"": [""CM-414"", ""Histone Deacetylase Inhibitors"", ""Phosphodiesterase 5 Inhibitors"", ""Pyrazoles"", ""Pyrimidinones""]}",False
DIRECTLY_DECREASES,37439,41145,2019,29334120,False,False,False,"We recently found that overexpression of TDP-43 enhances tau exon 10 inclusion and tau mRNA instability. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion.",#60:23,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2019-01-07"", ""ref"": ""29334120"", ""pub_year"": 2019, ""last_author"": ""Liu F"", ""type"": ""PubMed"", ""author_list"": [""Gu J"", ""Wang W"", ""Miao S"", ""Chen F"", ""Wu F"", ""Hu W"", ""Iqbal K"", ""Gong CX"", ""Liu F""], ""title"": ""Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion."", ""doi"": ""10.1002/1873-3468.12976""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""DNA-Binding Proteins"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Marine Toxins"", ""Okadaic Acid"", ""Oxazoles"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2"", ""Serine"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Marine Toxins"", ""Oxazoles"", ""TARDBP protein, human"", ""tau Proteins"", ""Okadaic Acid"", ""Serine"", ""calyculin A"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,21479,41371,2009,19401603,False,False,False,Pin1 is indicated to facilitate Tau dephosphorylation via PP2A by binding to the phospho-Thr-231-Pro or phospho-Thr-212-Pro site,#60:23,PMC2719320,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2009-10-20"", ""ref"": ""19401603"", ""pub_year"": 2009, ""last_author"": ""Hisanaga SI"", ""type"": ""PubMed"", ""author_list"": [""Yotsumoto K"", ""Saito T"", ""Asada A"", ""Oikawa T"", ""Kimura T"", ""Uchida C"", ""Ishiguro K"", ""Uchida T"", ""Hasegawa M"", ""Hisanaga SI""], ""title"": ""Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau."", ""doi"": ""10.1074/jbc.M109.003277""}","{""Confidence"": [""Medium""], ""mesh"": [""Amino Acid Substitution"", ""Animals"", ""Base Sequence"", ""Brain"", ""DNA Primers"", ""Humans"", ""In Vitro Techniques"", ""Kinetics"", ""Mice"", ""Mice, Knockout"", ""Microtubules"", ""Models, Neurological"", ""Mutation"", ""NIMA-Interacting Peptidylprolyl Isomerase"", ""Peptide Mapping"", ""Peptidylprolyl Isomerase"", ""Phosphorylation"", ""Protein Conformation"", ""Rats"", ""Recombinant Proteins"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""DNA Primers"", ""MAPT protein, human"", ""NIMA-Interacting Peptidylprolyl Isomerase"", ""Recombinant Proteins"", ""tau Proteins"", ""PIN1 protein, human"", ""Peptidylprolyl Isomerase"", ""Pin1 protein, mouse""]}",False
DIRECTLY_DECREASES,2137,6743,2016,26582367,False,False,False,"As a control we scavenged the superoxide by addition of superoxide dismutase-1 (SOD1) or by addition of Trolox, a water-soluble analog of vitamin E, into the medium. Both scavengers neutralized the superoxide that was induced by neural debris (Fig. 5d).",#57:0,PMC4652165,"{""full_journal_name"": ""Scientific reports"", ""pub_date"": ""2016-09-12"", ""ref"": ""26582367"", ""pub_year"": 2016, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Shahraz A"", ""Kopatz J"", ""Mathy R"", ""Kappler J"", ""Winter D"", ""Kapoor S"", ""Sch\u00fctza V"", ""Scheper T"", ""Gieselmann V"", ""Neumann H""], ""title"": ""Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages."", ""doi"": ""10.1038/srep16800""}","{""ChallengeType"": [""neural debris""], ""MeSHAnatomy"": [""Macrophages""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""TechnologyUsed"": [""Confocal Microscopy""], ""mesh"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Cell Line"", ""Chromatography, High Pressure Liquid"", ""Homeostasis"", ""Humans"", ""Lectins"", ""Lipopolysaccharides"", ""Macrophages"", ""Membrane Proteins"", ""Microspheres"", ""Molecular Weight"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Polymerization"", ""Respiratory Burst"", ""Sialic Acids"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neuroprotective Agents"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""TNF protein, human"", ""Tumor Necrosis Factor-alpha"", ""polysialic acid""]}",False
DIRECTLY_DECREASES,26960,7161,2006,16687508,False,False,False,"Alzheimer's disease (AD) is associated with accumulations of amyloid- beta (Abeta) peptides, oxidative damage, mitochondrial dysfunction, neurodegeneration, and dementia",#59:5,PMC6674260,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2006-05-31"", ""ref"": ""16687508"", ""pub_year"": 2006, ""last_author"": ""Mucke L"", ""type"": ""PubMed"", ""author_list"": [""Esposito L"", ""Raber J"", ""Kekonius L"", ""Yan F"", ""Yu GQ"", ""Bien-Ly N"", ""Puoliv\u00e4li J"", ""Scearce-Levie K"", ""Masliah E"", ""Mucke L""], ""title"": ""Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.""}","{""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""Amyloidogenic subgraph"", ""Response to oxidative stress""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Enzyme Activation"", ""Humans"", ""Mental Disorders"", ""Mice"", ""Mice, Transgenic"", ""Mitochondria"", ""Protease Nexins"", ""Receptors, Cell Surface"", ""Superoxide Dismutase""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Protease Nexins"", ""Receptors, Cell Surface"", ""Superoxide Dismutase"", ""superoxide dismutase 2""]}",False
DIRECTLY_DECREASES,1847,7180,2017,27794524,False,False,False,"Several phase III clinical trials using IFNbeta1a and IFNbeta1b in SPMS did not show permanent disability delay, but did reduce relapses risk (SPECTRIMS Study Group, 2001; Cohen et al., 2002; Andersen et al., 2004; Panitch et al.,2004).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,9390,2230,2013,22613765,False,False,False,"Taken together, our results identify the AICD as a novel inhibitory factor of the canonical Wnt signalling pathway and suggest its regulatory role in neuronal cell proliferation and differentiation.",#59:5,,"{""full_journal_name"": ""Biochimica et biophysica acta"", ""pub_date"": ""2013-02-21"", ""ref"": ""22613765"", ""pub_year"": 2013, ""last_author"": ""Zhang L"", ""type"": ""PubMed"", ""author_list"": [""Zhou F"", ""Gong K"", ""Song B"", ""Ma T"", ""van Laar T"", ""Gong Y"", ""Zhang L""], ""title"": ""The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth."", ""doi"": ""10.1016/j.bbamcr.2012.05.011""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Wnt signaling subgraph""], ""mesh"": [""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Cell Proliferation"", ""Gene Expression"", ""Gene Expression Regulation"", ""Genes, Reporter"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""HEK293 Cells"", ""Humans"", ""Luciferases, Renilla"", ""Membrane Glycoproteins"", ""Mice"", ""Nerve Growth Factor"", ""Neurites"", ""Neurons"", ""Primary Cell Culture"", ""Protein Structure, Tertiary"", ""Proto-Oncogene Proteins c-myc"", ""Wnt Signaling Pathway""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Membrane Glycoproteins"", ""Myc protein, mouse"", ""Proto-Oncogene Proteins c-myc"", ""nicastrin protein"", ""Nerve Growth Factor"", ""Luciferases, Renilla"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Gsk3b protein, rat"", ""Glycogen Synthase Kinase 3"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,26819,32340,2010,19996109,False,False,False,We have previously proposed that CLU-client complexes serve as vehicles to dispose of damaged misfolded extracellular proteins in vivo via receptor-mediated endocytosis,#59:5,PMC2823492,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2010-04-09"", ""ref"": ""19996109"", ""pub_year"": 2010, ""last_author"": ""Wilson MR"", ""type"": ""PubMed"", ""author_list"": [""Wyatt AR"", ""Wilson MR""], ""title"": ""Identification of human plasma proteins as major clients for the extracellular chaperone clusterin."", ""doi"": ""10.1074/jbc.M109.079566""}","{""Subgraph"": [""Endosomal lysosomal subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Blood Proteins"", ""Blotting, Western"", ""Ceruloplasmin"", ""Chromatography, Affinity"", ""Chromatography, Gel"", ""Clusterin"", ""Electrophoresis, Polyacrylamide Gel"", ""Enzyme-Linked Immunosorbent Assay"", ""Extracellular Space"", ""Fibrinogen"", ""Humans"", ""Molecular Chaperones"", ""Molecular Weight"", ""Protein Binding"", ""Proteomics"", ""Serum Albumin"", ""Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization"", ""Stress, Mechanical"", ""Temperature""], ""substances"": [""Blood Proteins"", ""Clusterin"", ""Molecular Chaperones"", ""Serum Albumin"", ""Fibrinogen"", ""Ceruloplasmin""]}",False
DIRECTLY_DECREASES,39680,38200,2012,21800078,False,False,False,"The study also revealed that the nuclear receptor peroxisome proliferators activated receptor γ (PPARγ) played an important role in the CLA-induced intracellular BACE1 decrease, as well as the extracellular sAPPalpha increase through knockdown of PPARγ transcription using siRNA. We hypothesize that CLA acts as an agonist or ligand, which binds with PPARγ and leads to the increase in APP cleavage via alpha-secretase-mediated pathway and the decrease in the deposition of Abeta.",#59:5,,"{""full_journal_name"": ""Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"", ""pub_date"": ""2012-03-30"", ""ref"": ""21800078"", ""pub_year"": 2012, ""last_author"": ""Zhong L"", ""type"": ""PubMed"", ""author_list"": [""Li YC"", ""Chen Q"", ""Wan XZ"", ""Yang XL"", ""Liu X"", ""Zhong L""], ""title"": ""Effects of conjugated linoleic acid on cleavage of amyloid precursor protein via PPAR\u03b3."", ""doi"": ""10.1007/s10072-011-0711-4""}","{""Subgraph"": [""Beta secretase subgraph"", ""Non-amyloidogenic subgraph"", ""Peroxisome proliferator activated receptor subgraph""], ""mesh"": [""ADAM Proteins"", ""ADAM10 Protein"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Analysis of Variance"", ""Aspartic Acid Endopeptidases"", ""Cell Line, Tumor"", ""Cell Survival"", ""Dose-Response Relationship, Drug"", ""Enzyme-Linked Immunosorbent Assay"", ""Gene Expression Regulation, Neoplastic"", ""Humans"", ""Linoleic Acid"", ""Membrane Proteins"", ""Neuroblastoma"", ""PPAR gamma"", ""RNA, Messenger""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Membrane Proteins"", ""PPAR gamma"", ""RNA, Messenger"", ""Linoleic Acid"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human"", ""ADAM Proteins"", ""ADAM10 Protein"", ""ADAM10 protein, human""]}",False
DIRECTLY_DECREASES,44021,4488,2011,22110360,False,False,False,"Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen- activated protein kinase kinase kinase family, is composed of an inhibitory N-terminal domain, a kinase domain, and a C-terminal regulatory domain (Ichijo et al., 1997). ASK1 can promote apoptosis in response to common pro-apoptotic stresses, such as oxidative stress (Song et al., 2002), death receptor ligands (Nishitoh et al., 1998), and endoplasmic reticulum stress (Nishitoh et al., 2002). ASK1 also phosphorylates and activates both p38 and JNK pathways (Ichijo et al., 1997). The mechanism of ASK1 activation is positively regulated by its binding proteins such as TNF receptor-ssociated factors 2/6 (Noguchi et al., 2005) and Daxx (Chang et al., 1998). On the other hand, several cellular proteins, including thioredoxin (Saitoh et al., 1998), Hsp90 (Zhang et al., 2005), and 14-3-3 (Zhang et al., 1999), have been reported to interact with ASK1 and inhibit ASK1 activity.",#58:79,PMC3213740,"{""full_journal_name"": ""Experimental neurobiology"", ""pub_date"": ""2011-11-23"", ""ref"": ""22110360"", ""pub_year"": 2011, ""last_author"": ""Chung KC"", ""type"": ""PubMed"", ""author_list"": [""Choi HK"", ""Chung KC""], ""title"": ""Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death."", ""doi"": ""10.5607/en.2011.20.1.35""}","{""Confidence"": [""High""], ""Published"": [""CDR story""], ""Subgraph"": [""MAPK-JNK subgraph"", ""Unfolded protein response subgraph""]}",False
DIRECTLY_DECREASES,3296,39990,2019,30962309,False,False,False,Overexpression of miR-302b-3p directly downregulates IRAK4 and thereby inhibits NLRP3 expression (63).,#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,3289,36767,2019,30962309,False,False,False,"Infected B cells can secrete ebv-miR-BART15-3p via exosomes and inhibit NLRP3 activity in noninfected cells, which may be a mechanism for the virus to evade host defense (47).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""B-Lymphocytes""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,36416,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,26435,18489,2017,28669544,False,False,False,"We confirmed that Tardbp transcript levels were significantly downregulated specifically in microglia isolated from cKO mice upon tamoxifen administration compared to WT controls, whereas overall cortical levels remained unchanged (Figures S4A and S4B).",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
DIRECTLY_DECREASES,11573,12024,2017,27794524,False,False,False,"MN-166 (ibudilast) is a non-selective phosphodiesterase inhibitor that suppresses pro-inflammatory cytokines, promotes neurotrophic factors, and attenuates activated glial cell (Suzumura et al., 2003; Feng et al., 2004).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,2054,14232,2017,28669544,False,False,False,"However, recent studies indicate that this process re-activates in Alzheimer’s disease (AD), in which amyloid promotes microglia-mediated removal of synapses (Hong et al., 2016).",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""Species"": [""10090""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
DIRECTLY_DECREASES,44564,40328,2016,26631930,False,False,False,"Protein phosphatase 1 (PP1), PP2A, PP2B, PP2C and PP5 have all been implicated in the dephosphorylation of tau",#59:49,,"{""full_journal_name"": ""Nature reviews. Neuroscience"", ""pub_date"": ""2016-04-20"", ""ref"": ""26631930"", ""pub_year"": 2016, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Wang Y"", ""Mandelkow E""], ""title"": ""Tau in physiology and pathology."", ""doi"": ""10.1038/nrn.2015.1""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Humans"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,21479,38130,2019,29228318,False,False,False,"These findings suggest a scenario in which MC-LR-mediated demethylation of PP2Ac is associated with GSK-3β phosphorylation at Ser9 and contributes to dissociation of Bα from PP2Ac, which would result in Bα degradation and disruption of PP2A/Bα-tau interactions, thus promoting tau hyperphosphorylation and paired helical filaments- tau accumulation and, consequently, axonal degeneration and cell death.",#60:23,,"{""full_journal_name"": ""Toxicological sciences : an official journal of the Society of Toxicology"", ""pub_date"": ""2019-02-25"", ""ref"": ""29228318"", ""pub_year"": 2019, ""last_author"": ""Yuan T"", ""type"": ""PubMed"", ""author_list"": [""Zhang Y"", ""Zhang J"", ""Wang E"", ""Qian W"", ""Fan Y"", ""Feng Y"", ""Yin H"", ""Li Y"", ""Wang Y"", ""Yuan T""], ""title"": ""Microcystin-Leucine-Arginine Induces Tau Pathology Through B\u03b1 Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3\u03b2 Phosphorylation."", ""doi"": ""10.1093/toxsci/kfx271""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Cell Line, Tumor"", ""Cell Survival"", ""Demethylation"", ""Glycogen Synthase Kinase 3 beta"", ""Hippocampus"", ""Humans"", ""Immunoprecipitation"", ""Male"", ""Marine Toxins"", ""Maze Learning"", ""Microcystins"", ""Neurons"", ""Protein Phosphatase 2"", ""Rats, Sprague-Dawley"", ""Spatial Memory"", ""tau Proteins""], ""substances"": [""Marine Toxins"", ""Microcystins"", ""tau Proteins"", ""Glycogen Synthase Kinase 3 beta"", ""Protein Phosphatase 2"", ""cyanoginosin LR""]}",False
DIRECTLY_DECREASES,1513,1421,2017,27794524,False,False,False,"Indeed, the most active cortical multiple sclerosis lesions are crowded with CD8 + T cells and contain few B cells or plasma cells, suggesting cortical inflammation might correlate with reduction in EBV-infected B/plasma cells numbers (Magliozzi et al., 2013).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""cortex""], ""Cell"": [""lymphocyte of B lineage"", ""plasma cell""], ""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1691,30506,2016,26390242,False,False,False,"The acetyl-mimicking mutant K174Q slows tau turnover and induces cognitive deficits in vivo. Acetyltransferase p300-induced tau acetylation is inhibited by salsalate and salicylate, which enhance tau turnover and reduce tau levels. In the PS19 transgenic mouse model of FTD, administration of salsalate after disease onset inhibited p300 activity, lowered levels of total tau and tau acetylated at K174, rescued tau-induced memory deficits and prevented hippocampal atrophy.",#60:23,PMC4598295,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2016-01-19"", ""ref"": ""26390242"", ""pub_year"": 2016, ""last_author"": ""Gan L"", ""type"": ""PubMed"", ""author_list"": [""Min SW"", ""Chen X"", ""Tracy TE"", ""Li Y"", ""Zhou Y"", ""Wang C"", ""Shirakawa K"", ""Minami SS"", ""Defensor E"", ""Mok SA"", ""Sohn PD"", ""Schilling B"", ""Cong X"", ""Ellerby L"", ""Gibson BW"", ""Johnson J"", ""Krogan N"", ""Shamloo M"", ""Gestwicki J"", ""Masliah E"", ""Verdin E"", ""Gan L""], ""title"": ""Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits."", ""doi"": ""10.1038/nm.3951""}","{""Confidence"": [""Medium""], ""Research_Model"": [""PS19 mice""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Behavior, Animal"", ""Cognition Disorders"", ""Humans"", ""Mice"", ""Neurodegenerative Diseases"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,37439,10964,2019,29334120,False,False,False,"We recently found that overexpression of TDP-43 enhances tau exon 10 inclusion and tau mRNA instability. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion.",#60:23,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2019-01-07"", ""ref"": ""29334120"", ""pub_year"": 2019, ""last_author"": ""Liu F"", ""type"": ""PubMed"", ""author_list"": [""Gu J"", ""Wang W"", ""Miao S"", ""Chen F"", ""Wu F"", ""Hu W"", ""Iqbal K"", ""Gong CX"", ""Liu F""], ""title"": ""Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion."", ""doi"": ""10.1002/1873-3468.12976""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""DNA-Binding Proteins"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Marine Toxins"", ""Okadaic Acid"", ""Oxazoles"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2"", ""Serine"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Marine Toxins"", ""Oxazoles"", ""TARDBP protein, human"", ""tau Proteins"", ""Okadaic Acid"", ""Serine"", ""calyculin A"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,24441,20824,2013,23533697,False,False,False,"In turn, evidence suggests that once activated, caspases may cleave critical cellular proteins in AD including APP, actin, fodrin, glial acidic fibrillary protein, beclin-1, and tau [28, 31–35].",#57:0,PMC3606781,"{""full_journal_name"": ""Oxidative medicine and cellular longevity"", ""pub_date"": ""2013-08-20"", ""ref"": ""23533697"", ""pub_year"": 2013, ""last_author"": ""Rohn TT"", ""type"": ""PubMed"", ""author_list"": [""Rohn TT""], ""title"": ""The triggering receptor expressed on myeloid cells 2: \""TREM-ming\"" the inflammatory component associated with Alzheimer's disease."", ""doi"": ""10.1155/2013/860959""}","{""Section"": [""3. Mechanisms of Neurodegeneration in AD""], ""mesh"": [""Alzheimer Disease"", ""Cytokines"", ""Humans"", ""Inflammation"", ""Membrane Glycoproteins"", ""Microglia"", ""Oxidative Stress"", ""Plaque, Amyloid"", ""Reactive Oxygen Species"", ""Receptors, Immunologic""], ""substances"": [""Cytokines"", ""Membrane Glycoproteins"", ""Reactive Oxygen Species"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
DIRECTLY_DECREASES,8671,20824,2013,23533697,False,False,False,"Beta-amyloid is formed following sequential cleavage of the amyloid precursor protein (APP) by two proteases, β-secretase and γ-secretase.",#57:0,PMC3606781,"{""full_journal_name"": ""Oxidative medicine and cellular longevity"", ""pub_date"": ""2013-08-20"", ""ref"": ""23533697"", ""pub_year"": 2013, ""last_author"": ""Rohn TT"", ""type"": ""PubMed"", ""author_list"": [""Rohn TT""], ""title"": ""The triggering receptor expressed on myeloid cells 2: \""TREM-ming\"" the inflammatory component associated with Alzheimer's disease."", ""doi"": ""10.1155/2013/860959""}","{""Section"": [""2. Pathology Associated with AD""], ""mesh"": [""Alzheimer Disease"", ""Cytokines"", ""Humans"", ""Inflammation"", ""Membrane Glycoproteins"", ""Microglia"", ""Oxidative Stress"", ""Plaque, Amyloid"", ""Reactive Oxygen Species"", ""Receptors, Immunologic""], ""substances"": [""Cytokines"", ""Membrane Glycoproteins"", ""Reactive Oxygen Species"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
DIRECTLY_DECREASES,13168,365,2007,17213958,False,False,False,"The overexpression of constitutively activated Akt, which is a downstream signalling element of the NGF receptor TrkA, delayed mitochondrial collapse and inhibited elevation of AChE activity. Thus, NGF prevented apoptosis and elevation of AChE activity by activating the Akt pathway and stabilizing the function of mitochondria",#59:5,,"{""full_journal_name"": ""Acta biochimica et biophysica Sinica"", ""pub_date"": ""2007-02-21"", ""ref"": ""17213958"", ""pub_year"": 2007, ""last_author"": ""Zhang X"", ""type"": ""PubMed"", ""author_list"": [""Jiang H"", ""Zhang J"", ""Zhu H"", ""Li H"", ""Zhang X""], ""title"": ""Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Akt subgraph"", ""Nerve growth factor subgraph""], ""mesh"": [""Acetylcholinesterase"", ""Animals"", ""Apoptosis"", ""Caspase 3"", ""Cytochromes c"", ""Enzyme Activation"", ""Glutathione"", ""Hydrogen Peroxide"", ""Nerve Growth Factor"", ""PC12 Cells"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Rats""], ""substances"": [""Cytochromes c"", ""Nerve Growth Factor"", ""Hydrogen Peroxide"", ""Proto-Oncogene Proteins c-akt"", ""Acetylcholinesterase"", ""Caspase 3"", ""Glutathione""]}",False
DIRECTLY_DECREASES,11762,28794,2014,24214965,False,False,False,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,#59:5,PMC3965067,"{""full_journal_name"": ""Nucleic acids research"", ""pub_date"": ""2014-03-17"", ""ref"": ""24214965"", ""pub_year"": 2014, ""last_author"": ""Overington JP"", ""type"": ""PubMed"", ""author_list"": [""Bento AP"", ""Gaulton A"", ""Hersey A"", ""Bellis LJ"", ""Chambers J"", ""Davies M"", ""Kr\u00fcger FA"", ""Light Y"", ""Mak L"", ""McGlinchey S"", ""Nowotka M"", ""Papadatos G"", ""Santos R"", ""Overington JP""], ""title"": ""The ChEMBL bioactivity database: an update."", ""doi"": ""10.1093/nar/gkt1031""}","{""Subgraph"": [""Cell cycle subgraph""], ""mesh"": [""Binding Sites"", ""Databases, Chemical"", ""Drug Discovery"", ""Humans"", ""Internet"", ""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""], ""substances"": [""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""]}",False
DIRECTLY_DECREASES,2729,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11666,32340,2012,22496686,False,False,False,"The increase in intracellular copper was correlated with a dramatic and rapid decrease in levels of extracellular ABeta¸ including ABeta¸1Ã¢â‚¬â€œ40 and 1Ã¢â‚¬â€œ42. It has been previously reported that CQ/copper complexes trigger the activation of PI3K and its downstream modulator Akt and the inhibition of glycogen synthase kinase 3 that in turn potentiated ERK1/2 phosphorylation.It is not clear if and how environmental factors take part to pathway discussed in this review, in which both ABeta¸PP and PS1 participate in the same signaling pathway leading, through Grb2 binding, to ERK1/2 activation and neurodegeneration. However, we may speculate that ERK1/2 activation by copper may contribute to the signal transduction system activated by ABeta¸PP, and PSs.",#59:5,PMC3306972,"{""full_journal_name"": ""Journal of toxicology"", ""pub_date"": ""2012-08-23"", ""ref"": ""22496686"", ""pub_year"": 2012, ""last_author"": ""Florio T"", ""type"": ""PubMed"", ""author_list"": [""Nizzari M"", ""Thellung S"", ""Corsaro A"", ""Villa V"", ""Pagano A"", ""Porcile C"", ""Russo C"", ""Florio T""], ""title"": ""Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling."", ""doi"": ""10.1155/2012/187297""}","{""Subgraph"": [""Non-amyloidogenic subgraph""]}",False
DIRECTLY_DECREASES,6187,32340,2012,21800078,False,False,False,"The study also revealed that the nuclear receptor peroxisome proliferators activated receptor γ (PPARγ) played an important role in the CLA-induced intracellular BACE1 decrease, as well as the extracellular sAPPalpha increase through knockdown of PPARγ transcription using siRNA. We hypothesize that CLA acts as an agonist or ligand, which binds with PPARγ and leads to the increase in APP cleavage via alpha-secretase-mediated pathway and the decrease in the deposition of Abeta.",#59:5,,"{""full_journal_name"": ""Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"", ""pub_date"": ""2012-03-30"", ""ref"": ""21800078"", ""pub_year"": 2012, ""last_author"": ""Zhong L"", ""type"": ""PubMed"", ""author_list"": [""Li YC"", ""Chen Q"", ""Wan XZ"", ""Yang XL"", ""Liu X"", ""Zhong L""], ""title"": ""Effects of conjugated linoleic acid on cleavage of amyloid precursor protein via PPAR\u03b3."", ""doi"": ""10.1007/s10072-011-0711-4""}","{""Subgraph"": [""Beta secretase subgraph"", ""Non-amyloidogenic subgraph"", ""Peroxisome proliferator activated receptor subgraph""], ""mesh"": [""ADAM Proteins"", ""ADAM10 Protein"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Analysis of Variance"", ""Aspartic Acid Endopeptidases"", ""Cell Line, Tumor"", ""Cell Survival"", ""Dose-Response Relationship, Drug"", ""Enzyme-Linked Immunosorbent Assay"", ""Gene Expression Regulation, Neoplastic"", ""Humans"", ""Linoleic Acid"", ""Membrane Proteins"", ""Neuroblastoma"", ""PPAR gamma"", ""RNA, Messenger""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Membrane Proteins"", ""PPAR gamma"", ""RNA, Messenger"", ""Linoleic Acid"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human"", ""ADAM Proteins"", ""ADAM10 Protein"", ""ADAM10 protein, human""]}",False
DIRECTLY_DECREASES,8145,4488,2011,22110360,False,False,False,"Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen- activated protein kinase kinase kinase family, is composed of an inhibitory N-terminal domain, a kinase domain, and a C-terminal regulatory domain (Ichijo et al., 1997). ASK1 can promote apoptosis in response to common pro-apoptotic stresses, such as oxidative stress (Song et al., 2002), death receptor ligands (Nishitoh et al., 1998), and endoplasmic reticulum stress (Nishitoh et al., 2002). ASK1 also phosphorylates and activates both p38 and JNK pathways (Ichijo et al., 1997). The mechanism of ASK1 activation is positively regulated by its binding proteins such as TNF receptor-ssociated factors 2/6 (Noguchi et al., 2005) and Daxx (Chang et al., 1998). On the other hand, several cellular proteins, including thioredoxin (Saitoh et al., 1998), Hsp90 (Zhang et al., 2005), and 14-3-3 (Zhang et al., 1999), have been reported to interact with ASK1 and inhibit ASK1 activity.",#58:79,PMC3213740,"{""full_journal_name"": ""Experimental neurobiology"", ""pub_date"": ""2011-11-23"", ""ref"": ""22110360"", ""pub_year"": 2011, ""last_author"": ""Chung KC"", ""type"": ""PubMed"", ""author_list"": [""Choi HK"", ""Chung KC""], ""title"": ""Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death."", ""doi"": ""10.5607/en.2011.20.1.35""}","{""Confidence"": [""High""], ""Published"": [""CDR story""], ""Subgraph"": [""Chaperone subgraph"", ""MAPK-JNK subgraph""]}",False
DIRECTLY_DECREASES,3296,3088,2019,30962309,False,False,False,Overexpression of miR-302b-3p directly downregulates IRAK4 and thereby inhibits NLRP3 expression (63).,#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,1381,3352,2019,30962309,False,False,False,"Several inflammasome-regulating miRNAs are downregulated in SLE: miR-223-3p in naive B cells of SLE patients (112), miR-20a-5p in monocytes (113), and miR-17-5p in PBMCs of adult (114) and pediatric SLE patients (115)",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,1381,3314,2019,30962309,False,False,False,"Several inflammasome-regulating miRNAs are downregulated in SLE: miR-223-3p in naive B cells of SLE patients (112), miR-20a-5p in monocytes (113), and miR-17-5p in PBMCs of adult (114) and pediatric SLE patients (115)",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,44519,5118,2017,27794524,False,False,False,"LINGO1, a CNS-specific membrane glycoprotein that suppresses oligodendrocyte differentiation and myelination, is possibly involved in failure of remyelination and axonal repair in multiple sclerosis (Yong, 2009); blockade of this protein may therefore be effective in promoting remyelination in a clinical setting.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1920,28420,2013,23737518,False,False,False,"Small molecules in the diaminothiazole class are potent Tau kinase inhibitors that target CDK5 and GSK3β. Lead compounds from the series have IC50 values toward CDK5/p25 and GSK3β in the low nanomolar range and no observed toxicity in the therapeutic dose range. Neuronal protective effects and decreased PHF-1 immunoreactivity were observed in two animal models, 3×Tg-AD and CK-p25. Treatment nearly eliminated Sarkosyl-insoluble Tau with the most prominent effect on the phosphorylation at Ser-404. Treatment also induced the recovery of memory in a fear conditioning assay.",#60:23,PMC3724657,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2013-11-04"", ""ref"": ""23737518"", ""pub_year"": 2013, ""last_author"": ""Kosik KS"", ""type"": ""PubMed"", ""author_list"": [""Zhang X"", ""Hernandez I"", ""Rei D"", ""Mair W"", ""Laha JK"", ""Cornwell ME"", ""Cuny GD"", ""Tsai LH"", ""Steen JA"", ""Kosik KS""], ""title"": ""Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models."", ""doi"": ""10.1074/jbc.M112.436402""}","{""Confidence"": [""Medium""], ""Half_life"": [""30 min""], ""IC50"": [""45 nM""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Blotting, Western"", ""Cyclin-Dependent Kinase 5"", ""Diamines"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Injections, Intraperitoneal"", ""Injections, Intraventricular"", ""Injections, Subcutaneous"", ""Learning"", ""Male"", ""Memory"", ""Mice"", ""Mice, Transgenic"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Tauopathies"", ""Thiazoles"", ""Treatment Outcome"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Diamines"", ""Neuroprotective Agents"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Thiazoles"", ""tau Proteins"", ""Cyclin-Dependent Kinase 5"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3""]}",False
DIRECTLY_DECREASES,11853,1844,2017,27794524,False,False,False,"In addition, non-toxic ferric iron is released into the extracellular space from damaged oligodendrocytes in multiple sclerosis lesions, where it undergoes transformation to the divalent ferrous form, further increasing ROS toxicity (Hametner et al., 2013).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""Disease"": [""multiple sclerosis""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,36311,40328,2016,26631930,False,False,False,"Protein phosphatase 1 (PP1), PP2A, PP2B, PP2C and PP5 have all been implicated in the dephosphorylation of tau",#59:49,,"{""full_journal_name"": ""Nature reviews. Neuroscience"", ""pub_date"": ""2016-04-20"", ""ref"": ""26631930"", ""pub_year"": 2016, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Wang Y"", ""Mandelkow E""], ""title"": ""Tau in physiology and pathology."", ""doi"": ""10.1038/nrn.2015.1""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Humans"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,6554,51,2018,28771976,False,False,False,"RGFP966, a selective HDAC3 inhibitor, has been shown to affect sensory cortical plasticity and memory formation (Bieszczad et al., 2015).",#60:23,PMC5595690,"{""full_journal_name"": ""Aging cell"", ""pub_date"": ""2018-05-15"", ""ref"": ""28771976"", ""pub_year"": 2018, ""last_author"": ""Xu Y"", ""type"": ""PubMed"", ""author_list"": [""Zhu X"", ""Wang S"", ""Yu L"", ""Jin J"", ""Ye X"", ""Liu Y"", ""Xu Y""], ""title"": ""HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease."", ""doi"": ""10.1111/acel.12642""}","{""Confidence"": [""Medium""], ""mesh"": [""Acrylamides"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Cell Nucleus"", ""Dendritic Spines"", ""Disease Models, Animal"", ""Gene Expression Regulation"", ""Genetic Vectors"", ""Hippocampus"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Lentivirus"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Phenylenediamines"", ""Phosphorylation"", ""Plaque, Amyloid"", ""tau Proteins""], ""substances"": [""Acrylamides"", ""Amyloid beta-Peptides"", ""Histone Deacetylase Inhibitors"", ""Mapt protein, mouse"", ""Phenylenediamines"", ""RGFP966"", ""tau Proteins"", ""Histone Deacetylases"", ""histone deacetylase 3""]}",False
DIRECTLY_DECREASES,37579,11567,2017,27794524,False,False,False,"If axonal Na+ rises above its nominal concentration, the Na+ /Ca2+ exchanger, normally exchanging axoplasmic Ca2+ for extracellular Na+ , will operate in a reverse Ca2+ importing mode.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11776,30506,2016,26390242,False,False,False,"The acetyl-mimicking mutant K174Q slows tau turnover and induces cognitive deficits in vivo. Acetyltransferase p300-induced tau acetylation is inhibited by salsalate and salicylate, which enhance tau turnover and reduce tau levels. In the PS19 transgenic mouse model of FTD, administration of salsalate after disease onset inhibited p300 activity, lowered levels of total tau and tau acetylated at K174, rescued tau-induced memory deficits and prevented hippocampal atrophy.",#60:23,PMC4598295,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2016-01-19"", ""ref"": ""26390242"", ""pub_year"": 2016, ""last_author"": ""Gan L"", ""type"": ""PubMed"", ""author_list"": [""Min SW"", ""Chen X"", ""Tracy TE"", ""Li Y"", ""Zhou Y"", ""Wang C"", ""Shirakawa K"", ""Minami SS"", ""Defensor E"", ""Mok SA"", ""Sohn PD"", ""Schilling B"", ""Cong X"", ""Ellerby L"", ""Gibson BW"", ""Johnson J"", ""Krogan N"", ""Shamloo M"", ""Gestwicki J"", ""Masliah E"", ""Verdin E"", ""Gan L""], ""title"": ""Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits."", ""doi"": ""10.1038/nm.3951""}","{""Confidence"": [""Medium""], ""Research_Model"": [""PS19 mice""], ""Species"": [""10090""], ""mesh"": [""Acetylation"", ""Animals"", ""Behavior, Animal"", ""Cognition Disorders"", ""Humans"", ""Mice"", ""Neurodegenerative Diseases"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,37439,16546,2019,29334120,False,False,False,"We recently found that overexpression of TDP-43 enhances tau exon 10 inclusion and tau mRNA instability. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion.",#60:23,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2019-01-07"", ""ref"": ""29334120"", ""pub_year"": 2019, ""last_author"": ""Liu F"", ""type"": ""PubMed"", ""author_list"": [""Gu J"", ""Wang W"", ""Miao S"", ""Chen F"", ""Wu F"", ""Hu W"", ""Iqbal K"", ""Gong CX"", ""Liu F""], ""title"": ""Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion."", ""doi"": ""10.1002/1873-3468.12976""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""DNA-Binding Proteins"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Marine Toxins"", ""Okadaic Acid"", ""Oxazoles"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2"", ""Serine"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Marine Toxins"", ""Oxazoles"", ""TARDBP protein, human"", ""tau Proteins"", ""Okadaic Acid"", ""Serine"", ""calyculin A"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,24441,41568,2013,23533697,False,False,False,"In turn, evidence suggests that once activated, caspases may cleave critical cellular proteins in AD including APP, actin, fodrin, glial acidic fibrillary protein, beclin-1, and tau [28, 31–35].",#57:0,PMC3606781,"{""full_journal_name"": ""Oxidative medicine and cellular longevity"", ""pub_date"": ""2013-08-20"", ""ref"": ""23533697"", ""pub_year"": 2013, ""last_author"": ""Rohn TT"", ""type"": ""PubMed"", ""author_list"": [""Rohn TT""], ""title"": ""The triggering receptor expressed on myeloid cells 2: \""TREM-ming\"" the inflammatory component associated with Alzheimer's disease."", ""doi"": ""10.1155/2013/860959""}","{""Section"": [""3. Mechanisms of Neurodegeneration in AD""], ""mesh"": [""Alzheimer Disease"", ""Cytokines"", ""Humans"", ""Inflammation"", ""Membrane Glycoproteins"", ""Microglia"", ""Oxidative Stress"", ""Plaque, Amyloid"", ""Reactive Oxygen Species"", ""Receptors, Immunologic""], ""substances"": [""Cytokines"", ""Membrane Glycoproteins"", ""Reactive Oxygen Species"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
DIRECTLY_DECREASES,40328,13072,2013,23533697,False,False,False,"However, upon hyperphosphorylation and posttranslational cleavage, tau loses its binding affinity for microtubules, leading to a destabilization of the cytoskeleton and self-assembly of tau into tangles of paired helical filaments (PHFs) [16].",#57:0,PMC3606781,"{""full_journal_name"": ""Oxidative medicine and cellular longevity"", ""pub_date"": ""2013-08-20"", ""ref"": ""23533697"", ""pub_year"": 2013, ""last_author"": ""Rohn TT"", ""type"": ""PubMed"", ""author_list"": [""Rohn TT""], ""title"": ""The triggering receptor expressed on myeloid cells 2: \""TREM-ming\"" the inflammatory component associated with Alzheimer's disease."", ""doi"": ""10.1155/2013/860959""}","{""Section"": [""2. Pathology Associated with AD""], ""mesh"": [""Alzheimer Disease"", ""Cytokines"", ""Humans"", ""Inflammation"", ""Membrane Glycoproteins"", ""Microglia"", ""Oxidative Stress"", ""Plaque, Amyloid"", ""Reactive Oxygen Species"", ""Receptors, Immunologic""], ""substances"": [""Cytokines"", ""Membrane Glycoproteins"", ""Reactive Oxygen Species"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
DIRECTLY_DECREASES,21493,30928,2013,23758787,False,False,False,"CYLD, a tumor suppressor and a target gene of NF-κB, negatively regulates NF-κB and JNK activation by removing K63-linked polyubiquitin chains from TRAF2 and TRAF6 as well as several other signaling proteins [214,215].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in cytokine receptor signaling""]}",False
DIRECTLY_DECREASES,3971,32340,2010,20007471,False,False,False,"Using screening approaches in primary neurons, we identified brain- derived neurotrophic factor (BDNF) as a major inducer of Sorla that activates receptor gene transcription through the ERK (extracellular regulated kinase) pathway.These findings demonstrate that the beneficial effects ascribed to BDNF in APP metabolism act through induction of Sorla that encodes a negative regulator of neuronal APP processing",#59:5,PMC6666105,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2010-01-19"", ""ref"": ""20007471"", ""pub_year"": 2010, ""last_author"": ""Willnow TE"", ""type"": ""PubMed"", ""author_list"": [""Rohe M"", ""Synowitz M"", ""Glass R"", ""Paul SM"", ""Nykjaer A"", ""Willnow TE""], ""title"": ""Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression."", ""doi"": ""10.1523/JNEUROSCI.3960-09.2009""}","{""Subgraph"": [""MAPK-ERK subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Animals, Newborn"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Disease Models, Animal"", ""Extracellular Signal-Regulated MAP Kinases"", ""Gene Expression Regulation"", ""Humans"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Membrane Transport Proteins"", ""Mice"", ""Mice, Knockout"", ""Neurons"", ""RNA, Messenger"", ""Receptor, trkB"", ""Receptors, LDL""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Brain-Derived Neurotrophic Factor"", ""Membrane Transport Proteins"", ""RNA, Messenger"", ""Receptors, LDL"", ""Sorl1 protein, mouse"", ""Receptor, trkB"", ""Extracellular Signal-Regulated MAP Kinases"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,11809,6708,2017,27794524,False,False,False,"Recently, two studies reported protective properties of MitoQ, a specific inhibitor for mitochondrial ROS production, in EAE (Davies et al.,2013).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,3959,32340,2009,19355846,False,False,False,Lower-expression of PS1 and over-expression of IDE or NEP may be helpful in potentially lowering brain Abeta levels in subjects with AD,#59:5,,"{""full_journal_name"": ""Current Alzheimer research"", ""pub_date"": ""2009-06-22"", ""ref"": ""19355846"", ""pub_year"": 2009, ""last_author"": ""Wang Y"", ""type"": ""PubMed"", ""author_list"": [""Tian J"", ""Shi J"", ""Zhang L"", ""Yin J"", ""Hu Q"", ""Xu Y"", ""Sheng S"", ""Wang P"", ""Ren Y"", ""Wang R"", ""Wang Y""], ""title"": ""GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.""}","{""Subgraph"": [""Non-amyloidogenic subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Analysis of Variance"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Disease Models, Animal"", ""Donepezil"", ""Drug Therapy, Combination"", ""Drugs, Chinese Herbal"", ""Ginsenosides"", ""Hippocampus"", ""Humans"", ""Indans"", ""Insulysin"", ""Male"", ""Memory"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Mutation"", ""Neprilysin"", ""Neuropsychological Tests"", ""Piperidines"", ""Presenilin-1"", ""Space Perception"", ""Time Factors""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Drugs, Chinese Herbal"", ""Ginsenosides"", ""Indans"", ""Piperidines"", ""Presenilin-1"", ""Donepezil"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Neprilysin"", ""Insulysin""]}",False
DIRECTLY_DECREASES,4196,5034,2005,15817521,False,False,False,"the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARgamma) which acts to inhibit the expression of proinflammatory genes, this receptor appears a good candidate to mediate the observed anti-inflammatory effects",#59:5,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2005-09-13"", ""ref"": ""15817521"", ""pub_year"": 2005, ""last_author"": ""Landreth GE"", ""type"": ""PubMed"", ""author_list"": [""Heneka MT"", ""Sastre M"", ""Dumitrescu-Ozimek L"", ""Hanke A"", ""Dewachter I"", ""Kuiperi C"", ""O'Banion K"", ""Klockgether T"", ""Van Leuven F"", ""Landreth GE""], ""title"": ""Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.""}","{""Subgraph"": [""Inflammatory response subgraph"", ""Peroxisome proliferator activated receptor subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloidosis"", ""Animals"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Aspartic Acid Endopeptidases"", ""Cyclooxygenase 2"", ""Disease Models, Animal"", ""Endopeptidases"", ""Glial Fibrillary Acidic Protein"", ""Hippocampus"", ""Ibuprofen"", ""Immunoenzyme Techniques"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Nitric Oxide Synthase"", ""Nitric Oxide Synthase Type II"", ""PPAR gamma"", ""Peptide Fragments"", ""Pioglitazone"", ""Prostaglandin-Endoperoxide Synthases"", ""RNA, Messenger"", ""Thiazolidinediones""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Glial Fibrillary Acidic Protein"", ""PPAR gamma"", ""Peptide Fragments"", ""RNA, Messenger"", ""Thiazolidinediones"", ""amyloid beta-protein (1-42)"", ""Nitric Oxide Synthase"", ""Nitric Oxide Synthase Type II"", ""Nos2 protein, mouse"", ""Cyclooxygenase 2"", ""Prostaglandin-Endoperoxide Synthases"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Ibuprofen"", ""Pioglitazone""]}",False
DIRECTLY_DECREASES,44271,4488,2011,22110360,False,False,False,"Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen- activated protein kinase kinase kinase family, is composed of an inhibitory N-terminal domain, a kinase domain, and a C-terminal regulatory domain (Ichijo et al., 1997). ASK1 can promote apoptosis in response to common pro-apoptotic stresses, such as oxidative stress (Song et al., 2002), death receptor ligands (Nishitoh et al., 1998), and endoplasmic reticulum stress (Nishitoh et al., 2002). ASK1 also phosphorylates and activates both p38 and JNK pathways (Ichijo et al., 1997). The mechanism of ASK1 activation is positively regulated by its binding proteins such as TNF receptor-ssociated factors 2/6 (Noguchi et al., 2005) and Daxx (Chang et al., 1998). On the other hand, several cellular proteins, including thioredoxin (Saitoh et al., 1998), Hsp90 (Zhang et al., 2005), and 14-3-3 (Zhang et al., 1999), have been reported to interact with ASK1 and inhibit ASK1 activity.",#58:79,PMC3213740,"{""full_journal_name"": ""Experimental neurobiology"", ""pub_date"": ""2011-11-23"", ""ref"": ""22110360"", ""pub_year"": 2011, ""last_author"": ""Chung KC"", ""type"": ""PubMed"", ""author_list"": [""Choi HK"", ""Chung KC""], ""title"": ""Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death."", ""doi"": ""10.5607/en.2011.20.1.35""}","{""Confidence"": [""High""], ""Published"": [""CDR story""], ""Subgraph"": [""Chaperone subgraph"", ""MAPK-JNK subgraph""]}",False
DIRECTLY_DECREASES,3356,7238,2019,30962309,False,False,False,The miR-146a-5p–deficient mice developed a more severe phenotype of gouty arthritis (64).,#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,1235,3343,2019,30962309,False,False,False,The expression level of miR-7-5p is decreased in the serum of patients with PD (52).,#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Serum""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,1381,3299,2019,30962309,False,False,False,"Several inflammasome-regulating miRNAs are downregulated in SLE: miR-223-3p in naive B cells of SLE patients (112), miR-20a-5p in monocytes (113), and miR-17-5p in PBMCs of adult (114) and pediatric SLE patients (115)",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,38960,1214,2017,27794524,False,False,False,"Increased sex hormone levels in females may protect against grey matter atrophy (Cutter et al., 2006). In contrast, testosterone was shown to amplify oligodendrocyte excitotoxicity, potentially limiting remyelination (Caruso et al., 2004).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""central nervous system gray matter layer""], ""Gender"": [""Female""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,35288,40328,2016,26631930,False,False,False,"Protein phosphatase 1 (PP1), PP2A, PP2B, PP2C and PP5 have all been implicated in the dephosphorylation of tau",#59:49,,"{""full_journal_name"": ""Nature reviews. Neuroscience"", ""pub_date"": ""2016-04-20"", ""ref"": ""26631930"", ""pub_year"": 2016, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Wang Y"", ""Mandelkow E""], ""title"": ""Tau in physiology and pathology."", ""doi"": ""10.1038/nrn.2015.1""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Humans"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,14251,40917,2017,27794524,False,False,False,"Masitinib is a selective tyrosine kinase inhibitor controlling mast cell degranulation, NO-mediated damage, and dendritic cell activity (Dubreuil et al., 2009).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,40891,40328,2016,26631930,False,False,False,"Protein phosphatase 1 (PP1), PP2A, PP2B, PP2C and PP5 have all been implicated in the dephosphorylation of tau",#59:49,,"{""full_journal_name"": ""Nature reviews. Neuroscience"", ""pub_date"": ""2016-04-20"", ""ref"": ""26631930"", ""pub_year"": 2016, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Wang Y"", ""Mandelkow E""], ""title"": ""Tau in physiology and pathology."", ""doi"": ""10.1038/nrn.2015.1""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Humans"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,6776,28420,2013,23737518,False,False,False,"Small molecules in the diaminothiazole class are potent Tau kinase inhibitors that target CDK5 and GSK3β. Lead compounds from the series have IC50 values toward CDK5/p25 and GSK3β in the low nanomolar range and no observed toxicity in the therapeutic dose range. Neuronal protective effects and decreased PHF-1 immunoreactivity were observed in two animal models, 3×Tg-AD and CK-p25. Treatment nearly eliminated Sarkosyl-insoluble Tau with the most prominent effect on the phosphorylation at Ser-404. Treatment also induced the recovery of memory in a fear conditioning assay.",#60:23,PMC3724657,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2013-11-04"", ""ref"": ""23737518"", ""pub_year"": 2013, ""last_author"": ""Kosik KS"", ""type"": ""PubMed"", ""author_list"": [""Zhang X"", ""Hernandez I"", ""Rei D"", ""Mair W"", ""Laha JK"", ""Cornwell ME"", ""Cuny GD"", ""Tsai LH"", ""Steen JA"", ""Kosik KS""], ""title"": ""Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models."", ""doi"": ""10.1074/jbc.M112.436402""}","{""Confidence"": [""Medium""], ""Half_life"": [""29 min""], ""IC50"": [""19 nM""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Blotting, Western"", ""Cyclin-Dependent Kinase 5"", ""Diamines"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Injections, Intraperitoneal"", ""Injections, Intraventricular"", ""Injections, Subcutaneous"", ""Learning"", ""Male"", ""Memory"", ""Mice"", ""Mice, Transgenic"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Tauopathies"", ""Thiazoles"", ""Treatment Outcome"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Diamines"", ""Neuroprotective Agents"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Thiazoles"", ""tau Proteins"", ""Cyclin-Dependent Kinase 5"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3""]}",False
DIRECTLY_DECREASES,44519,2413,2017,27794524,False,False,False,"LINGO1, a CNS-specific membrane glycoprotein that suppresses oligodendrocyte differentiation and myelination, is possibly involved in failure of remyelination and axonal repair in multiple sclerosis (Yong, 2009); blockade of this protein may therefore be effective in promoting remyelination in a clinical setting.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1748,19086,2011,21427723,False,False,False,"Although low-level tau acetylation was observed in untreated HEK-T40 cells, treatment with the pan histone deacetylase (HDAC) inhibitor trichostatin A (TSA), but not the Sir2 class inhibitor nicotinamide, resulted in a dramatic increase in acetylated tau levels.",#60:23,PMC3120096,"{""full_journal_name"": ""Nature communications"", ""pub_date"": ""2011-08-01"", ""ref"": ""21427723"", ""pub_year"": 2011, ""last_author"": ""Lee VM"", ""type"": ""PubMed"", ""author_list"": [""Cohen TJ"", ""Guo JL"", ""Hurtado DE"", ""Kwong LK"", ""Mills IP"", ""Trojanowski JQ"", ""Lee VM""], ""title"": ""The acetylation of tau inhibits its function and promotes pathological tau aggregation."", ""doi"": ""10.1038/ncomms1255""}","{""Cell_Line"": [""HEK293""], ""Confidence"": [""High""], ""mesh"": [""Acetylation"", ""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Animals"", ""Brain"", ""Female"", ""HEK293 Cells"", ""Humans"", ""Immunohistochemistry"", ""Lysine"", ""Male"", ""Mass Spectrometry"", ""Membrane Proteins"", ""Mice"", ""Mice, Transgenic"", ""Microtomy"", ""Microtubules"", ""Middle Aged"", ""Neurons"", ""Phosphorylation"", ""Protein Binding"", ""Protein Processing, Post-Translational"", ""Recombinant Proteins"", ""Transfection""], ""substances"": [""Membrane Proteins"", ""Recombinant Proteins"", ""tau 40 protein, human"", ""Lysine""]}",False
DIRECTLY_DECREASES,3506,38739,2019,29334120,False,False,False,"We recently found that overexpression of TDP-43 enhances tau exon 10 inclusion and tau mRNA instability. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion.",#60:23,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2019-01-07"", ""ref"": ""29334120"", ""pub_year"": 2019, ""last_author"": ""Liu F"", ""type"": ""PubMed"", ""author_list"": [""Gu J"", ""Wang W"", ""Miao S"", ""Chen F"", ""Wu F"", ""Hu W"", ""Iqbal K"", ""Gong CX"", ""Liu F""], ""title"": ""Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion."", ""doi"": ""10.1002/1873-3468.12976""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""DNA-Binding Proteins"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Marine Toxins"", ""Okadaic Acid"", ""Oxazoles"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2"", ""Serine"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Marine Toxins"", ""Oxazoles"", ""TARDBP protein, human"", ""tau Proteins"", ""Okadaic Acid"", ""Serine"", ""calyculin A"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,24441,12721,2013,23533697,False,False,False,"In turn, evidence suggests that once activated, caspases may cleave critical cellular proteins in AD including APP, actin, fodrin, glial acidic fibrillary protein, beclin-1, and tau [28, 31–35].",#57:0,PMC3606781,"{""full_journal_name"": ""Oxidative medicine and cellular longevity"", ""pub_date"": ""2013-08-20"", ""ref"": ""23533697"", ""pub_year"": 2013, ""last_author"": ""Rohn TT"", ""type"": ""PubMed"", ""author_list"": [""Rohn TT""], ""title"": ""The triggering receptor expressed on myeloid cells 2: \""TREM-ming\"" the inflammatory component associated with Alzheimer's disease."", ""doi"": ""10.1155/2013/860959""}","{""Section"": [""3. Mechanisms of Neurodegeneration in AD""], ""mesh"": [""Alzheimer Disease"", ""Cytokines"", ""Humans"", ""Inflammation"", ""Membrane Glycoproteins"", ""Microglia"", ""Oxidative Stress"", ""Plaque, Amyloid"", ""Reactive Oxygen Species"", ""Receptors, Immunologic""], ""substances"": [""Cytokines"", ""Membrane Glycoproteins"", ""Reactive Oxygen Species"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
DIRECTLY_DECREASES,2137,6743,2016,26582367,False,False,False,SOD1 and Trolox scavenged the amyloid-β1–42 triggered superoxide molecules (Fig. 6d).,#57:0,PMC4652165,"{""full_journal_name"": ""Scientific reports"", ""pub_date"": ""2016-09-12"", ""ref"": ""26582367"", ""pub_year"": 2016, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Shahraz A"", ""Kopatz J"", ""Mathy R"", ""Kappler J"", ""Winter D"", ""Kapoor S"", ""Sch\u00fctza V"", ""Scheper T"", ""Gieselmann V"", ""Neumann H""], ""title"": ""Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages."", ""doi"": ""10.1038/srep16800""}","{""ChallengeType"": [""amyloid-\u03b21\u201342""], ""MeSHAnatomy"": [""Macrophages""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Cell Line"", ""Chromatography, High Pressure Liquid"", ""Homeostasis"", ""Humans"", ""Lectins"", ""Lipopolysaccharides"", ""Macrophages"", ""Membrane Proteins"", ""Microspheres"", ""Molecular Weight"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Polymerization"", ""Respiratory Burst"", ""Sialic Acids"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neuroprotective Agents"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""TNF protein, human"", ""Tumor Necrosis Factor-alpha"", ""polysialic acid""]}",False
DIRECTLY_DECREASES,6987,8105,2016,26582367,False,False,False,We incubated human macrophages with biotinylated fibrillary amyloid-β1–42 and visualized the uptake into the cells by confocal microscopy and 3D-reconstruction (Fig. 6a). PolySia avDP20 slightly reduced the uptake of amyloid-β1–42 into macrophages.,#57:0,PMC4652165,"{""full_journal_name"": ""Scientific reports"", ""pub_date"": ""2016-09-12"", ""ref"": ""26582367"", ""pub_year"": 2016, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Shahraz A"", ""Kopatz J"", ""Mathy R"", ""Kappler J"", ""Winter D"", ""Kapoor S"", ""Sch\u00fctza V"", ""Scheper T"", ""Gieselmann V"", ""Neumann H""], ""title"": ""Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages."", ""doi"": ""10.1038/srep16800""}","{""PublicationType"": [""Research""], ""Section"": [""Results""], ""TechnologyUsed"": [""Confocal Microscopy""], ""mesh"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Cell Line"", ""Chromatography, High Pressure Liquid"", ""Homeostasis"", ""Humans"", ""Lectins"", ""Lipopolysaccharides"", ""Macrophages"", ""Membrane Proteins"", ""Microspheres"", ""Molecular Weight"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Polymerization"", ""Respiratory Burst"", ""Sialic Acids"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neuroprotective Agents"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""TNF protein, human"", ""Tumor Necrosis Factor-alpha"", ""polysialic acid""]}",False
DIRECTLY_DECREASES,32340,15159,2011,20847424,False,False,False,"Mitochondrial Aï¿½-binding alcohol dehydrogenase (ABAD): ABAD is a member of the short chain dehydrogenase reductase family in mitochondria that binds Aï¿½. Binding of Aï¿½ to ABAD distorts the enzymeï¿½s structure, rendering it inactive. In neurons, ABAD is predominately localized to mitochondria. Upon binding ABAD, Aï¿½ triggers events leading to neuronal apoptosis through a mitochondrial pathway.Interestingly, mitochondrial ABAD is upregulated in neurons from AD patients. The ABAD-Aï¿½ complex has been hypothesized to induce oxidant stress and mitochondrial dysfunction. Increased expression of ABAD exacerbates Aï¿½-mediated mitochondrial and neuronal stress. Aï¿½ binding to ABAD causes free radical production and neuronal apoptotic process",#59:5,PMC3079354,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2011-06-09"", ""ref"": ""20847424"", ""pub_year"": 2011, ""last_author"": ""Brewer GJ"", ""type"": ""PubMed"", ""author_list"": [""Parihar MS"", ""Brewer GJ""], ""title"": ""Amyloid-\u03b2 as a modulator of synaptic plasticity."", ""doi"": ""10.3233/JAD-2010-101020""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Free radical formation subgraph"", ""Metabolism of steroid hormones subgraph"", ""Mitochondrial translocation subgraph""], ""mesh"": [""Aging"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Humans"", ""Neuronal Plasticity"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides""]}",False
DIRECTLY_DECREASES,26674,7105,2019,30962309,False,False,False,"The resulting duplex is incorporated into an Argonaute protein and unwound so that only one strand (i.e., the mature miRNA) is kept in the RNA-induced silencing complex, which targets transcripts with matching sequences for degradation and prevents translation into proteins (25, 29, 30).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,14467,5394,2017,27794524,False,False,False,"Laquinimod, an emerging oral medication for multiple sclerosis (see below) with significant CNS impact, reduces astrocyte activation (Bruck et al., 2012), and inhibits microglial activation in human brain cell cultures.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain""], ""Species"": [""9606""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11762,8241,2014,24214965,False,False,False,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,#59:5,PMC3965067,"{""full_journal_name"": ""Nucleic acids research"", ""pub_date"": ""2014-03-17"", ""ref"": ""24214965"", ""pub_year"": 2014, ""last_author"": ""Overington JP"", ""type"": ""PubMed"", ""author_list"": [""Bento AP"", ""Gaulton A"", ""Hersey A"", ""Bellis LJ"", ""Chambers J"", ""Davies M"", ""Kr\u00fcger FA"", ""Light Y"", ""Mak L"", ""McGlinchey S"", ""Nowotka M"", ""Papadatos G"", ""Santos R"", ""Overington JP""], ""title"": ""The ChEMBL bioactivity database: an update."", ""doi"": ""10.1093/nar/gkt1031""}","{""Subgraph"": [""Cell cycle subgraph""], ""mesh"": [""Binding Sites"", ""Databases, Chemical"", ""Drug Discovery"", ""Humans"", ""Internet"", ""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""], ""substances"": [""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""]}",False
DIRECTLY_DECREASES,25240,24158,2012,21769591,False,False,False,"The ApoE gene responsible for the Alzheimer's disease has been examined to identify functional consequences of single-nucleotide polymorphisms (SNPs). Eighty-eight SNPs have been identified in the ApoE gene in which 31 are found to be nonsynonymous, 8 of them are coding synonymous, 33 are found to be in intron, and 3 are in untranslated region. The SNPs found in the untranslated region consisted of two SNPs from 5' and one SNP from the 3'. Twenty-nine percent of the identified nsSNPs have been reported as damaging. In the analysis of SNPs in the UTR regions, it has been recognized that rs72654467 from 5' and rs71673244 from 5' and 3' are responsible for the alteration in levels of expression. Both native and mutant protein structures were analyzed along with the stabilization residues. It has been concluded that among all SNPs of ApoE, the mutation in rs11542041 (R132S) has the most significant effect on functional variation.",#64:44,,"{""full_journal_name"": ""Functional & integrative genomics"", ""pub_date"": ""2012-03-06"", ""ref"": ""21769591"", ""pub_year"": 2012, ""last_author"": ""Nidheesh M"", ""type"": ""PubMed"", ""author_list"": [""Namboori PK"", ""Vineeth KV"", ""Rohith V"", ""Hassan I"", ""Sekhar L"", ""Sekhar A"", ""Nidheesh M""], ""title"": ""The ApoE gene of Alzheimer's disease (AD)."", ""doi"": ""10.1007/s10142-011-0238-z""}","{""Confidence"": [""Very High""], ""Disease"": [""Alzheimer's disease""], ""Subgraph"": [""APOE subgraph"", ""Amyloidogenic subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amino Acid Substitution"", ""Apolipoproteins E"", ""Computer Simulation"", ""Humans"", ""Models, Genetic"", ""Polymorphism, Single Nucleotide""], ""substances"": [""Apolipoproteins E""]}",False
DIRECTLY_DECREASES,8150,5228,2019,30962309,False,False,False,"IL-1R2, a receptor that inhibits IL-1 signaling in a competitive manner (67), is downregulated by miR-383-3p (68).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,1596,3303,2019,30962309,False,False,False,"Moreover, miR-22-3p is downregulated in whole blood of newly diagnosed and in treated PD patients compared with healthy controls (126), and miR-34c-3p is downregulated in brain areas of PD patients with neuropathological lesions (127).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""MeSHAnatomy"": [""Brain""], ""MeSHDisease"": [""Parkinson Disease""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,2729,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11298,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,7540,25138,2017,28669544,False,False,False,"Specifically, PSD95, a scaffold protein located in dendritic spines, was significantly reduced (Figure 3F), while levels of MAP2, a dendritic structural protein, were comparable between WT and cKO mice",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""CellStructure"": [""Dendritic Spines""], ""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
DIRECTLY_DECREASES,31728,35322,2019,29226865,False,False,False,"We found that SIRT1 interacts with and deacetylates SC35, and inhibits SC35-promoted tau exon 10 inclusion. Substituting K52 residue of SC35 by arginine impairs the role of SC35 in tau exon 10 inclusion. These results suggest that SIRT1 may serve as a therapeutic target for tauopathy by regulating SC35-mediated tau exon 10 splicing.",#60:23,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2019-01-15"", ""ref"": ""29226865"", ""pub_year"": 2019, ""last_author"": ""Qian W"", ""type"": ""PubMed"", ""author_list"": [""Yin X"", ""Jiang X"", ""Wang J"", ""Qian S"", ""Liu F"", ""Qian W""], ""title"": ""SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion."", ""doi"": ""10.3233/JAD-170418""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""Alzheimer Disease"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Phosphorylation"", ""Ribonucleoproteins"", ""Serine-Arginine Splicing Factors"", ""Sirtuin 1"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""Ribonucleoproteins"", ""tau Proteins"", ""SRSF2 protein, human"", ""Serine-Arginine Splicing Factors"", ""SIRT1 protein, human"", ""Sirtuin 1""]}",False
DIRECTLY_DECREASES,37579,14470,2017,27794524,False,False,False,"If axonal Na+ rises above its nominal concentration, the Na+ /Ca2+ exchanger, normally exchanging axoplasmic Ca2+ for extracellular Na+ , will operate in a reverse Ca2+ importing mode.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,42894,11034,2017,27209302,False,False,False,"SIRT1 inhibitor NAM exerted a greater impact on increases of acetylation status of TFEB than HDACI/II/IV inhibitors TSA, indicating that TFEB is specifically acetylated by SIRT1 rather than other HDACs (Fig. 4E).",#68:6,PMC4887328,"{""full_journal_name"": ""Protein & cell"", ""pub_date"": ""2017-04-20"", ""ref"": ""27209302"", ""pub_year"": 2017, ""last_author"": ""Ji J"", ""type"": ""PubMed"", ""author_list"": [""Bao J"", ""Zheng L"", ""Zhang Q"", ""Li X"", ""Zhang X"", ""Li Z"", ""Bai X"", ""Zhang Z"", ""Huo W"", ""Zhao X"", ""Shang S"", ""Wang Q"", ""Zhang C"", ""Ji J""], ""title"": ""Deacetylation of TFEB promotes fibrillar A\u03b2 degradation by upregulating lysosomal biogenesis in microglia."", ""doi"": ""10.1007/s13238-016-0269-2""}","{""CellLine"": [""HEK293T""], ""Confidence"": [""High""], ""MeSHDisease"": [""Alzheimer Disease""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Brain"", ""Cells, Cultured"", ""Chloride Channels"", ""Disease Models, Animal"", ""HEK293 Cells"", ""Humans"", ""Lysosomes"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Mutagenesis, Site-Directed"", ""Peptides"", ""Protein Binding"", ""RNA Interference"", ""Sirtuin 1""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Basic Helix-Loop-Helix Leucine Zipper Transcription Factors"", ""Chloride Channels"", ""Peptides"", ""TFEB protein, human"", ""Sirtuin 1""]}",False
DIRECTLY_DECREASES,30332,36595,2014,24078628,False,False,False,The pulldown of biotinylated proteins and subsequent detection of TREM2 FL or its CTF demonstrated a strong accumulation of the TREM2 CTF and a less pronounced increase of TREM2 FL at the cell surface upon γ-secretase inhibition (Fig. 3A).,#57:0,PMC3829152,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2014-01-23"", ""ref"": ""24078628"", ""pub_year"": 2014, ""last_author"": ""Walter J"", ""type"": ""PubMed"", ""author_list"": [""Wunderlich P"", ""Glebov K"", ""Kemmerling N"", ""Tien NT"", ""Neumann H"", ""Walter J""], ""title"": ""Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage."", ""doi"": ""10.1074/jbc.M113.517540""}","{""Section"": [""Results""], ""mesh"": [""Adaptor Proteins, Signal Transducing"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Animals"", ""COS Cells"", ""Cell Membrane"", ""Chlorocebus aethiops"", ""HEK293 Cells"", ""Humans"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Phosphorylation"", ""Protein Structure, Tertiary"", ""Proteolysis"", ""Receptors, Immunologic"", ""Signal Transduction""], ""substances"": [""Adaptor Proteins, Signal Transducing"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Receptors, Immunologic"", ""TREM2 protein, human"", ""TYROBP protein, human"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,11657,30506,2010,20869593,False,False,False,"Next, we treated primary neurons with C646, a pyrazolone-containing small-molecule inhibitor of p300 with a Ki of 400 nM (Bowers et al., 2010). Under cell-free conditions, C646 at 10 μM inhibits p300 in a highly selective manner (86% inhibition vs. <10% for the six other acetyltransferases) (Bowers et al., 2010). Inhibition of p300 with C646 (20 μM) drastically reduced levels of ac-tau in primary neurons within 8 h.",#60:23,PMC3035103,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2010-10-15"", ""ref"": ""20869593"", ""pub_year"": 2010, ""last_author"": ""Gan L"", ""type"": ""PubMed"", ""author_list"": [""Min SW"", ""Cho SH"", ""Zhou Y"", ""Schroeder S"", ""Haroutunian V"", ""Seeley WW"", ""Huang EJ"", ""Shen Y"", ""Masliah E"", ""Mukherjee C"", ""Meyers D"", ""Cole PA"", ""Ott M"", ""Gan L""], ""title"": ""Acetylation of tau inhibits its degradation and contributes to tauopathy."", ""doi"": ""10.1016/j.neuron.2010.08.044""}","{""Confidence"": [""Medium""], ""mesh"": [""Acetylation"", ""Analysis of Variance"", ""Animals"", ""Animals, Newborn"", ""Carbazoles"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Cycloheximide"", ""Disease Models, Animal"", ""Enzyme Inhibitors"", ""Gene Expression Regulation"", ""Humans"", ""Immunoprecipitation"", ""Mice"", ""Mice, Transgenic"", ""Models, Biological"", ""Mutation"", ""Neurons"", ""Phosphorylation"", ""Protein Synthesis Inhibitors"", ""Rats"", ""Rats, Sprague-Dawley"", ""Sirtuin 1"", ""Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization"", ""Tauopathies"", ""Time Factors"", ""Transfection"", ""Ubiquitination"", ""p300-CBP Transcription Factors"", ""tau Proteins""], ""substances"": [""6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide"", ""Carbazoles"", ""Enzyme Inhibitors"", ""MAPT protein, human"", ""Protein Synthesis Inhibitors"", ""tau Proteins"", ""Cycloheximide"", ""p300-CBP Transcription Factors"", ""p300-CBP-associated factor"", ""SIRT1 protein, human"", ""Sirtuin 1""]}",False
DIRECTLY_DECREASES,3506,32534,2019,29334120,False,False,False,"We recently found that overexpression of TDP-43 enhances tau exon 10 inclusion and tau mRNA instability. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion.",#60:23,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2019-01-07"", ""ref"": ""29334120"", ""pub_year"": 2019, ""last_author"": ""Liu F"", ""type"": ""PubMed"", ""author_list"": [""Gu J"", ""Wang W"", ""Miao S"", ""Chen F"", ""Wu F"", ""Hu W"", ""Iqbal K"", ""Gong CX"", ""Liu F""], ""title"": ""Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion."", ""doi"": ""10.1002/1873-3468.12976""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""DNA-Binding Proteins"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Marine Toxins"", ""Okadaic Acid"", ""Oxazoles"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2"", ""Serine"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Marine Toxins"", ""Oxazoles"", ""TARDBP protein, human"", ""tau Proteins"", ""Okadaic Acid"", ""Serine"", ""calyculin A"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,24441,29425,2013,23533697,False,False,False,"In turn, evidence suggests that once activated, caspases may cleave critical cellular proteins in AD including APP, actin, fodrin, glial acidic fibrillary protein, beclin-1, and tau [28, 31–35].",#57:0,PMC3606781,"{""full_journal_name"": ""Oxidative medicine and cellular longevity"", ""pub_date"": ""2013-08-20"", ""ref"": ""23533697"", ""pub_year"": 2013, ""last_author"": ""Rohn TT"", ""type"": ""PubMed"", ""author_list"": [""Rohn TT""], ""title"": ""The triggering receptor expressed on myeloid cells 2: \""TREM-ming\"" the inflammatory component associated with Alzheimer's disease."", ""doi"": ""10.1155/2013/860959""}","{""Section"": [""3. Mechanisms of Neurodegeneration in AD""], ""mesh"": [""Alzheimer Disease"", ""Cytokines"", ""Humans"", ""Inflammation"", ""Membrane Glycoproteins"", ""Microglia"", ""Oxidative Stress"", ""Plaque, Amyloid"", ""Reactive Oxygen Species"", ""Receptors, Immunologic""], ""substances"": [""Cytokines"", ""Membrane Glycoproteins"", ""Reactive Oxygen Species"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
DIRECTLY_DECREASES,10636,43537,2013,22615186,False,False,False,"On ligand binding, ITIM‐signaling receptors recruit SH2 domain‐containing inositol 5′‐phosphatase (SHIP) and SH2 domain‐containing tyrosine phosphatases (SHP1 and SHP2) which in turn can terminate the function of various signaling pathways by the dephosphorylation of signaling intermediates (Fig. 1; Cao et al.,2009; Crocker et al.,2007; Flannagan et al.,2011; Linnartz et al.,2010; Lowell,2011; Salminen and Kaarniranta,2009).",#57:0,,"{""full_journal_name"": ""Glia"", ""pub_date"": ""2013-09-04"", ""ref"": ""22615186"", ""pub_year"": 2013, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Linnartz B"", ""Neumann H""], ""title"": ""Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx."", ""doi"": ""10.1002/glia.22359""}","{""PublicationType"": [""Review""], ""Section"": [""ITAM SIGNALING FOR PHAGOCYTOSIS""], ""mesh"": [""Animals"", ""Glycocalyx"", ""Humans"", ""Immunoreceptor Tyrosine-Based Activation Motif"", ""Immunoreceptor Tyrosine-Based Inhibition Motif"", ""Microglia"", ""Neurons"", ""Signal Transduction""]}",False
DIRECTLY_DECREASES,41150,6743,2016,26582367,False,False,False,SOD1 and Trolox scavenged the amyloid-β1–42 triggered superoxide molecules (Fig. 6d).,#57:0,PMC4652165,"{""full_journal_name"": ""Scientific reports"", ""pub_date"": ""2016-09-12"", ""ref"": ""26582367"", ""pub_year"": 2016, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Shahraz A"", ""Kopatz J"", ""Mathy R"", ""Kappler J"", ""Winter D"", ""Kapoor S"", ""Sch\u00fctza V"", ""Scheper T"", ""Gieselmann V"", ""Neumann H""], ""title"": ""Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages."", ""doi"": ""10.1038/srep16800""}","{""ChallengeType"": [""amyloid-\u03b21\u201342""], ""MeSHAnatomy"": [""Macrophages""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Cell Line"", ""Chromatography, High Pressure Liquid"", ""Homeostasis"", ""Humans"", ""Lectins"", ""Lipopolysaccharides"", ""Macrophages"", ""Membrane Proteins"", ""Microspheres"", ""Molecular Weight"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Polymerization"", ""Respiratory Burst"", ""Sialic Acids"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neuroprotective Agents"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""TNF protein, human"", ""Tumor Necrosis Factor-alpha"", ""polysialic acid""]}",False
DIRECTLY_DECREASES,14440,5351,2007,17213958,False,False,False,Hydrogen peroxide was reported to initiate the apoptotic cascade by perturbing the intracellular redox balance. GSH is the most abundant low molecular weight thiol that maintains cellular redox homeostasis,#59:5,,"{""full_journal_name"": ""Acta biochimica et biophysica Sinica"", ""pub_date"": ""2007-02-21"", ""ref"": ""17213958"", ""pub_year"": 2007, ""last_author"": ""Zhang X"", ""type"": ""PubMed"", ""author_list"": [""Jiang H"", ""Zhang J"", ""Zhu H"", ""Li H"", ""Zhang X""], ""title"": ""Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Hydrogen peroxide subgraph""], ""mesh"": [""Acetylcholinesterase"", ""Animals"", ""Apoptosis"", ""Caspase 3"", ""Cytochromes c"", ""Enzyme Activation"", ""Glutathione"", ""Hydrogen Peroxide"", ""Nerve Growth Factor"", ""PC12 Cells"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Rats""], ""substances"": [""Cytochromes c"", ""Nerve Growth Factor"", ""Hydrogen Peroxide"", ""Proto-Oncogene Proteins c-akt"", ""Acetylcholinesterase"", ""Caspase 3"", ""Glutathione""]}",False
DIRECTLY_DECREASES,11762,24415,2014,24214965,False,False,False,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,#59:5,PMC3965067,"{""full_journal_name"": ""Nucleic acids research"", ""pub_date"": ""2014-03-17"", ""ref"": ""24214965"", ""pub_year"": 2014, ""last_author"": ""Overington JP"", ""type"": ""PubMed"", ""author_list"": [""Bento AP"", ""Gaulton A"", ""Hersey A"", ""Bellis LJ"", ""Chambers J"", ""Davies M"", ""Kr\u00fcger FA"", ""Light Y"", ""Mak L"", ""McGlinchey S"", ""Nowotka M"", ""Papadatos G"", ""Santos R"", ""Overington JP""], ""title"": ""The ChEMBL bioactivity database: an update."", ""doi"": ""10.1093/nar/gkt1031""}","{""Subgraph"": [""Regulation of actin cytoskeleton subgraph""], ""mesh"": [""Binding Sites"", ""Databases, Chemical"", ""Drug Discovery"", ""Humans"", ""Internet"", ""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""], ""substances"": [""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""]}",False
DIRECTLY_DECREASES,11809,1535,2017,27794524,False,False,False,"Because levels of inflammation were not affected by MitoQ, it is conceivable that increased mitochondrial protection against ROS is sufficient to reduce axonal damage.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11762,24032,2014,24214965,False,False,False,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,#59:5,PMC3965067,"{""full_journal_name"": ""Nucleic acids research"", ""pub_date"": ""2014-03-17"", ""ref"": ""24214965"", ""pub_year"": 2014, ""last_author"": ""Overington JP"", ""type"": ""PubMed"", ""author_list"": [""Bento AP"", ""Gaulton A"", ""Hersey A"", ""Bellis LJ"", ""Chambers J"", ""Davies M"", ""Kr\u00fcger FA"", ""Light Y"", ""Mak L"", ""McGlinchey S"", ""Nowotka M"", ""Papadatos G"", ""Santos R"", ""Overington JP""], ""title"": ""The ChEMBL bioactivity database: an update."", ""doi"": ""10.1093/nar/gkt1031""}","{""Subgraph"": [""Cell cycle subgraph""], ""mesh"": [""Binding Sites"", ""Databases, Chemical"", ""Drug Discovery"", ""Humans"", ""Internet"", ""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""], ""substances"": [""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""]}",False
DIRECTLY_DECREASES,1658,3193,2017,28148553,False,False,False,"In the presence of annonacin, mRNA levels of the tau splicing factor SRSF2 increased (Fig 3F). Interestingly, the PERK activator blocked this effect.",#59:55,PMC5331260,"{""full_journal_name"": ""EMBO molecular medicine"", ""pub_date"": ""2017-10-04"", ""ref"": ""28148553"", ""pub_year"": 2017, ""last_author"": ""H\u00f6glinger GU"", ""type"": ""PubMed"", ""author_list"": [""Bruch J"", ""Xu H"", ""R\u00f6sler TW"", ""De Andrade A"", ""Kuhn PH"", ""Lichtenthaler SF"", ""Arzberger T"", ""Winklhofer KF"", ""M\u00fcller U"", ""H\u00f6glinger GU""], ""title"": {""#text"": ""PERK activation mitigates tau pathology  and ."", ""i"": [""in\u00a0vitro"", ""in\u00a0vivo""]}, ""doi"": ""10.15252/emmm.201606664""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Brain"", ""Cell Survival"", ""Cells, Cultured"", ""Humans"", ""Locomotion"", ""Memory"", ""Mice, Transgenic"", ""Phosphorylation"", ""Protein Conformation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""eIF-2 Kinase"", ""tau Proteins""], ""substances"": [""MAPT protein, human"", ""tau Proteins"", ""EIF2AK3 protein, human"", ""eIF-2 Kinase""]}",False
DIRECTLY_DECREASES,3346,3088,2019,30962309,False,False,False,Overexpression of miR-9-5p inhibits NLRP3 inflammasome priming in atherosclerosis inflammation models using human THP-1–derived macrophages and primary peripheral blood monocytes (72),#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Cell"": [""macrophage"", ""peripheral blood mononuclear cell""], ""CellLine"": [""THP-1""], ""Confidence"": [""High""], ""MeSHDisease"": [""Atherosclerosis""], ""Species"": [""9606""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,14202,7180,2017,27956442,False,False,False,"If the relapse is of moderate functional severity or worse, then high- dose methylprednisolone therapy should be considered, at a dose of 500–1,000 mg per day for 3–5 days as per local guidelines.",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,14467,5394,2017,27794524,False,False,False,"Laquinimod, an emerging oral medication for multiple sclerosis (see below) with significant CNS impact, reduces astrocyte activation (Bruck et al., 2012), and inhibits microglial activation in human brain cell cultures.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""MeSHAnatomy"": [""Brain""], ""Species"": [""9606""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,15000,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,44519,2413,2017,27794524,False,False,False,"LINGO1, a CNS-specific membrane glycoprotein that suppresses oligodendrocyte differentiation and myelination, is possibly involved in failure of remyelination and axonal repair in multiple sclerosis (Yong, 2009); blockade of this protein may therefore be effective in promoting remyelination in a clinical setting.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,6776,30128,2013,23737518,False,False,False,"Small molecules in the diaminothiazole class are potent Tau kinase inhibitors that target CDK5 and GSK3β. Lead compounds from the series have IC50 values toward CDK5/p25 and GSK3β in the low nanomolar range and no observed toxicity in the therapeutic dose range. Neuronal protective effects and decreased PHF-1 immunoreactivity were observed in two animal models, 3×Tg-AD and CK-p25. Treatment nearly eliminated Sarkosyl-insoluble Tau with the most prominent effect on the phosphorylation at Ser-404. Treatment also induced the recovery of memory in a fear conditioning assay.",#60:23,PMC3724657,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2013-11-04"", ""ref"": ""23737518"", ""pub_year"": 2013, ""last_author"": ""Kosik KS"", ""type"": ""PubMed"", ""author_list"": [""Zhang X"", ""Hernandez I"", ""Rei D"", ""Mair W"", ""Laha JK"", ""Cornwell ME"", ""Cuny GD"", ""Tsai LH"", ""Steen JA"", ""Kosik KS""], ""title"": ""Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models."", ""doi"": ""10.1074/jbc.M112.436402""}","{""Confidence"": [""Medium""], ""Half_life"": [""29 min""], ""IC50"": [""62 nM""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Blotting, Western"", ""Cyclin-Dependent Kinase 5"", ""Diamines"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Injections, Intraperitoneal"", ""Injections, Intraventricular"", ""Injections, Subcutaneous"", ""Learning"", ""Male"", ""Memory"", ""Mice"", ""Mice, Transgenic"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Tauopathies"", ""Thiazoles"", ""Treatment Outcome"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Diamines"", ""Neuroprotective Agents"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Thiazoles"", ""tau Proteins"", ""Cyclin-Dependent Kinase 5"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3""]}",False
DIRECTLY_DECREASES,44519,5118,2017,27794524,False,False,False,"LINGO1, a CNS-specific membrane glycoprotein that suppresses oligodendrocyte differentiation and myelination, is possibly involved in failure of remyelination and axonal repair in multiple sclerosis (Yong, 2009); blockade of this protein may therefore be effective in promoting remyelination in a clinical setting.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1385,25138,2017,28669544,False,False,False,"The decrease in PSD95 was significant despite no changes in MAP2 levels, indicative of a selective synapse loss rather than general neuronal death (Figures 4A and 4E).",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""Confidence"": [""High""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
DIRECTLY_DECREASES,2137,14283,2014,24227736,False,False,False,"The increased DHE staining of microglia having phagocytozed neural debris after knockdown of Siglec-E was abrogated by addition of SOD1 or the radical scavenger Trolox, a vitamin E derivate that is known to scavenge radicals (Fig. 2D).",#57:0,PMC3828472,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2014-01-06"", ""ref"": ""24227736"", ""pub_year"": 2014, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Claude J"", ""Linnartz-Gerlach B"", ""Kudin AP"", ""Kunz WS"", ""Neumann H""], ""title"": ""Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst."", ""doi"": ""10.1523/JNEUROSCI.2211-13.2013""}","{""ChallengeType"": [""neural debris""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""Species"": [""10090""], ""mesh"": [""Animals"", ""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cells, Cultured"", ""Coculture Techniques"", ""Female"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Microglia"", ""Neurons"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Protein Binding"", ""Respiratory Burst"", ""Sialic Acid Binding Ig-like Lectin 3""], ""substances"": [""Antigens, CD"", ""Antigens, Differentiation, B-Lymphocyte"", ""Cd33 protein, mouse"", ""Neuroprotective Agents"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Siglece protein, mouse""]}",False
DIRECTLY_DECREASES,40413,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,3506,41145,2019,29334120,False,False,False,"We recently found that overexpression of TDP-43 enhances tau exon 10 inclusion and tau mRNA instability. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion.",#60:23,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2019-01-07"", ""ref"": ""29334120"", ""pub_year"": 2019, ""last_author"": ""Liu F"", ""type"": ""PubMed"", ""author_list"": [""Gu J"", ""Wang W"", ""Miao S"", ""Chen F"", ""Wu F"", ""Hu W"", ""Iqbal K"", ""Gong CX"", ""Liu F""], ""title"": ""Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion."", ""doi"": ""10.1002/1873-3468.12976""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""DNA-Binding Proteins"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Marine Toxins"", ""Okadaic Acid"", ""Oxazoles"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2"", ""Serine"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Marine Toxins"", ""Oxazoles"", ""TARDBP protein, human"", ""tau Proteins"", ""Okadaic Acid"", ""Serine"", ""calyculin A"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,24441,3778,2013,23533697,False,False,False,"In turn, evidence suggests that once activated, caspases may cleave critical cellular proteins in AD including APP, actin, fodrin, glial acidic fibrillary protein, beclin-1, and tau [28, 31–35].",#57:0,PMC3606781,"{""full_journal_name"": ""Oxidative medicine and cellular longevity"", ""pub_date"": ""2013-08-20"", ""ref"": ""23533697"", ""pub_year"": 2013, ""last_author"": ""Rohn TT"", ""type"": ""PubMed"", ""author_list"": [""Rohn TT""], ""title"": ""The triggering receptor expressed on myeloid cells 2: \""TREM-ming\"" the inflammatory component associated with Alzheimer's disease."", ""doi"": ""10.1155/2013/860959""}","{""Section"": [""3. Mechanisms of Neurodegeneration in AD""], ""mesh"": [""Alzheimer Disease"", ""Cytokines"", ""Humans"", ""Inflammation"", ""Membrane Glycoproteins"", ""Microglia"", ""Oxidative Stress"", ""Plaque, Amyloid"", ""Reactive Oxygen Species"", ""Receptors, Immunologic""], ""substances"": [""Cytokines"", ""Membrane Glycoproteins"", ""Reactive Oxygen Species"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
DIRECTLY_DECREASES,10636,39430,2013,22615186,False,False,False,"On ligand binding, ITIM‐signaling receptors recruit SH2 domain‐containing inositol 5′‐phosphatase (SHIP) and SH2 domain‐containing tyrosine phosphatases (SHP1 and SHP2) which in turn can terminate the function of various signaling pathways by the dephosphorylation of signaling intermediates (Fig. 1; Cao et al.,2009; Crocker et al.,2007; Flannagan et al.,2011; Linnartz et al.,2010; Lowell,2011; Salminen and Kaarniranta,2009).",#57:0,,"{""full_journal_name"": ""Glia"", ""pub_date"": ""2013-09-04"", ""ref"": ""22615186"", ""pub_year"": 2013, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Linnartz B"", ""Neumann H""], ""title"": ""Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx."", ""doi"": ""10.1002/glia.22359""}","{""PublicationType"": [""Review""], ""Section"": [""ITAM SIGNALING FOR PHAGOCYTOSIS""], ""mesh"": [""Animals"", ""Glycocalyx"", ""Humans"", ""Immunoreceptor Tyrosine-Based Activation Motif"", ""Immunoreceptor Tyrosine-Based Inhibition Motif"", ""Microglia"", ""Neurons"", ""Signal Transduction""]}",False
DIRECTLY_DECREASES,287,44143,2013,23758787,False,False,False,"Upon IL-1 stimulation, TRAF6 undergoes deglutathionylation catalyzed by glutaredoxin-1 (GRX-1), a process that is essential for TRAF6 auto- ubiquitination and subsequent NF-κB activation [239].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in cytokine receptor signaling""]}",False
DIRECTLY_DECREASES,18634,7753,2013,23758787,False,False,False,"DUBA specifically targets and de-conjugates the K63-linked polyubiquitin chains from TRAF3, resulting in TBK1-IKKϵ dissociation from TRAF3 and inhibition of type I IFN production induced by TLRs and RLRs [128,185,216].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in cytokine receptor signaling""], ""SignalingPathway"": [""RLR"", ""TLR""]}",False
DIRECTLY_DECREASES,4221,32340,2010,20007471,False,False,False,"Using screening approaches in primary neurons, we identified brain- derived neurotrophic factor (BDNF) as a major inducer of Sorla that activates receptor gene transcription through the ERK (extracellular regulated kinase) pathway.These findings demonstrate that the beneficial effects ascribed to BDNF in APP metabolism act through induction of Sorla that encodes a negative regulator of neuronal APP processing",#59:5,PMC6666105,"{""full_journal_name"": ""The Journal of neuroscience : the official journal of the Society for Neuroscience"", ""pub_date"": ""2010-01-19"", ""ref"": ""20007471"", ""pub_year"": 2010, ""last_author"": ""Willnow TE"", ""type"": ""PubMed"", ""author_list"": [""Rohe M"", ""Synowitz M"", ""Glass R"", ""Paul SM"", ""Nykjaer A"", ""Willnow TE""], ""title"": ""Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression."", ""doi"": ""10.1523/JNEUROSCI.3960-09.2009""}","{""Subgraph"": [""MAPK-ERK subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Animals, Newborn"", ""Brain"", ""Brain-Derived Neurotrophic Factor"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Disease Models, Animal"", ""Extracellular Signal-Regulated MAP Kinases"", ""Gene Expression Regulation"", ""Humans"", ""Huntington Disease"", ""MAP Kinase Signaling System"", ""Membrane Transport Proteins"", ""Mice"", ""Mice, Knockout"", ""Neurons"", ""RNA, Messenger"", ""Receptor, trkB"", ""Receptors, LDL""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Brain-Derived Neurotrophic Factor"", ""Membrane Transport Proteins"", ""RNA, Messenger"", ""Receptors, LDL"", ""Sorl1 protein, mouse"", ""Receptor, trkB"", ""Extracellular Signal-Regulated MAP Kinases"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,7118,3348,2019,30962309,False,False,False,"Furthermore, the expression of miR-9-5p is decreased in plasma of RA patients compared with healthy controls (99).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,2583,1419,2017,27794524,False,False,False,"Recent investigations have demonstrated that in chronic phases of EAE, astrocyte depletion ameliorates disease severity, a deleterious effects mediated by preferential expression of 4-galactosyltransferase 5 and 6 (B4GALT5 and B4GALT6; Mayo et al., 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,7786,6908,1971,4255369,False,False,False,"We found that DC8E8 therapy significantly reduced the levels of sarcosyl-insoluble tau oligomers (89%) (Figure 3C and D). Strikingly, total tau levels did not differ between the groups (Figure 3A and B).",#63:73,,"{""full_journal_name"": ""Gigiena i sanitariia"", ""pub_date"": ""1971-12-02"", ""ref"": ""4255369"", ""pub_year"": 1971, ""last_author"": ""Kosiachenko EP"", ""type"": ""PubMed"", ""author_list"": [""Kosiachenko EP""], ""title"": ""[Organization and carrying out of sanitary-educational work in the Berezov region of the Brest Oblast].""}","{""Confidence"": [""High""], ""Species"": [""10090""], ""mesh"": [""Health Education"", ""Republic of Belarus""]}",False
DIRECTLY_DECREASES,1119,3311,2019,30962309,False,False,False,"Other miRNAs are decreased in MS patient serum (e.g., miR-23a-3p and miR-223-3p in primary progressive MS) (92).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,7165,7180,2017,27956442,False,False,False,"Plasma exchange is occasionally used, as an adjunctive therapy or alone, if the relapse is rapidly progressive or severe. Therapy interventions, such as physiotherapy, should also be used early to enhance recovery. [4]",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,2583,1419,2017,27794524,False,False,False,"Recent investigations have demonstrated that in chronic phases of EAE, astrocyte depletion ameliorates disease severity, a deleterious effects mediated by preferential expression of 4-galactosyltransferase 5 and 6 (B4GALT5 and B4GALT6; Mayo et al., 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11512,7180,2017,27794524,False,False,False,"Several phase III clinical trials using IFNbeta1a and IFNbeta1b in SPMS did not show permanent disability delay, but did reduce relapses risk (SPECTRIMS Study Group, 2001; Cohen et al., 2002; Andersen et al., 2004; Panitch et al.,2004).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,7208,6942,2017,27794524,False,False,False,Global NAA measured across the whole brain is abnormally low in multiple sclerosis,#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,44564,40328,2016,26631930,False,False,False,"Among them, PP2A is the main phosphatase:it accounts for ~70% of the human brain tau phosphatase activity, and its activity is reduced in the AD brain (by ~20% and ~40% in the grey and white matter, respectively)",#59:49,,"{""full_journal_name"": ""Nature reviews. Neuroscience"", ""pub_date"": ""2016-04-20"", ""ref"": ""26631930"", ""pub_year"": 2016, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Wang Y"", ""Mandelkow E""], ""title"": ""Tau in physiology and pathology."", ""doi"": ""10.1038/nrn.2015.1""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Humans"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,7032,31687,2011,21882945,False,False,False,"Since this discovery, a number of high-affinity analogs, such as 17-AAG, and alternative synthetic scaffolds, including radicicol and PU-H71, have been reported (Figure 1) [85,88]. These compounds bind in either the N-terminal ATP-binding site (e.g., 17-AAG, radicicol and PU-H71) [89] or C-terminal dimerization domain (e.g., novobiocin and A4) [90,91], and they show great promise as both anticancer compounds and research tools for understanding Hsp90 biology",#69:73,PMC3190966,"{""full_journal_name"": ""Future medicinal chemistry"", ""pub_date"": ""2011-12-23"", ""ref"": ""21882945"", ""pub_year"": 2011, ""last_author"": ""Gestwicki JE"", ""type"": ""PubMed"", ""author_list"": [""Miyata Y"", ""Koren J"", ""Kiray J"", ""Dickey CA"", ""Gestwicki JE""], ""title"": ""Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies."", ""doi"": ""10.4155/fmc.11.88""}","{""Confidence"": [""Medium""], ""mesh"": [""Drug Evaluation, Preclinical"", ""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Humans"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""Protein Interaction Mapping"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""tau Proteins""]}",False
DIRECTLY_DECREASES,3506,39058,2014,25001178,False,False,False,"In primary neurons, overexpression of miR-125b causes tau hyperphosphorylation and an upregulation of p35, cdk5, and p44/42-MAPK signaling. In parallel, the phosphatases DUSP6 and PPP1CA and the anti-apoptotic factor Bcl-W are downregulated as direct targets of miR-125b. Knockdown of these phosphatases induces tau hyperphosphorylation, and overexpression of PPP1CA and Bcl-W prevents miR-125b-induced tau phosphorylation, suggesting that they mediate the effects of miR-125b on tau. Conversely, suppression of miR-125b in neurons by tough decoys reduces tau phosphorylation and kinase expression/activity. Injecting miR-125b into the hippocampus of mice impairs associative learning and is accompanied by downregulation of Bcl-W, DUSP6, and PPP1CA, resulting in increased tau phosphorylation in vivo. Importantly, DUSP6 and PPP1CA are also reduced in AD brains.",#60:23,PMC4194100,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2014-09-30"", ""ref"": ""25001178"", ""pub_year"": 2014, ""last_author"": ""Edbauer D"", ""type"": ""PubMed"", ""author_list"": [""Banzhaf-Strathmann J"", ""Benito E"", ""May S"", ""Arzberger T"", ""Tahirovic S"", ""Kretzschmar H"", ""Fischer A"", ""Edbauer D""], ""title"": ""MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease."", ""doi"": ""10.15252/embj.201387576""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Apoptosis Regulatory Proteins"", ""Cells, Cultured"", ""Cognition Disorders"", ""Down-Regulation"", ""Dual Specificity Phosphatase 6"", ""Gene Knockout Techniques"", ""Hippocampus"", ""Humans"", ""Memory"", ""Mice"", ""Mice, Inbred C57BL"", ""MicroRNAs"", ""Neurons"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""tau Proteins""], ""substances"": [""Apoptosis Regulatory Proteins"", ""BCL2L2 protein, human"", ""MAPT protein, human"", ""MIRN125 microRNA, human"", ""MicroRNAs"", ""tau Proteins"", ""PPP1CA protein, human"", ""Protein Phosphatase 1"", ""DUSP6 protein, human"", ""Dual Specificity Phosphatase 6""]}",False
DIRECTLY_DECREASES,38960,1214,2017,27794524,False,False,False,"Increased sex hormone levels in females may protect against grey matter atrophy (Cutter et al., 2006). In contrast, testosterone was shown to amplify oligodendrocyte excitotoxicity, potentially limiting remyelination (Caruso et al., 2004).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""central nervous system gray matter layer""], ""Confidence"": [""High""], ""Gender"": [""Female""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,3506,10964,2019,29334120,False,False,False,"We recently found that overexpression of TDP-43 enhances tau exon 10 inclusion and tau mRNA instability. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion.",#60:23,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2019-01-07"", ""ref"": ""29334120"", ""pub_year"": 2019, ""last_author"": ""Liu F"", ""type"": ""PubMed"", ""author_list"": [""Gu J"", ""Wang W"", ""Miao S"", ""Chen F"", ""Wu F"", ""Hu W"", ""Iqbal K"", ""Gong CX"", ""Liu F""], ""title"": ""Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion."", ""doi"": ""10.1002/1873-3468.12976""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""DNA-Binding Proteins"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Marine Toxins"", ""Okadaic Acid"", ""Oxazoles"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2"", ""Serine"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Marine Toxins"", ""Oxazoles"", ""TARDBP protein, human"", ""tau Proteins"", ""Okadaic Acid"", ""Serine"", ""calyculin A"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,24441,43753,2013,23533697,False,False,False,"In turn, evidence suggests that once activated, caspases may cleave critical cellular proteins in AD including APP, actin, fodrin, glial acidic fibrillary protein, beclin-1, and tau [28, 31–35].",#57:0,PMC3606781,"{""full_journal_name"": ""Oxidative medicine and cellular longevity"", ""pub_date"": ""2013-08-20"", ""ref"": ""23533697"", ""pub_year"": 2013, ""last_author"": ""Rohn TT"", ""type"": ""PubMed"", ""author_list"": [""Rohn TT""], ""title"": ""The triggering receptor expressed on myeloid cells 2: \""TREM-ming\"" the inflammatory component associated with Alzheimer's disease."", ""doi"": ""10.1155/2013/860959""}","{""Section"": [""3. Mechanisms of Neurodegeneration in AD""], ""mesh"": [""Alzheimer Disease"", ""Cytokines"", ""Humans"", ""Inflammation"", ""Membrane Glycoproteins"", ""Microglia"", ""Oxidative Stress"", ""Plaque, Amyloid"", ""Reactive Oxygen Species"", ""Receptors, Immunologic""], ""substances"": [""Cytokines"", ""Membrane Glycoproteins"", ""Reactive Oxygen Species"", ""Receptors, Immunologic"", ""TREM2 protein, human""]}",False
DIRECTLY_DECREASES,11645,8640,2005,15597323,False,False,False,"The IL‐1β response (protein and steady‐state mRNA levels) to anti‐CD33 or to neuraminidase was dramatically enhanced by treatment of monocytes with the PI3K‐specific inhibitor LY294002, and it was abolished after treatment with the p38 MAPK inhibitor SB203580 (p<0.001).",#57:0,,"{""full_journal_name"": ""European journal of immunology"", ""pub_date"": ""2005-02-23"", ""ref"": ""15597323"", ""pub_year"": 2005, ""last_author"": ""Chizzolini C"", ""type"": ""PubMed"", ""author_list"": [""Lajaunias F"", ""Dayer JM"", ""Chizzolini C""], ""title"": ""Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.""}","{""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Gene Silencing"", ""Humans"", ""Immunity, Innate"", ""In Vitro Techniques"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-8"", ""Monocytes"", ""N-Acetylneuraminic Acid"", ""Phosphatidylinositol 3-Kinases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Signal Transduction"", ""Tumor Necrosis Factor-alpha"", ""p38 Mitogen-Activated Protein Kinases""], ""substances"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Interleukin-1"", ""Interleukin-8"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Tumor Necrosis Factor-alpha"", ""Phosphatidylinositol 3-Kinases"", ""p38 Mitogen-Activated Protein Kinases"", ""N-Acetylneuraminic Acid""]}",False
DIRECTLY_DECREASES,4678,25337,2015,26207229,False,False,False,"IL-18 (interferon-γ-inducing factor, IL-1γ), a pro-inflammatory cytokines belonging to the IL-1 cytokine family, is synthesized as an inactive 24-kDa precursor protein (pro-IL-18) and cleaved by the intracellular cystein protease caspase-1 and proteinase-3 to generate a 18 kDa mature and biologically active form.",#57:0,PMC4486922,"{""full_journal_name"": ""Annals of translational medicine"", ""pub_date"": ""2015-07-24"", ""ref"": ""26207229"", ""pub_year"": 2015, ""last_author"": ""Tan L"", ""type"": ""PubMed"", ""author_list"": [""Wang WY"", ""Tan MS"", ""Yu JT"", ""Tan L""], ""title"": ""Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease."", ""doi"": ""10.3978/j.issn.2305-5839.2015.03.49""}","{""PublicationType"": [""Review""], ""Section"": [""Pro-inflammatory cytokine signaling in AD""]}",False
DIRECTLY_DECREASES,493,30928,2013,23758787,False,False,False,"A20 is a target gene of NF-κB, and able to remove K63-linked polyubiquitin chains from TRAF6 to turn off NF-κB activation.",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in cytokine receptor signaling""]}",False
DIRECTLY_DECREASES,2442,32340,2010,20580937,False,False,False,"In conclusion clathrin-dependent APP endocytosis appears to be very sensitive to the levels of membrane cholesterol. These results suggest that cholesterol increase in AD could be responsible for the enhanced internalization of clathrin-, dynamin2-, Eps15- and Rab5-dependent endocytosis of APP and the ensuing overproduction of Abeta",#59:5,,"{""full_journal_name"": ""Biochimica et biophysica acta"", ""pub_date"": ""2010-08-10"", ""ref"": ""20580937"", ""pub_year"": 2010, ""last_author"": ""Potier MC"", ""type"": ""PubMed"", ""author_list"": [""Cossec JC"", ""Simon A"", ""Marquer C"", ""Moldrich RX"", ""Leterrier C"", ""Rossier J"", ""Duyckaerts C"", ""Lenkei Z"", ""Potier MC""], ""title"": ""Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol."", ""doi"": ""10.1016/j.bbalip.2010.05.010""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Amyloidogenic subgraph"", ""Cholesterol metabolism subgraph"", ""Endosomal lysosomal subgraph""], ""mesh"": [""Adaptor Proteins, Signal Transducing"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Calcium-Binding Proteins"", ""Cell Membrane"", ""Cells, Cultured"", ""Cholesterol"", ""Clathrin"", ""Clathrin-Coated Vesicles"", ""Dynamin II"", ""Endocytosis"", ""Humans"", ""Intracellular Signaling Peptides and Proteins"", ""Phosphoproteins"", ""Secretory Pathway"", ""rab5 GTP-Binding Proteins""], ""substances"": [""Adaptor Proteins, Signal Transducing"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Calcium-Binding Proteins"", ""Clathrin"", ""EPS15 protein, human"", ""Intracellular Signaling Peptides and Proteins"", ""Phosphoproteins"", ""Cholesterol"", ""rab5 GTP-Binding Proteins"", ""Dynamin II""]}",False
DIRECTLY_DECREASES,26674,2678,2019,30962309,False,False,False,"The resulting duplex is incorporated into an Argonaute protein and unwound so that only one strand (i.e., the mature miRNA) is kept in the RNA-induced silencing complex, which targets transcripts with matching sequences for degradation and prevents translation into proteins (25, 29, 30).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,14472,1630,2017,27794524,False,False,False,"The antioxidant idebenone was proven to be beneficial in Leber’s hereditary optic neuropathy, a disorder caused by mitochondrial defects.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11990,36416,2019,30962309,False,False,False,"Furthermore, several therapies that are currently in use to treat autoimmune disorders, such as IFN-beta and glatiramer acetate in MS, glucocorticoids in systemic lupus erythematosus (SLE), and the TNF- alpha inhibitor infliximab in rheumatic diseases, partially affect the regulation of inflammasomes (11–14).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,1119,3353,2019,30962309,False,False,False,"Other miRNAs are decreased in MS patient serum (e.g., miR-23a-3p and miR-223-3p in primary progressive MS) (92).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,2041,43398,2017,27956442,False,False,False,The most serious side effect occurred unexpectedly about a decade ago with natalizumab – a humanised monoclonal antibody against the cell adhesion molecule alpha 4-integrin – where activation of the John Cunningham virus (JCV) resulted in progressive multifocal leukoencephalopathy (PML).,#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,14291,1116,2017,27794524,False,False,False,"NO has been shown to cause irreversible conduction blockade in axons and to drive spinal cord degeneration in rats (Smith et al., 2001).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Species"": [""10114""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1847,7180,2017,27794524,False,False,False,"Several phase III clinical trials using IFNbeta1a and IFNbeta1b in SPMS did not show permanent disability delay, but did reduce relapses risk (SPECTRIMS Study Group, 2001; Cohen et al., 2002; Andersen et al., 2004; Panitch et al.,2004).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,7180,6942,2017,27794524,False,False,False,"Whole brain MRS has successfully shown significant reduction in both NAA and NAA/creatine (NAA/Cr) ratio, in clinically isolated syndrome and RRMS, compared to healthy controls.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1385,44002,2017,28669544,False,False,False,"Since demyelination can occur in many neurodegenerative disorders, we also assayed levels of myelin binding protein (MBP) isoforms and found a significant decrease (Figures 4A and 4D).",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
DIRECTLY_DECREASES,16835,9459,2002,11812770,False,False,False,"GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",#62:7,,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2002-05-13"", ""ref"": ""11812770"", ""pub_year"": 2002, ""last_author"": ""Paudel HK"", ""type"": ""PubMed"", ""author_list"": [""Sun W"", ""Qureshi HY"", ""Cafferty PW"", ""Sobue K"", ""Agarwal-Mawal A"", ""Neufield KD"", ""Paudel HK""], ""title"": ""Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.""}","{""Confidence"": [""Medium""], ""Method"": [""Immunoaffinity Chromatography"", ""Immunoblotting"", ""Immunoprecipitation"", ""Microtubule Sedimentation Assay"", ""Pull-down Assay"", ""SDS-PAGE""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Binding Sites"", ""Brain"", ""Calcium-Calmodulin-Dependent Protein Kinases"", ""Cattle"", ""Chromatography, Gel"", ""Cloning, Molecular"", ""DNA, Complementary"", ""Electrophoresis, Polyacrylamide Gel"", ""Glutathione Transferase"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinases"", ""Humans"", ""Immunoblotting"", ""Microtubules"", ""Peptides"", ""Phosphorylation"", ""Precipitin Tests"", ""Protein Binding"", ""tau Proteins""], ""substances"": [""DNA, Complementary"", ""Peptides"", ""tau Proteins"", ""Glutathione Transferase"", ""Glycogen Synthase Kinases"", ""Calcium-Calmodulin-Dependent Protein Kinases"", ""Glycogen Synthase Kinase 3""]}",False
DIRECTLY_DECREASES,11593,30258,2016,26692334,False,False,False,"Rolipram is a specific phosphodiesterase type 4 (PDE4) inhibitor that increases cAMP levels in multiple tissues in vivo. The chymotrypsin- like activity of the 26S proteasomes in crude extracts was elevated after administration of db-cAMP or rolipram but was blocked by epoxomicin Exposure of slices from the early-stage mice to rolipram or db-cAMP for 8 h reduced amounts of total and insoluble tau (Fig. 3a), including phosphorylated tau (Supplementary Fig. 4a,b). In contrast, epoxomicin treatment increased levels of phosphorylated tau (Supplementary Fig. 4), although the amount of total tau remained unchanged (Fig. 3a). PKA is known to phosphorylate tau at Ser214 (pS214)29. We therefore monitored the amount of pS214 tau to determine whether rolipram and db-cAMP activated PKA. The amount of pS214 tau was higher in db-cAMP– and rolipram-treated samples than in control (DMSO) and epoxomicin-treated slices (Fig. 3a).",#60:23,PMC4787271,"{""full_journal_name"": ""Nature medicine"", ""pub_date"": ""2016-05-24"", ""ref"": ""26692334"", ""pub_year"": 2016, ""last_author"": ""Duff KE"", ""type"": ""PubMed"", ""author_list"": [""Myeku N"", ""Clelland CL"", ""Emrani S"", ""Kukushkin NV"", ""Yu WH"", ""Goldberg AL"", ""Duff KE""], ""title"": ""Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling."", ""doi"": ""10.1038/nm.4011""}","{""Confidence"": [""Medium""], ""mesh"": [""Animals"", ""Behavior, Animal"", ""Brain"", ""Cognition"", ""Cognition Disorders"", ""Cyclic AMP"", ""Cyclic AMP-Dependent Protein Kinases"", ""Disease Models, Animal"", ""Fluorescent Antibody Technique"", ""HEK293 Cells"", ""Humans"", ""Immunoblotting"", ""Immunoprecipitation"", ""In Vitro Techniques"", ""Mice"", ""Mice, Transgenic"", ""Native Polyacrylamide Gel Electrophoresis"", ""Phosphodiesterase 4 Inhibitors"", ""Proteasome Endopeptidase Complex"", ""Protein Aggregation, Pathological"", ""Rolipram"", ""Signal Transduction"", ""Tauopathies"", ""Ubiquitination"", ""tau Proteins""], ""substances"": [""Phosphodiesterase 4 Inhibitors"", ""tau Proteins"", ""Cyclic AMP"", ""Cyclic AMP-Dependent Protein Kinases"", ""Proteasome Endopeptidase Complex"", ""ATP dependent 26S protease"", ""Rolipram""]}",False
DIRECTLY_DECREASES,6949,44519,2017,27794524,False,False,False,"BIIB033, a fully human monoclonal antibody that selectively antagonizes LINGO1, was found to be safe and well-tolerated in phase 1 studies (Tran et al., 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,3506,16546,2019,29334120,False,False,False,"We recently found that overexpression of TDP-43 enhances tau exon 10 inclusion and tau mRNA instability. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion.",#60:23,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2019-01-07"", ""ref"": ""29334120"", ""pub_year"": 2019, ""last_author"": ""Liu F"", ""type"": ""PubMed"", ""author_list"": [""Gu J"", ""Wang W"", ""Miao S"", ""Chen F"", ""Wu F"", ""Hu W"", ""Iqbal K"", ""Gong CX"", ""Liu F""], ""title"": ""Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion."", ""doi"": ""10.1002/1873-3468.12976""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""DNA-Binding Proteins"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Marine Toxins"", ""Okadaic Acid"", ""Oxazoles"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2"", ""Serine"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Marine Toxins"", ""Oxazoles"", ""TARDBP protein, human"", ""tau Proteins"", ""Okadaic Acid"", ""Serine"", ""calyculin A"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,14968,36863,2014,24078628,False,False,False,The C-terminal fragment (CTF) of TREM2 generated by ectodomain shedding is cleaved by γ-secretase.,#57:0,PMC3829152,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2014-01-23"", ""ref"": ""24078628"", ""pub_year"": 2014, ""last_author"": ""Walter J"", ""type"": ""PubMed"", ""author_list"": [""Wunderlich P"", ""Glebov K"", ""Kemmerling N"", ""Tien NT"", ""Neumann H"", ""Walter J""], ""title"": ""Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage."", ""doi"": ""10.1074/jbc.M113.517540""}","{""Section"": [""Abstract""], ""mesh"": [""Adaptor Proteins, Signal Transducing"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Animals"", ""COS Cells"", ""Cell Membrane"", ""Chlorocebus aethiops"", ""HEK293 Cells"", ""Humans"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Phosphorylation"", ""Protein Structure, Tertiary"", ""Proteolysis"", ""Receptors, Immunologic"", ""Signal Transduction""], ""substances"": [""Adaptor Proteins, Signal Transducing"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Receptors, Immunologic"", ""TREM2 protein, human"", ""TYROBP protein, human"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,14364,18587,2005,15597323,False,False,False,"The IL‐1β response (protein and steady‐state mRNA levels) to anti‐CD33 or to neuraminidase was dramatically enhanced by treatment of monocytes with the PI3K‐specific inhibitor LY294002, and it was abolished after treatment with the p38 MAPK inhibitor SB203580 (p<0.001).",#57:0,,"{""full_journal_name"": ""European journal of immunology"", ""pub_date"": ""2005-02-23"", ""ref"": ""15597323"", ""pub_year"": 2005, ""last_author"": ""Chizzolini C"", ""type"": ""PubMed"", ""author_list"": [""Lajaunias F"", ""Dayer JM"", ""Chizzolini C""], ""title"": ""Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.""}","{""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Gene Silencing"", ""Humans"", ""Immunity, Innate"", ""In Vitro Techniques"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-8"", ""Monocytes"", ""N-Acetylneuraminic Acid"", ""Phosphatidylinositol 3-Kinases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Signal Transduction"", ""Tumor Necrosis Factor-alpha"", ""p38 Mitogen-Activated Protein Kinases""], ""substances"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Interleukin-1"", ""Interleukin-8"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Tumor Necrosis Factor-alpha"", ""Phosphatidylinositol 3-Kinases"", ""p38 Mitogen-Activated Protein Kinases"", ""N-Acetylneuraminic Acid""]}",False
DIRECTLY_DECREASES,509,25337,2015,26207229,False,False,False,"IL-18 (interferon-γ-inducing factor, IL-1γ), a pro-inflammatory cytokines belonging to the IL-1 cytokine family, is synthesized as an inactive 24-kDa precursor protein (pro-IL-18) and cleaved by the intracellular cystein protease caspase-1 and proteinase-3 to generate a 18 kDa mature and biologically active form.",#57:0,PMC4486922,"{""full_journal_name"": ""Annals of translational medicine"", ""pub_date"": ""2015-07-24"", ""ref"": ""26207229"", ""pub_year"": 2015, ""last_author"": ""Tan L"", ""type"": ""PubMed"", ""author_list"": [""Wang WY"", ""Tan MS"", ""Yu JT"", ""Tan L""], ""title"": ""Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease."", ""doi"": ""10.3978/j.issn.2305-5839.2015.03.49""}","{""PublicationType"": [""Review""], ""Section"": [""Pro-inflammatory cytokine signaling in AD""]}",False
DIRECTLY_DECREASES,32340,40054,2012,22470521,False,False,False,"Molecular mechanisms of APP cleavage products in the regulation of GD3S enzyme activity. (A) In absence of Ab peptides a-series ganglioside GM3 binds to GD3S and is converted to the b-series ganglioside GD3. In presence of Ab, Ab binds ganglioside GM3, forming an Ab-GM3 complex. This complex still binds to GD3S, but cannot be converted to GD3. (B) Dual function of Ab and AICD in GD3S regulation. Ab reduces enzyme activity of GD3S by forming an Ab-GM3 complex, resulting in reduced turnover of GM3 to GD3. AICD binds the adaptor protein Fe65 and reduces GD3S gene transcription, which also results in reduced turnover of GM3 to GD3.",#59:5,PMC3314703,"{""full_journal_name"": ""PloS one"", ""pub_date"": ""2012-08-03"", ""ref"": ""22470521"", ""pub_year"": 2012, ""last_author"": ""Hartmann T"", ""type"": ""PubMed"", ""author_list"": [""Grimm MO"", ""Zinser EG"", ""Gr\u00f6sgen S"", ""Hundsd\u00f6rfer B"", ""Rothhaar TL"", ""Burg VK"", ""Kaestner L"", ""Bayer TA"", ""Lipp P"", ""M\u00fcller U"", ""Grimm HS"", ""Hartmann T""], ""title"": ""Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism."", ""doi"": ""10.1371/journal.pone.0034095""}","{""MeSHAnatomy"": [""Autonomic Fibers, Preganglionic"", ""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""Sphingolipid metabolic subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""COS Cells"", ""Cell Line"", ""Chlorocebus aethiops"", ""Gangliosides"", ""Homeostasis"", ""Immunoprecipitation"", ""Mice"", ""Presenilin-1"", ""Presenilin-2"", ""Protein Binding"", ""RNA Interference"", ""RNA, Small Interfering"", ""Sialyltransferases""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Gangliosides"", ""Presenilin-1"", ""Presenilin-2"", ""RNA, Small Interfering"", ""Sialyltransferases"", ""alpha-N-acetylneuraminate alpha-2,8-sialyltransferase""]}",False
DIRECTLY_DECREASES,34909,12037,2007,17213958,False,False,False,"As indicated in Fig. 2, the presence of GSH protected the cells against H2O2-induced apoptosis and the increase in AChE activity. Therefore, the redox imbalance resulted in mitochondrial dysfunction and enhanced mitochondrial reactive oxygen species (ROS) generation.",#59:5,,"{""full_journal_name"": ""Acta biochimica et biophysica Sinica"", ""pub_date"": ""2007-02-21"", ""ref"": ""17213958"", ""pub_year"": 2007, ""last_author"": ""Zhang X"", ""type"": ""PubMed"", ""author_list"": [""Jiang H"", ""Zhang J"", ""Zhu H"", ""Li H"", ""Zhang X""], ""title"": ""Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Acetylcholine signaling subgraph"", ""Glutathione reductase subgraph""], ""mesh"": [""Acetylcholinesterase"", ""Animals"", ""Apoptosis"", ""Caspase 3"", ""Cytochromes c"", ""Enzyme Activation"", ""Glutathione"", ""Hydrogen Peroxide"", ""Nerve Growth Factor"", ""PC12 Cells"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Rats""], ""substances"": [""Cytochromes c"", ""Nerve Growth Factor"", ""Hydrogen Peroxide"", ""Proto-Oncogene Proteins c-akt"", ""Acetylcholinesterase"", ""Caspase 3"", ""Glutathione""]}",False
DIRECTLY_DECREASES,11762,18940,2014,24214965,False,False,False,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,#59:5,PMC3965067,"{""full_journal_name"": ""Nucleic acids research"", ""pub_date"": ""2014-03-17"", ""ref"": ""24214965"", ""pub_year"": 2014, ""last_author"": ""Overington JP"", ""type"": ""PubMed"", ""author_list"": [""Bento AP"", ""Gaulton A"", ""Hersey A"", ""Bellis LJ"", ""Chambers J"", ""Davies M"", ""Kr\u00fcger FA"", ""Light Y"", ""Mak L"", ""McGlinchey S"", ""Nowotka M"", ""Papadatos G"", ""Santos R"", ""Overington JP""], ""title"": ""The ChEMBL bioactivity database: an update."", ""doi"": ""10.1093/nar/gkt1031""}","{""Subgraph"": [""Regulation of actin cytoskeleton subgraph""], ""mesh"": [""Binding Sites"", ""Databases, Chemical"", ""Drug Discovery"", ""Humans"", ""Internet"", ""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""], ""substances"": [""Ligands"", ""Pharmaceutical Preparations"", ""Proteins""]}",False
DIRECTLY_DECREASES,5394,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,6938,2132,2017,27794524,False,False,False,"In turn, scavengers reducing ROS and RNS levels in EAE were able to attenuate focal axonal degeneration without altering the number of immune cells is EAE lesions.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,7118,3336,2019,30962309,False,False,False,"In RA, miR-22-3p levels are reduced in synovial tissue from RA patients compared with osteoarthritis patients (97), and low expression of miR-22-3p is associated with a good response to adalimumab treatment (98).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Cell"": [""synovial cell""], ""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,1809,1287,2017,27956442,False,False,False,"In rapidly progressing SPMS patients, intravenous mitoxantrone can be considered, but this requires close monitoring for cardiac side effects and acute myelogenous leukaemia.",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,14291,2351,2017,27794524,False,False,False,"NO has been shown to cause irreversible conduction blockade in axons and to drive spinal cord degeneration in rats (Smith et al., 2001).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Species"": [""10114""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,6905,1287,2017,27794524,False,False,False,"Thus, ocrelizumab becomes the first agent to have shown positive results in pivotal studies in PPMS (NCT 1194570).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,35403,698,2015,26088141,False,False,False,"As shown in Fig. 3A, coupling between Gαq and α7 nAChRs was virtually abolished by expression of α7345–348A. A noticeable loss in Gαq (−62.18%) and Gβγ (−20.03%) expression within the α7 nAChR complex IP was seen in cells transfected with α7345–348A (Fig. 3A).",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
DIRECTLY_DECREASES,6949,44519,2017,27794524,False,False,False,"BIIB033, a fully human monoclonal antibody that selectively antagonizes LINGO1, was found to be safe and well-tolerated in phase 1 studies (Tran et al., 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,16835,12915,2002,11812770,False,False,False,"GSK3Beta may directly bind to tau within a GSK3Beta-tau complex.To identify the GSK3Beta-binding region within tau, we constructed three tau deletion mutants: R-tau-(1–244) containing the N-terminal projection domain, R-tau-(245–369) containing the microtubule-binding region, and R-tau-(245–441) containing both the microtubule-binding region and the C-terminal tail. We evaluated the binding of these mutants and wild-type R-tau with GST-GSK3Beta by the GST pull-down assay. GSK3Beta bound to wild type (Fig. 5B) and R-tau-(1–244) (Fig. 5C) but not R-tau-(245–369) (Fig. 5D) and R-tau-(245–441) (Fig.5E). These data demonstrate that GSK3Beta binds to the Nterminal projection domain of tau.",#62:7,,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2002-05-13"", ""ref"": ""11812770"", ""pub_year"": 2002, ""last_author"": ""Paudel HK"", ""type"": ""PubMed"", ""author_list"": [""Sun W"", ""Qureshi HY"", ""Cafferty PW"", ""Sobue K"", ""Agarwal-Mawal A"", ""Neufield KD"", ""Paudel HK""], ""title"": ""Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.""}","{""Confidence"": [""Medium""], ""Method"": [""Immunoaffinity Chromatography"", ""Immunoblotting"", ""Immunoprecipitation"", ""Microtubule Sedimentation Assay"", ""Pull-down Assay"", ""SDS-PAGE""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Binding Sites"", ""Brain"", ""Calcium-Calmodulin-Dependent Protein Kinases"", ""Cattle"", ""Chromatography, Gel"", ""Cloning, Molecular"", ""DNA, Complementary"", ""Electrophoresis, Polyacrylamide Gel"", ""Glutathione Transferase"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinases"", ""Humans"", ""Immunoblotting"", ""Microtubules"", ""Peptides"", ""Phosphorylation"", ""Precipitin Tests"", ""Protein Binding"", ""tau Proteins""], ""substances"": [""DNA, Complementary"", ""Peptides"", ""tau Proteins"", ""Glutathione Transferase"", ""Glycogen Synthase Kinases"", ""Calcium-Calmodulin-Dependent Protein Kinases"", ""Glycogen Synthase Kinase 3""]}",False
DIRECTLY_DECREASES,1687,30128,2013,23737518,False,False,False,"Small molecules in the diaminothiazole class are potent Tau kinase inhibitors that target CDK5 and GSK3β. Lead compounds from the series have IC50 values toward CDK5/p25 and GSK3β in the low nanomolar range and no observed toxicity in the therapeutic dose range. Neuronal protective effects and decreased PHF-1 immunoreactivity were observed in two animal models, 3×Tg-AD and CK-p25. Treatment nearly eliminated Sarkosyl-insoluble Tau with the most prominent effect on the phosphorylation at Ser-404. Treatment also induced the recovery of memory in a fear conditioning assay.",#60:23,PMC3724657,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2013-11-04"", ""ref"": ""23737518"", ""pub_year"": 2013, ""last_author"": ""Kosik KS"", ""type"": ""PubMed"", ""author_list"": [""Zhang X"", ""Hernandez I"", ""Rei D"", ""Mair W"", ""Laha JK"", ""Cornwell ME"", ""Cuny GD"", ""Tsai LH"", ""Steen JA"", ""Kosik KS""], ""title"": ""Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models."", ""doi"": ""10.1074/jbc.M112.436402""}","{""Confidence"": [""Medium""], ""Half_life"": [""70 min""], ""IC50"": [""90 nM""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Blotting, Western"", ""Cyclin-Dependent Kinase 5"", ""Diamines"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Injections, Intraperitoneal"", ""Injections, Intraventricular"", ""Injections, Subcutaneous"", ""Learning"", ""Male"", ""Memory"", ""Mice"", ""Mice, Transgenic"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Tauopathies"", ""Thiazoles"", ""Treatment Outcome"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Diamines"", ""Neuroprotective Agents"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Thiazoles"", ""tau Proteins"", ""Cyclin-Dependent Kinase 5"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3""]}",False
DIRECTLY_DECREASES,9355,18838,2013,23758787,False,False,False,"The binding of TRAF6 to the TIM of the IL-2R β-chain negatively regulates IL-2-induced Jak1 activation in CD4 T cells, which is likely involved in the proper regulation of T cell activation and development [172].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""MeSHAnatomy"": [""CD4-Positive T-Lymphocytes""], ""PublicationType"": [""Review""], ""Section"": [""TRAFs in cytokine receptor signaling""]}",False
DIRECTLY_DECREASES,14993,28963,2015,26142647,False,False,False,The growth arrest and DNA damage protein (GADD) 34 is up-regulated in response to ER stress and regulates subunit of protein phosphatase 1 (PP1) complex that dephosphorylates eukaryotic translation initiator factor 2α (elF2α).,#60:23,,"{""full_journal_name"": ""Neuroscience letters"", ""pub_date"": ""2015-10-28"", ""ref"": ""26142647"", ""pub_year"": 2015, ""last_author"": ""Kawakami K"", ""type"": ""PubMed"", ""author_list"": [""Honjo Y"", ""Ayaki T"", ""Tomiyama T"", ""Horibe T"", ""Ito H"", ""Mori H"", ""Takahashi R"", ""Kawakami K""], ""title"": ""Increased GADD34 in oligodendrocytes in Alzheimer's disease."", ""doi"": ""10.1016/j.neulet.2015.06.052""}","{""Confidence"": [""Medium""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Brain"", ""Case-Control Studies"", ""Female"", ""Humans"", ""Male"", ""Mice, Transgenic"", ""Middle Aged"", ""Neurons"", ""Oligodendroglia"", ""Protein Phosphatase 1""], ""substances"": [""Amyloid beta-Protein Precursor"", ""PPP1R15A protein, human"", ""Protein Phosphatase 1""]}",False
DIRECTLY_DECREASES,14333,24479,2014,24078628,False,False,False,"As members of the matrix metalloprotease (MMP) family or the A Disintegrin And Metalloprotease (ADAM) family are major proteases involved in the cleavage of cell surface proteins, COS7 cells were incubated in absence or presence of batimastat, a well known inhibitor of proteases of both families (19, 20).",#57:0,PMC3829152,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2014-01-23"", ""ref"": ""24078628"", ""pub_year"": 2014, ""last_author"": ""Walter J"", ""type"": ""PubMed"", ""author_list"": [""Wunderlich P"", ""Glebov K"", ""Kemmerling N"", ""Tien NT"", ""Neumann H"", ""Walter J""], ""title"": ""Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage."", ""doi"": ""10.1074/jbc.M113.517540""}","{""Section"": [""Results""], ""mesh"": [""Adaptor Proteins, Signal Transducing"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Animals"", ""COS Cells"", ""Cell Membrane"", ""Chlorocebus aethiops"", ""HEK293 Cells"", ""Humans"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Phosphorylation"", ""Protein Structure, Tertiary"", ""Proteolysis"", ""Receptors, Immunologic"", ""Signal Transduction""], ""substances"": [""Adaptor Proteins, Signal Transducing"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Receptors, Immunologic"", ""TREM2 protein, human"", ""TYROBP protein, human"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,14364,7926,2005,15597323,False,False,False,"Consistent with these findings, phosphorylation of p38 was observed in monocytes activated by anti‐CD33 (Fig. 5E) or neuraminidase (not shown), and p38 phosphorylation was abrogated by SB203580.",#57:0,,"{""full_journal_name"": ""European journal of immunology"", ""pub_date"": ""2005-02-23"", ""ref"": ""15597323"", ""pub_year"": 2005, ""last_author"": ""Chizzolini C"", ""type"": ""PubMed"", ""author_list"": [""Lajaunias F"", ""Dayer JM"", ""Chizzolini C""], ""title"": ""Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.""}","{""PublicationType"": [""Research""], ""Section"": [""Results""], ""mesh"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""Gene Silencing"", ""Humans"", ""Immunity, Innate"", ""In Vitro Techniques"", ""Inflammation"", ""Interleukin-1"", ""Interleukin-8"", ""Monocytes"", ""N-Acetylneuraminic Acid"", ""Phosphatidylinositol 3-Kinases"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Signal Transduction"", ""Tumor Necrosis Factor-alpha"", ""p38 Mitogen-Activated Protein Kinases""], ""substances"": [""Antibodies, Monoclonal"", ""Antigens, CD"", ""Antigens, Differentiation, Myelomonocytic"", ""CD33 protein, human"", ""Interleukin-1"", ""Interleukin-8"", ""Sialic Acid Binding Ig-like Lectin 3"", ""Tumor Necrosis Factor-alpha"", ""Phosphatidylinositol 3-Kinases"", ""p38 Mitogen-Activated Protein Kinases"", ""N-Acetylneuraminic Acid""]}",False
DIRECTLY_DECREASES,28107,6990,2017,27429982,False,False,False,"In accordance with this, greater numbers of Arg+ microglia containing Aβ were found when compared to iNOS+ microglia in the inflamed hemisphere [24].",#57:0,PMC4939332,"{""full_journal_name"": ""BioMed research international"", ""pub_date"": ""2017-02-22"", ""ref"": ""27429982"", ""pub_year"": 2017, ""last_author"": ""Yin M"", ""type"": ""PubMed"", ""author_list"": [""Chen P"", ""Zhao W"", ""Guo Y"", ""Xu J"", ""Yin M""], ""title"": ""CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection."", ""doi"": ""10.1155/2016/8090918""}","{""PublicationType"": [""Review""], ""Section"": [""CX3CL1/CX3CR1 and Microglia""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Chemokine CX3CL1"", ""Humans"", ""Microglia"", ""Neuronal Plasticity"", ""Neuroprotection"", ""Receptors, Chemokine""], ""substances"": [""Chemokine CX3CL1"", ""Receptors, Chemokine""]}",False
DIRECTLY_DECREASES,40328,12070,2008,18675468,False,False,False,"During the course of AD tau becomes hyperphosphorylated and dissociates from microtubules which then depolymerize. The hyperphosphorylated tau self-aggregates and accumulates in the cell body where it forms paired-helical filaments (neurofibrillary tangles). As a consequence of accumulation of Abeta at synapses, Ca2+ regulation is impaired",#59:5,PMC2566585,"{""full_journal_name"": ""Trends in neurosciences"", ""pub_date"": ""2008-11-25"", ""ref"": ""18675468"", ""pub_year"": 2008, ""last_author"": ""Mattson MP"", ""type"": ""PubMed"", ""author_list"": [""Bezprozvanny I"", ""Mattson MP""], ""title"": ""Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease."", ""doi"": ""10.1016/j.tins.2008.06.005""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""Regulation of actin cytoskeleton subgraph"", ""Tau protein subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Calcium"", ""Calcium Signaling"", ""Humans"", ""Neurons"", ""Presenilins"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides"", ""Presenilins"", ""Calcium""]}",False
DIRECTLY_DECREASES,34909,365,2007,17213958,False,False,False,"As indicated in Fig. 2, the presence of GSH protected the cells against H2O2-induced apoptosis and the increase in AChE activity. Therefore, the redox imbalance resulted in mitochondrial dysfunction and enhanced mitochondrial reactive oxygen species (ROS) generation.",#59:5,,"{""full_journal_name"": ""Acta biochimica et biophysica Sinica"", ""pub_date"": ""2007-02-21"", ""ref"": ""17213958"", ""pub_year"": 2007, ""last_author"": ""Zhang X"", ""type"": ""PubMed"", ""author_list"": [""Jiang H"", ""Zhang J"", ""Zhu H"", ""Li H"", ""Zhang X""], ""title"": ""Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Acetylcholine signaling subgraph"", ""Glutathione reductase subgraph""], ""mesh"": [""Acetylcholinesterase"", ""Animals"", ""Apoptosis"", ""Caspase 3"", ""Cytochromes c"", ""Enzyme Activation"", ""Glutathione"", ""Hydrogen Peroxide"", ""Nerve Growth Factor"", ""PC12 Cells"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Rats""], ""substances"": [""Cytochromes c"", ""Nerve Growth Factor"", ""Hydrogen Peroxide"", ""Proto-Oncogene Proteins c-akt"", ""Acetylcholinesterase"", ""Caspase 3"", ""Glutathione""]}",False
DIRECTLY_DECREASES,4213,4144,2012,22046233,False,False,False,"We previously reported that genetic variants in SORCS1 increase the risk of AD, that over-expression of SorCS1 reduces gamma-secretase activity and ABeta¸ levels, and that SorCS1 suppression increases gamma-secretase processing of APP and ABeta¸ levels. We now explored the effect of variation in SORCS1 on memory.Variation in intron 1 in SORCS1 is associated with memory changes in AD",#59:5,PMC3202519,"{""full_journal_name"": ""PloS one"", ""pub_date"": ""2012-03-26"", ""ref"": ""22046233"", ""pub_year"": 2012, ""last_author"": ""Mayeux R"", ""type"": ""PubMed"", ""author_list"": [""Reitz C"", ""Lee JH"", ""Rogers RS"", ""Mayeux R""], ""title"": ""Impact of genetic variation in SORCS1 on memory retention."", ""doi"": ""10.1371/journal.pone.0024588""}","{""Subgraph"": [""Gamma secretase subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Case-Control Studies"", ""Hispanic or Latino"", ""Humans"", ""Memory"", ""Polymorphism, Single Nucleotide"", ""Receptors, Cell Surface""], ""substances"": [""Receptors, Cell Surface"", ""SORCS1 protein, human""]}",False
DIRECTLY_DECREASES,7118,3278,2019,30962309,False,False,False,"Of interest, levels of miR-146a-5p are reduced in regulatory T cells of RA patients with active disease and correlate with joint inflammation (106).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,1850,41494,2017,27794524,False,False,False,"Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,12004,7118,2019,30962309,False,False,False,"In RA, miR-22-3p levels are reduced in synovial tissue from RA patients compared with osteoarthritis patients (97), and low expression of miR-22-3p is associated with a good response to adalimumab treatment (98).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Cell"": [""synovial cell""], ""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,6905,25565,2017,27956442,False,False,False,"However, the counter to this may be the recently announced groundbreaking results from the ORATORIO trial (NCT01194570, ClinicalTrials.gov) of ocrelizumab – an anti-CD20 depleting molecule – in PPMS and the EXPAND trial (NCT01665144, ClinicalTrials.gov) of siponimod – a selective sphingosine-1-phosphate receptor modulator – in SPMS that delayed the confirmed progression of MS by about 20–25% over 2–3 years [34,35]",#72:27,PMC6329568,"{""full_journal_name"": ""Clinical medicine (London, England)"", ""pub_date"": ""2017-02-24"", ""ref"": ""27956442"", ""pub_year"": 2017, ""last_author"": ""Chataway J"", ""type"": ""PubMed"", ""author_list"": [""Doshi A"", ""Chataway J""], ""title"": ""Multiple sclerosis, a treatable disease.""}","{""Confidence"": [""High""], ""mesh"": [""Humans"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,6938,2132,2017,27794524,False,False,False,"In turn, scavengers reducing ROS and RNS levels in EAE were able to attenuate focal axonal degeneration without altering the number of immune cells is EAE lesions.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11809,6708,2017,27794524,False,False,False,"Recently, two studies reported protective properties of MitoQ, a specific inhibitor for mitochondrial ROS production, in EAE (Davies et al.,2013).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,35403,9358,2015,26088141,False,False,False,"As shown in Fig. 3A, coupling between Gαq and α7 nAChRs was virtually abolished by expression of α7345–348A. A noticeable loss in Gαq (−62.18%) and Gβγ (−20.03%) expression within the α7 nAChR complex IP was seen in cells transfected with α7345–348A (Fig. 3A).",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
DIRECTLY_DECREASES,9735,14831,2015,25652642,False,False,False,"Unlike neurons, NF-κB is present in the cytoplasm as an inactive complex with the IκB proteins in glial cells under physiological conditions",#65:71,PMC5873291,"{""full_journal_name"": ""Expert opinion on therapeutic targets"", ""pub_date"": ""2015-11-23"", ""ref"": ""25652642"", ""pub_year"": 2015, ""last_author"": ""Lahiri DK"", ""type"": ""PubMed"", ""author_list"": [""Srinivasan M"", ""Lahiri DK""], ""title"": ""Significance of NF-\u03baB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis."", ""doi"": ""10.1517/14728222.2014.989834""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""Cytoplasm"", ""Neuroglia""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Drug Design"", ""Humans"", ""Multiple Sclerosis"", ""NF-kappa B"", ""Neuroprotective Agents"", ""Signal Transduction"", ""Up-Regulation""], ""substances"": [""NF-kappa B"", ""Neuroprotective Agents""]}",False
DIRECTLY_DECREASES,14907,32034,1999,10464280,False,False,False,"Thus, MTs inhibited the rate of tau dephosphorylation by ABaC.",#62:7,,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""1999-10-07"", ""ref"": ""10464280"", ""pub_year"": 1999, ""last_author"": ""Bloom GS"", ""type"": ""PubMed"", ""author_list"": [""Sontag E"", ""Nunbhakdi-Craig V"", ""Lee G"", ""Brandt R"", ""Kamibayashi C"", ""Kuret J"", ""White CL"", ""Mumby MC"", ""Bloom GS""], ""title"": ""Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.""}","{""Confidence"": [""High""], ""Method"": [""Dephosphorylation Assay, Colorimetric"", ""Enhanced Chemioluminescence visualization (ECL)"", ""Microtubule Co-Sedimentation Assay"", ""SDS-PAGE"", ""Western Blot""], ""TauIsoform"": [""Isoform F (441 aa)""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cattle"", ""Humans"", ""Microtubules"", ""Neurons"", ""Phosphoprotein Phosphatases"", ""Phosphorylation"", ""Protein Phosphatase 2"", ""tau Proteins""], ""substances"": [""tau Proteins"", ""Phosphoprotein Phosphatases"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,1687,28420,2013,23737518,False,False,False,"Small molecules in the diaminothiazole class are potent Tau kinase inhibitors that target CDK5 and GSK3β. Lead compounds from the series have IC50 values toward CDK5/p25 and GSK3β in the low nanomolar range and no observed toxicity in the therapeutic dose range. Neuronal protective effects and decreased PHF-1 immunoreactivity were observed in two animal models, 3×Tg-AD and CK-p25. Treatment nearly eliminated Sarkosyl-insoluble Tau with the most prominent effect on the phosphorylation at Ser-404. Treatment also induced the recovery of memory in a fear conditioning assay.",#60:23,PMC3724657,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2013-11-04"", ""ref"": ""23737518"", ""pub_year"": 2013, ""last_author"": ""Kosik KS"", ""type"": ""PubMed"", ""author_list"": [""Zhang X"", ""Hernandez I"", ""Rei D"", ""Mair W"", ""Laha JK"", ""Cornwell ME"", ""Cuny GD"", ""Tsai LH"", ""Steen JA"", ""Kosik KS""], ""title"": ""Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models."", ""doi"": ""10.1074/jbc.M112.436402""}","{""Confidence"": [""Medium""], ""Half_life"": [""70 min""], ""IC50"": [""38 nM""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Blotting, Western"", ""Cyclin-Dependent Kinase 5"", ""Diamines"", ""Disease Models, Animal"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Injections, Intraperitoneal"", ""Injections, Intraventricular"", ""Injections, Subcutaneous"", ""Learning"", ""Male"", ""Memory"", ""Mice"", ""Mice, Transgenic"", ""Neuroprotective Agents"", ""Phosphorylation"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Tauopathies"", ""Thiazoles"", ""Treatment Outcome"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Diamines"", ""Neuroprotective Agents"", ""Presenilin-1"", ""Protein Kinase Inhibitors"", ""Thiazoles"", ""tau Proteins"", ""Cyclin-Dependent Kinase 5"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3""]}",False
DIRECTLY_DECREASES,30332,36595,2016,26792193,False,False,False,We show that inhibition of γ-secretase-dependent cleavage of the TREM2 C-terminal fragment in cellular membranes interferes with TREM2-dependent signaling and cellular function.,#57:0,PMC4721188,"{""full_journal_name"": ""Journal of neuroinflammation"", ""pub_date"": ""2016-10-06"", ""ref"": ""26792193"", ""pub_year"": 2016, ""last_author"": ""Walter J"", ""type"": ""PubMed"", ""author_list"": [""Glebov K"", ""Wunderlich P"", ""Karaca I"", ""Walter J""], ""title"": ""Functional involvement of \u03b3-secretase in signaling of the triggering receptor expressed on myeloid cells-2 (TREM2)."", ""doi"": ""10.1186/s12974-016-0479-9""}","{""Section"": [""Abstract""], ""mesh"": [""Amyloid Precursor Protein Secretases"", ""Animals"", ""COS Cells"", ""Calcium Signaling"", ""Cell Line, Transformed"", ""Chlorocebus aethiops"", ""Green Fluorescent Proteins"", ""Membrane Glycoproteins"", ""Mice"", ""Microglia"", ""Models, Biological"", ""Myeloid Cells"", ""Phagocytosis"", ""Receptors, Immunologic"", ""Signal Transduction"", ""Time Factors"", ""Transfection""], ""substances"": [""Membrane Glycoproteins"", ""Receptors, Immunologic"", ""Trem2 protein, mouse"", ""Green Fluorescent Proteins"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,37957,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,30332,36863,2014,24078628,False,False,False,"Interestingly, the pharmacological inhibition of γ-secretase with DAPT led to a significant increase of TREM2 CTFs (239.6 ± 10.8% versus 100 ± 18.2%; Fig. 2A).",#57:0,PMC3829152,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2014-01-23"", ""ref"": ""24078628"", ""pub_year"": 2014, ""last_author"": ""Walter J"", ""type"": ""PubMed"", ""author_list"": [""Wunderlich P"", ""Glebov K"", ""Kemmerling N"", ""Tien NT"", ""Neumann H"", ""Walter J""], ""title"": ""Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage."", ""doi"": ""10.1074/jbc.M113.517540""}","{""Section"": [""Results""], ""mesh"": [""Adaptor Proteins, Signal Transducing"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Animals"", ""COS Cells"", ""Cell Membrane"", ""Chlorocebus aethiops"", ""HEK293 Cells"", ""Humans"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Phosphorylation"", ""Protein Structure, Tertiary"", ""Proteolysis"", ""Receptors, Immunologic"", ""Signal Transduction""], ""substances"": [""Adaptor Proteins, Signal Transducing"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Receptors, Immunologic"", ""TREM2 protein, human"", ""TYROBP protein, human"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,32922,21632,2013,23758787,False,False,False,"Similarly, TRAF4 physically interacts with and functionally counteracts TRAF6 and TRIF in TLR signaling [99].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in TLR signaling""]}",False
DIRECTLY_DECREASES,36490,28584,2019,29158945,False,False,False,Inhibition of NF-κB in T cells by transgenic expression of a degradation-resistant form of IκBα lacking its N-terminal sequence impairs Th1 responses.40,#57:0,PMC5661633,"{""full_journal_name"": ""Signal transduction and targeted therapy"", ""pub_date"": ""2021-02-02"", ""ref"": ""29158945"", ""pub_year"": 2021, ""last_author"": ""Sun SC"", ""type"": ""PubMed"", ""author_list"": [""Liu T"", ""Zhang L"", ""Joo D"", ""Sun SC""], ""title"": ""NF-\u03baB signaling in inflammation."", ""doi"": ""10.1038/sigtrans.2017.23""}","{""PublicationType"": [""Review""], ""Section"": [""NF-\u03baB function in T cells""]}",False
DIRECTLY_DECREASES,40328,5279,2008,18675468,False,False,False,"During the course of AD tau becomes hyperphosphorylated and dissociates from microtubules which then depolymerize. The hyperphosphorylated tau self-aggregates and accumulates in the cell body where it forms paired-helical filaments (neurofibrillary tangles). As a consequence of accumulation of Abeta at synapses, Ca2+ regulation is impaired",#59:5,PMC2566585,"{""full_journal_name"": ""Trends in neurosciences"", ""pub_date"": ""2008-11-25"", ""ref"": ""18675468"", ""pub_year"": 2008, ""last_author"": ""Mattson MP"", ""type"": ""PubMed"", ""author_list"": [""Bezprozvanny I"", ""Mattson MP""], ""title"": ""Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease."", ""doi"": ""10.1016/j.tins.2008.06.005""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""Tau protein subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Calcium"", ""Calcium Signaling"", ""Humans"", ""Neurons"", ""Presenilins"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides"", ""Presenilins"", ""Calcium""]}",False
DIRECTLY_DECREASES,37712,4488,2011,22110360,False,False,False,"Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen- activated protein kinase kinase kinase family, is composed of an inhibitory N-terminal domain, a kinase domain, and a C-terminal regulatory domain (Ichijo et al., 1997). ASK1 can promote apoptosis in response to common pro-apoptotic stresses, such as oxidative stress (Song et al., 2002), death receptor ligands (Nishitoh et al., 1998), and endoplasmic reticulum stress (Nishitoh et al., 2002). ASK1 also phosphorylates and activates both p38 and JNK pathways (Ichijo et al., 1997). The mechanism of ASK1 activation is positively regulated by its binding proteins such as TNF receptor-ssociated factors 2/6 (Noguchi et al., 2005) and Daxx (Chang et al., 1998). On the other hand, several cellular proteins, including thioredoxin (Saitoh et al., 1998), Hsp90 (Zhang et al., 2005), and 14-3-3 (Zhang et al., 1999), have been reported to interact with ASK1 and inhibit ASK1 activity.",#59:5,PMC3213740,"{""full_journal_name"": ""Experimental neurobiology"", ""pub_date"": ""2011-11-23"", ""ref"": ""22110360"", ""pub_year"": 2011, ""last_author"": ""Chung KC"", ""type"": ""PubMed"", ""author_list"": [""Choi HK"", ""Chung KC""], ""title"": ""Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death."", ""doi"": ""10.5607/en.2011.20.1.35""}","{""Subgraph"": [""MAPK-JNK subgraph""]}",False
DIRECTLY_DECREASES,14221,13152,2004,14976144,False,False,False,"Additional experiments were designed to investigate the presence of p35, CDK5, and p35/CDK5 kinase activity in β-cell lines. Biochemical characterization of CDK5 kinase activity was also investigated. Among the different cell lines tested, only INS-1 cells, an insulin- producing β-cell line, showed expression of p35 (Fig. 2A). These cells also contain protein kinase activity that can be immunoprecipitated with a p35-specific antibody (Fig. 2B). Both p35 expression and p35/CDK5 activity were absent in other cell lines, such as HeLa and NIH-3T3 (Fig. 2, A and B), although these cell lines expressed CDK5 protein (Fig. 2A). We then investigated whether the kinase activity immunoprecipitated by the p35 antibody was due to its association with CDK5. We performed experiments with roscovitine, a relatively specific inhibitor of CDK5 activity (17). The p35/CDK5 activity in INS-1 cells was inhibited by roscovitine, but not by other protein kinase inhibitors, such as H89 (protein kinase A) and SB202190 (p38MAPK; Fig. 2C). Also, the inhibition by roscovitine was dose dependent (Fig. 2D), with a 50% inhibitory concentration of 128 nm, within the range of that previously reported for CDK5 (18).",#59:5,,"{""full_journal_name"": ""Endocrinology"", ""pub_date"": ""2004-06-24"", ""ref"": ""14976144"", ""pub_year"": 2004, ""last_author"": ""Habener JF"", ""type"": ""PubMed"", ""author_list"": [""Ubeda M"", ""Kemp DM"", ""Habener JF""], ""title"": ""Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells.""}","{""Subgraph"": [""Cyclin-CDK subgraph"", ""Insulin signal transduction""], ""UserdefinedCellLine"": [""INS-1 cells""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Cell Line"", ""Culture Techniques"", ""Cyclin-Dependent Kinase 5"", ""Cyclin-Dependent Kinases"", ""Glucose"", ""Humans"", ""Insulin"", ""Islets of Langerhans"", ""Male"", ""Nerve Tissue Proteins"", ""Osmolar Concentration"", ""Precipitin Tests"", ""Protein Kinases"", ""Rats"", ""Rats, Wistar"", ""Signal Transduction"", ""Transcription, Genetic"", ""Transfection""], ""substances"": [""Insulin"", ""Nerve Tissue Proteins"", ""neuronal Cdk5 activator (p25-p35)"", ""Protein Kinases"", ""Cyclin-Dependent Kinase 5"", ""CDK5 protein, human"", ""Cdk5 protein, rat"", ""Cyclin-Dependent Kinases"", ""Glucose""]}",False
DIRECTLY_DECREASES,32290,4951,2019,30962309,False,False,False,"In humans, mRNA destabilization by deadenylation and subsequent exonucleolytic decay dominates the regulatory effect of miRNAs, whereas the contribution from direct translational repression is relatively small (35–39).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,11853,1844,2017,27794524,False,False,False,"In addition, non-toxic ferric iron is released into the extracellular space from damaged oligodendrocytes in multiple sclerosis lesions, where it undergoes transformation to the divalent ferrous form, further increasing ROS toxicity (Hametner et al., 2013).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Disease"": [""multiple sclerosis""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,6938,1885,2017,27794524,False,False,False,"In turn, scavengers reducing ROS and RNS levels in EAE were able to attenuate focal axonal degeneration without altering the number of immune cells is EAE lesions.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1834,5403,2020,30967783,False,False,False,"Furthermore, astroglial ATP ampliﬁes microglial signals and subsequently promotes glutamate release from astroglia, which directly inhibits synaptic transmission (Kettenmann et al., 2013).",#70:13,PMC6438858,"{""full_journal_name"": ""Frontiers in pharmacology"", ""pub_date"": ""2020-09-30"", ""ref"": ""30967783"", ""pub_year"": 2020, ""last_author"": ""He Q"", ""type"": ""PubMed"", ""author_list"": [""Wang J"", ""Wang J"", ""Wang J"", ""Yang B"", ""Weng Q"", ""He Q""], ""title"": ""Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis."", ""doi"": ""10.3389/fphar.2019.00286""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""]}",False
DIRECTLY_DECREASES,6938,1885,2017,27794524,False,False,False,"In turn, scavengers reducing ROS and RNS levels in EAE were able to attenuate focal axonal degeneration without altering the number of immune cells is EAE lesions.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11809,1535,2017,27794524,False,False,False,"Because levels of inflammation were not affected by MitoQ, it is conceivable that increased mitochondrial protection against ROS is sufficient to reduce axonal damage.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,35403,698,2015,26088141,False,False,False,An increase in G protein association within the α7 complex was observed in α7+ cells (Gαq +16.71%; Gβγ +19.90%) (Fig. 3A). Similar findings in transfected N2a cells indicate a loss in G protein association within the α7 complex when α7345–348A nAChRs are expressed (Fig. 3B).,#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
DIRECTLY_DECREASES,7049,31687,2011,21882945,False,False,False,"Since this discovery, a number of high-affinity analogs, such as 17-AAG, and alternative synthetic scaffolds, including radicicol and PU-H71, have been reported (Figure 1) [85,88]. These compounds bind in either the N-terminal ATP-binding site (e.g., 17-AAG, radicicol and PU-H71) [89] or C-terminal dimerization domain (e.g., novobiocin and A4) [90,91], and they show great promise as both anticancer compounds and research tools for understanding Hsp90 biology",#69:73,PMC3190966,"{""full_journal_name"": ""Future medicinal chemistry"", ""pub_date"": ""2011-12-23"", ""ref"": ""21882945"", ""pub_year"": 2011, ""last_author"": ""Gestwicki JE"", ""type"": ""PubMed"", ""author_list"": [""Miyata Y"", ""Koren J"", ""Kiray J"", ""Dickey CA"", ""Gestwicki JE""], ""title"": ""Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies."", ""doi"": ""10.4155/fmc.11.88""}","{""Confidence"": [""Medium""], ""mesh"": [""Drug Evaluation, Preclinical"", ""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Humans"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""Protein Interaction Mapping"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""tau Proteins""]}",False
DIRECTLY_DECREASES,1935,853,2015,25331948,False,False,False,We have previously shown that the L-type calcium channel (LCC) antagonist nilvadipine reduces brain amyloid-β (Aβ) accumulation by affecting both Aβ production and Aβ clearance across the blood-brain barrier (BBB).,#60:23,PMC4256331,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-03-03"", ""ref"": ""25331948"", ""pub_year"": 2015, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Ait-Ghezala G"", ""Bachmeier C"", ""Laco G"", ""Beaulieu-Abdelahad D"", ""Lin Y"", ""Jin C"", ""Crawford F"", ""Mullan M""], ""title"": ""The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-\u03b2 production and Tau hyperphosphorylation."", ""doi"": ""10.1074/jbc.M114.608091""}","{""Confidence"": [""Medium""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""CHO Cells"", ""Calcium Channel Blockers"", ""Cell Line, Tumor"", ""Cricetulus"", ""Gene Expression Regulation"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""Neurons"", ""Nifedipine"", ""Phosphorylation"", ""Protein-Tyrosine Kinases"", ""Signal Transduction"", ""Syk Kinase"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Calcium Channel Blockers"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""tau Proteins"", ""nilvadipine"", ""Protein-Tyrosine Kinases"", ""SYK protein, human"", ""Syk Kinase"", ""Syk protein, mouse"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""Nifedipine""]}",False
DIRECTLY_DECREASES,2181,30244,2015,25672970,False,False,False,"In this study, we modified the PCAF inhibitor by chemical derivatization and selected compound C-30-27 as the most potent PCAF inhibitor. We demonstrated that C-30-27 selectively inhibited acetylation-dependent nuclear factor-κB (NF-κB) at Lys-122 and suppressed the NF-κB-mediated inflammatory response induced by lipopolysaccharide (LPS) or Aβ in both BV2 and Neuro-2A (N2A) cells. Finally, we demonstrated that C-30-27 improved cognitive deficits, as well as the capacity for locomotion and the damaged cholinergic system in the Aβ-treated rats.",#60:23,,"{""full_journal_name"": ""International journal of molecular medicine"", ""pub_date"": ""2015-12-01"", ""ref"": ""25672970"", ""pub_year"": 2015, ""last_author"": ""Yoon HG"", ""type"": ""PubMed"", ""author_list"": [""Park SY"", ""Kim MJ"", ""Kim YJ"", ""Lee YH"", ""Bae D"", ""Kim S"", ""Na Y"", ""Yoon HG""], ""title"": ""Selective PCAF inhibitor ameliorates cognitive and behavioral deficits by suppressing NF-\u03baB-mediated neuroinflammation induced by A\u03b2 in a model of Alzheimer's disease."", ""doi"": ""10.3892/ijmm.2015.2099""}","{""Cell_Line"": [""BV2"", ""N2a""], ""Confidence"": [""Medium""], ""mesh"": [""Acetylation"", ""Acetylcholine"", ""Acetylcholinesterase"", ""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Behavior, Animal"", ""Cell Death"", ""Cell Line"", ""Cognition"", ""Cytokines"", ""Disease Models, Animal"", ""Enzyme Inhibitors"", ""Mice"", ""Microglia"", ""NF-kappa B"", ""Neurons"", ""Rats"", ""p300-CBP Transcription Factors""], ""substances"": [""Amyloid beta-Peptides"", ""Cytokines"", ""Enzyme Inhibitors"", ""NF-kappa B"", ""p300-CBP Transcription Factors"", ""p300-CBP-associated factor"", ""Acetylcholinesterase"", ""Acetylcholine""]}",False
DIRECTLY_DECREASES,9671,37225,2017,28559417,False,False,False,"Upon shedding of Trem2, a C‐terminal membrane‐associated fragment is retained and further degraded by γ‐secretase (Wunderlich et al, 2013).",#57:0,PMC5494459,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2017-07-14"", ""ref"": ""28559417"", ""pub_year"": 2017, ""last_author"": ""Haass C"", ""type"": ""PubMed"", ""author_list"": [""Kleinberger G"", ""Brendel M"", ""Mracsko E"", ""Wefers B"", ""Groeneweg L"", ""Xiang X"", ""Focke C"", ""Deu\u00dfing M"", ""Su\u00e1rez-Calvet M"", ""Mazaheri F"", ""Parhizkar S"", ""Pettkus N"", ""Wurst W"", ""Feederle R"", ""Bartenstein P"", ""Mueggler T"", ""Arzberger T"", ""Knuesel I"", ""Rominger A"", ""Haass C""], ""title"": ""The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism."", ""doi"": ""10.15252/embj.201796516""}","{""Section"": [""Results""], ""mesh"": [""Animals"", ""Brain"", ""Disease Models, Animal"", ""Frontotemporal Dementia"", ""Gene Knock-In Techniques"", ""Glucose"", ""Humans"", ""Immunohistochemistry"", ""Magnetic Resonance Imaging"", ""Membrane Glycoproteins"", ""Mice"", ""Microglia"", ""Mutant Proteins"", ""Mutation, Missense"", ""Perfusion"", ""Positron-Emission Tomography"", ""Receptors, Immunologic""], ""substances"": [""Membrane Glycoproteins"", ""Mutant Proteins"", ""Receptors, Immunologic"", ""Trem2 protein, mouse"", ""Glucose""]}",False
DIRECTLY_DECREASES,7208,6942,2017,27794524,False,False,False,Global NAA measured across the whole brain is abnormally low in multiple sclerosis,#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,7042,30332,2014,24078628,False,False,False,"Interestingly, the pharmacological inhibition of γ-secretase with DAPT led to a significant increase of TREM2 CTFs (239.6 ± 10.8% versus 100 ± 18.2%; Fig. 2A).",#57:0,PMC3829152,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2014-01-23"", ""ref"": ""24078628"", ""pub_year"": 2014, ""last_author"": ""Walter J"", ""type"": ""PubMed"", ""author_list"": [""Wunderlich P"", ""Glebov K"", ""Kemmerling N"", ""Tien NT"", ""Neumann H"", ""Walter J""], ""title"": ""Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage."", ""doi"": ""10.1074/jbc.M113.517540""}","{""Section"": [""Results""], ""mesh"": [""Adaptor Proteins, Signal Transducing"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Animals"", ""COS Cells"", ""Cell Membrane"", ""Chlorocebus aethiops"", ""HEK293 Cells"", ""Humans"", ""Male"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Phosphorylation"", ""Protein Structure, Tertiary"", ""Proteolysis"", ""Receptors, Immunologic"", ""Signal Transduction""], ""substances"": [""Adaptor Proteins, Signal Transducing"", ""Membrane Glycoproteins"", ""Membrane Proteins"", ""Phosphatidylinositol 4,5-Diphosphate"", ""Receptors, Immunologic"", ""TREM2 protein, human"", ""TYROBP protein, human"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,28987,10666,2013,23758787,False,False,False,"TRAF4 binds directly to NOD2 in an agonist-dependent manner, and inhibits NOD2-induced NF-κB activation and bacterial killing [109]. This inhibitory effect of TRAF4 requires its phosphorylation at Ser426 by IKKα, which is also recruited to the NOD2 signaling complex [113].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in NLR signaling""]}",False
DIRECTLY_DECREASES,25240,24158,2012,21769591,False,False,False,"The ApoE gene responsible for the Alzheimer's disease has been examined to identify functional consequences of single-nucleotide polymorphisms (SNPs). Eighty-eight SNPs have been identified in the ApoE gene in which 31 are found to be nonsynonymous, 8 of them are coding synonymous, 33 are found to be in intron, and 3 are in untranslated region. The SNPs found in the untranslated region consisted of two SNPs from 5' and one SNP from the 3'. Twenty-nine percent of the identified nsSNPs have been reported as damaging. In the analysis of SNPs in the UTR regions, it has been recognized that rs72654467 from 5' and rs71673244 from 5' and 3' are responsible for the alteration in levels of expression. Both native and mutant protein structures were analyzed along with the stabilization residues. It has been concluded that among all SNPs of ApoE, the mutation in rs11542041 (R132S) has the most significant effect on functional variation.",#59:5,,"{""full_journal_name"": ""Functional & integrative genomics"", ""pub_date"": ""2012-03-06"", ""ref"": ""21769591"", ""pub_year"": 2012, ""last_author"": ""Nidheesh M"", ""type"": ""PubMed"", ""author_list"": [""Namboori PK"", ""Vineeth KV"", ""Rohith V"", ""Hassan I"", ""Sekhar L"", ""Sekhar A"", ""Nidheesh M""], ""title"": ""The ApoE gene of Alzheimer's disease (AD)."", ""doi"": ""10.1007/s10142-011-0238-z""}","{""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""APOE subgraph"", ""Amyloidogenic subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amino Acid Substitution"", ""Apolipoproteins E"", ""Computer Simulation"", ""Humans"", ""Models, Genetic"", ""Polymorphism, Single Nucleotide""], ""substances"": [""Apolipoproteins E""]}",False
DIRECTLY_DECREASES,40328,5349,2008,18675468,False,False,False,"During the course of AD tau becomes hyperphosphorylated and dissociates from microtubules which then depolymerize. The hyperphosphorylated tau self-aggregates and accumulates in the cell body where it forms paired-helical filaments (neurofibrillary tangles). As a consequence of accumulation of Abeta at synapses, Ca2+ regulation is impaired",#59:5,PMC2566585,"{""full_journal_name"": ""Trends in neurosciences"", ""pub_date"": ""2008-11-25"", ""ref"": ""18675468"", ""pub_year"": 2008, ""last_author"": ""Mattson MP"", ""type"": ""PubMed"", ""author_list"": [""Bezprozvanny I"", ""Mattson MP""], ""title"": ""Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease."", ""doi"": ""10.1016/j.tins.2008.06.005""}","{""MeSHAnatomy"": [""Neurons""], ""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""Tau protein subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Calcium"", ""Calcium Signaling"", ""Humans"", ""Neurons"", ""Presenilins"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides"", ""Presenilins"", ""Calcium""]}",False
DIRECTLY_DECREASES,21142,4488,2011,22110360,False,False,False,"Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen- activated protein kinase kinase kinase family, is composed of an inhibitory N-terminal domain, a kinase domain, and a C-terminal regulatory domain (Ichijo et al., 1997). ASK1 can promote apoptosis in response to common pro-apoptotic stresses, such as oxidative stress (Song et al., 2002), death receptor ligands (Nishitoh et al., 1998), and endoplasmic reticulum stress (Nishitoh et al., 2002). ASK1 also phosphorylates and activates both p38 and JNK pathways (Ichijo et al., 1997). The mechanism of ASK1 activation is positively regulated by its binding proteins such as TNF receptor-ssociated factors 2/6 (Noguchi et al., 2005) and Daxx (Chang et al., 1998). On the other hand, several cellular proteins, including thioredoxin (Saitoh et al., 1998), Hsp90 (Zhang et al., 2005), and 14-3-3 (Zhang et al., 1999), have been reported to interact with ASK1 and inhibit ASK1 activity.",#59:5,PMC3213740,"{""full_journal_name"": ""Experimental neurobiology"", ""pub_date"": ""2011-11-23"", ""ref"": ""22110360"", ""pub_year"": 2011, ""last_author"": ""Chung KC"", ""type"": ""PubMed"", ""author_list"": [""Choi HK"", ""Chung KC""], ""title"": ""Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death."", ""doi"": ""10.5607/en.2011.20.1.35""}","{""Subgraph"": [""MAPK-JNK subgraph""]}",False
DIRECTLY_DECREASES,32340,6454,2013,22212405,False,False,False,The present review raises the hypothesis that the onset of AD pathology is closely related with mitochondrial dysfunction induced by Abeta and brain-derived neurotrophic factor (BDNF) axonal transport deficits. It is well-known that axonal transport defect and attenuation of BDNF-neurotrophic tyrosine receptor kinase 2 (TrkB) signal are fatal to neuronal function and survival.We hypothesized that abnormal amyloid precursor protein (APP) processing and Abeta production in mitochondria disturb the axonal transport by impairing mitochondrial function and attenuate BDNF-neurotrophic tyrosine receptor kinase 2 signal subsequently.,#59:5,,"{""full_journal_name"": ""Neurobiology of aging"", ""pub_date"": ""2013-01-24"", ""ref"": ""22212405"", ""pub_year"": 2013, ""last_author"": ""Zhang D"", ""type"": ""PubMed"", ""author_list"": [""Ye X"", ""Tai W"", ""Zhang D""], ""title"": ""The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits."", ""doi"": ""10.1016/j.neurobiolaging.2011.11.004""}","{""CellStructure"": [""Mitochondria""], ""Subgraph"": [""Nerve growth factor subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Axonal Transport"", ""Brain-Derived Neurotrophic Factor"", ""Cell Line, Tumor"", ""Cells, Cultured"", ""Humans"", ""Mice"", ""Mice, Inbred C57BL"", ""Mitochondria"", ""Neural Inhibition""], ""substances"": [""Amyloid beta-Peptides"", ""Brain-Derived Neurotrophic Factor""]}",False
DIRECTLY_DECREASES,2071,24136,1997,8940412,False,False,False,"Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",#59:50,,"{""full_journal_name"": ""Endocrinology"", ""pub_date"": ""1997-01-23"", ""ref"": ""8940412"", ""pub_year"": 1997, ""last_author"": ""Chrousos GP"", ""type"": ""PubMed"", ""author_list"": [""Webster EL"", ""Lewis DB"", ""Torpy DJ"", ""Zachman EK"", ""Rice KC"", ""Chrousos GP""], ""title"": ""In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.""}","{""Anatomy"": [""pituitary gland""], ""AssayType"": [""B""], ""Confidence"": [""Medium""], ""MeasurementRelation"": [""=""], ""MeasurementType"": [""Ki""], ""MeasurementUnits"": [""nM""], ""MeasurementValue"": [""1.9""], ""Species"": [""10116""], ""mesh"": [""Adrenocorticotropic Hormone"", ""Animals"", ""Binding, Competitive"", ""Carrageenan"", ""Cerebellum"", ""Corticotropin-Releasing Hormone"", ""Frontal Lobe"", ""Inflammation"", ""Injections, Subcutaneous"", ""Male"", ""Myocardium"", ""Pituitary Gland"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Sprague-Dawley"", ""Receptors, Corticotropin-Releasing Hormone"", ""Sheep""], ""substances"": [""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""antalarmin"", ""Carrageenan"", ""Adrenocorticotropic Hormone"", ""Corticotropin-Releasing Hormone""]}",False
DIRECTLY_DECREASES,40413,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1850,40834,2017,27794524,False,False,False,"Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1513,1421,2017,27794524,False,False,False,"Indeed, the most active cortical multiple sclerosis lesions are crowded with CD8 + T cells and contain few B cells or plasma cells, suggesting cortical inflammation might correlate with reduction in EBV-infected B/plasma cells numbers (Magliozzi et al., 2013).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Anatomy"": [""cortex""], ""Cell"": [""lymphocyte of B lineage"", ""plasma cell""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,7207,1535,2017,27794524,False,False,False,"However, when mitochondrial injury surpasses a certain threshold, energy deficiency will lead to axonal degeneration and cell death (Friese et al., 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,14472,1630,2017,27794524,False,False,False,"The antioxidant idebenone was proven to be beneficial in Leber’s hereditary optic neuropathy, a disorder caused by mitochondrial defects.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,35403,9358,2015,26088141,False,False,False,An increase in G protein association within the α7 complex was observed in α7+ cells (Gαq +16.71%; Gβγ +19.90%) (Fig. 3A). Similar findings in transfected N2a cells indicate a loss in G protein association within the α7 complex when α7345–348A nAChRs are expressed (Fig. 3B).,#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
DIRECTLY_DECREASES,1927,31687,2011,21882945,False,False,False,"Since this discovery, a number of high-affinity analogs, such as 17-AAG, and alternative synthetic scaffolds, including radicicol and PU-H71, have been reported (Figure 1) [85,88]. These compounds bind in either the N-terminal ATP-binding site (e.g., 17-AAG, radicicol and PU-H71) [89] or C-terminal dimerization domain (e.g., novobiocin and A4) [90,91], and they show great promise as both anticancer compounds and research tools for understanding Hsp90 biology",#69:73,PMC3190966,"{""full_journal_name"": ""Future medicinal chemistry"", ""pub_date"": ""2011-12-23"", ""ref"": ""21882945"", ""pub_year"": 2011, ""last_author"": ""Gestwicki JE"", ""type"": ""PubMed"", ""author_list"": [""Miyata Y"", ""Koren J"", ""Kiray J"", ""Dickey CA"", ""Gestwicki JE""], ""title"": ""Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies."", ""doi"": ""10.4155/fmc.11.88""}","{""Confidence"": [""Medium""], ""mesh"": [""Drug Evaluation, Preclinical"", ""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Humans"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""Protein Interaction Mapping"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""tau Proteins""]}",False
DIRECTLY_DECREASES,7018,24511,2015,25331948,False,False,False,"We observed that pharmacological inhibition of Syk with BAY61-3606 stimulates Ser-9 phosphorylation of GSK3β in SH-SY5Y cells (Fig. 9, A and B) suggesting that blocking Syk activity results in GSK3β inhibition.",#60:23,PMC4256331,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-03-03"", ""ref"": ""25331948"", ""pub_year"": 2015, ""last_author"": ""Mullan M"", ""type"": ""PubMed"", ""author_list"": [""Paris D"", ""Ait-Ghezala G"", ""Bachmeier C"", ""Laco G"", ""Beaulieu-Abdelahad D"", ""Lin Y"", ""Jin C"", ""Crawford F"", ""Mullan M""], ""title"": ""The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-\u03b2 production and Tau hyperphosphorylation."", ""doi"": ""10.1074/jbc.M114.608091""}","{""Cell_Line"": [""SH-SY5Y""], ""Confidence"": [""Medium""], ""mesh"": [""Amyloid beta-Peptides"", ""Animals"", ""CHO Cells"", ""Calcium Channel Blockers"", ""Cell Line, Tumor"", ""Cricetulus"", ""Gene Expression Regulation"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""Humans"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""Neurons"", ""Nifedipine"", ""Phosphorylation"", ""Protein-Tyrosine Kinases"", ""Signal Transduction"", ""Syk Kinase"", ""tau Proteins""], ""substances"": [""Amyloid beta-Peptides"", ""Calcium Channel Blockers"", ""Intracellular Signaling Peptides and Proteins"", ""NF-kappa B"", ""tau Proteins"", ""nilvadipine"", ""Protein-Tyrosine Kinases"", ""SYK protein, human"", ""Syk Kinase"", ""Syk protein, mouse"", ""GSK3B protein, human"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, mouse"", ""Glycogen Synthase Kinase 3"", ""Nifedipine""]}",False
DIRECTLY_DECREASES,1694,4481,2015,24844691,False,False,False,"In the present study, we tested the potential of two selective HDAC6 inhibitors, tubastatin A and ACY-1215, to rescue cognitive deficits in a mouse model of AD. We found that both tubastatin A and ACY-1215 alleviated behavioral deficits, altered amyloid-β (Aβ) load, and reduced tau hyperphosphorylation in AD mice without obvious adverse effects. Our data suggested that tubastatin A and ACY-1215 not only promoted tubulin acetylation, but also reduced production and facilitated autophagic clearance of Aβ and hyperphosphorylated tau.",#60:23,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-03-30"", ""ref"": ""24844691"", ""pub_year"": 2015, ""last_author"": ""Qin C"", ""type"": ""PubMed"", ""author_list"": [""Zhang L"", ""Liu C"", ""Wu J"", ""Tao JJ"", ""Sui XL"", ""Yao ZG"", ""Xu YF"", ""Huang L"", ""Zhu H"", ""Sheng SL"", ""Qin C""], ""title"": ""Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice."", ""doi"": ""10.3233/JAD-140066""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Brain"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Exploratory Behavior"", ""Gene Expression Regulation"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Hydroxamic Acids"", ""Indoles"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Peptide Fragments"", ""Phosphorylation"", ""Presenilin-1"", ""Pyrimidines"", ""Tubulin""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Histone Deacetylase Inhibitors"", ""Hydroxamic Acids"", ""Indoles"", ""PSEN1 protein, human"", ""Peptide Fragments"", ""Presenilin-1"", ""Pyrimidines"", ""Tubulin"", ""amyloid beta-protein (1-40)"", ""amyloid beta-protein (1-42)"", ""tubastatin A"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""ricolinostat""]}",False
DIRECTLY_DECREASES,37008,39058,2014,25001178,False,False,False,"In primary neurons, overexpression of miR-125b causes tau hyperphosphorylation and an upregulation of p35, cdk5, and p44/42-MAPK signaling. In parallel, the phosphatases DUSP6 and PPP1CA and the anti-apoptotic factor Bcl-W are downregulated as direct targets of miR-125b. Knockdown of these phosphatases induces tau hyperphosphorylation, and overexpression of PPP1CA and Bcl-W prevents miR-125b-induced tau phosphorylation, suggesting that they mediate the effects of miR-125b on tau. Conversely, suppression of miR-125b in neurons by tough decoys reduces tau phosphorylation and kinase expression/activity. Injecting miR-125b into the hippocampus of mice impairs associative learning and is accompanied by downregulation of Bcl-W, DUSP6, and PPP1CA, resulting in increased tau phosphorylation in vivo. Importantly, DUSP6 and PPP1CA are also reduced in AD brains.",#60:23,PMC4194100,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2014-09-30"", ""ref"": ""25001178"", ""pub_year"": 2014, ""last_author"": ""Edbauer D"", ""type"": ""PubMed"", ""author_list"": [""Banzhaf-Strathmann J"", ""Benito E"", ""May S"", ""Arzberger T"", ""Tahirovic S"", ""Kretzschmar H"", ""Fischer A"", ""Edbauer D""], ""title"": ""MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease."", ""doi"": ""10.15252/embj.201387576""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Apoptosis Regulatory Proteins"", ""Cells, Cultured"", ""Cognition Disorders"", ""Down-Regulation"", ""Dual Specificity Phosphatase 6"", ""Gene Knockout Techniques"", ""Hippocampus"", ""Humans"", ""Memory"", ""Mice"", ""Mice, Inbred C57BL"", ""MicroRNAs"", ""Neurons"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""tau Proteins""], ""substances"": [""Apoptosis Regulatory Proteins"", ""BCL2L2 protein, human"", ""MAPT protein, human"", ""MIRN125 microRNA, human"", ""MicroRNAs"", ""tau Proteins"", ""PPP1CA protein, human"", ""Protein Phosphatase 1"", ""DUSP6 protein, human"", ""Dual Specificity Phosphatase 6""]}",False
DIRECTLY_DECREASES,29218,12350,2007,17213958,False,False,False,"Acetylcholinesterase (AChE) is thought to play an important role during apoptotic process. Our results showed that H2O2 induced AChE activity, a functional marker in apoptotic process, increases in neuronal-like PC12 cells. Glutathione, which is involved in cellular redox homeostasis, inhibited the increase of AChE activity, suggesting that reactive oxygen species (ROS) play a key role in this process. Further investigation showed that the elevation of AChE was observed after the degradation of Akt, release of cytochrome c from mitochondria into the cytosol, and activation of caspase family members. When nerve growth factor (NGF) was present, with the maintenance of Akt level, the elevation of AChE, the cytochrome c diffusion, as well as apoptotic process were markedly attenuated in H2O2-treated PC12 cells",#59:5,,"{""full_journal_name"": ""Acta biochimica et biophysica Sinica"", ""pub_date"": ""2007-02-21"", ""ref"": ""17213958"", ""pub_year"": 2007, ""last_author"": ""Zhang X"", ""type"": ""PubMed"", ""author_list"": [""Jiang H"", ""Zhang J"", ""Zhu H"", ""Li H"", ""Zhang X""], ""title"": ""Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Acetylcholine signaling subgraph"", ""Caspase subgraph""], ""mesh"": [""Acetylcholinesterase"", ""Animals"", ""Apoptosis"", ""Caspase 3"", ""Cytochromes c"", ""Enzyme Activation"", ""Glutathione"", ""Hydrogen Peroxide"", ""Nerve Growth Factor"", ""PC12 Cells"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Rats""], ""substances"": [""Cytochromes c"", ""Nerve Growth Factor"", ""Hydrogen Peroxide"", ""Proto-Oncogene Proteins c-akt"", ""Acetylcholinesterase"", ""Caspase 3"", ""Glutathione""]}",False
DIRECTLY_DECREASES,36416,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,12746,1017,2013,23758787,False,False,False,"Interestingly, a recent study shows that linear ubiquitination of NEMO switches it from a positive to a negative regulator of RIG-I signaling, as linear ubiquitinated NEMO associates with TRAF3 but disrupts the MAVS-TRAF3 complex [138].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in RLR signaling""]}",False
DIRECTLY_DECREASES,5379,32340,2012,21696420,False,False,False,"HSPB8 is a small heat shock protein that forms a complex with the co- chaperone BAG3. Overexpression of the HSPB8-BAG3 complex in cells stimulates autophagy and facilitates the clearance of mutated aggregation-prone proteins, whose accumulation is a hallmark of many neurodegenerative disorders.",#59:5,,"{""full_journal_name"": ""Neuropathology and applied neurobiology"", ""pub_date"": ""2012-04-25"", ""ref"": ""21696420"", ""pub_year"": 2012, ""last_author"": ""Carra S"", ""type"": ""PubMed"", ""author_list"": [""Seidel K"", ""Vinet J"", ""Dunnen WF"", ""Brunt ER"", ""Meister M"", ""Boncoraglio A"", ""Zijlstra MP"", ""Boddeke HW"", ""R\u00fcb U"", ""Kampinga HH"", ""Carra S""], ""title"": ""The HSPB8-BAG3 chaperone complex is upregulated in astrocytes in the human brain affected by protein aggregation diseases."", ""doi"": ""10.1111/j.1365-2990.2011.01198.x""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Autophagy signaling subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Adaptor Proteins, Signal Transducing"", ""Apoptosis Regulatory Proteins"", ""Astrocytes"", ""Blotting, Western"", ""Fluorescent Antibody Technique"", ""Heat-Shock Proteins"", ""Humans"", ""Immunohistochemistry"", ""Molecular Chaperones"", ""Neurodegenerative Diseases"", ""Protein Serine-Threonine Kinases"", ""Up-Regulation""], ""substances"": [""Adaptor Proteins, Signal Transducing"", ""Apoptosis Regulatory Proteins"", ""BAG3 protein, human"", ""HSPB8 protein, human"", ""Heat-Shock Proteins"", ""Molecular Chaperones"", ""Protein Serine-Threonine Kinases""]}",False
DIRECTLY_DECREASES,32340,8557,2008,18675468,False,False,False,Amyloidogenic APP processing may prevent a-secretase (a) cleavage of APP which would otherwise generate a secreted form of APP (sAPPa).,#59:5,PMC2566585,"{""full_journal_name"": ""Trends in neurosciences"", ""pub_date"": ""2008-11-25"", ""ref"": ""18675468"", ""pub_year"": 2008, ""last_author"": ""Mattson MP"", ""type"": ""PubMed"", ""author_list"": [""Bezprozvanny I"", ""Mattson MP""], ""title"": ""Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease."", ""doi"": ""10.1016/j.tins.2008.06.005""}","{""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""ADAM Metallopeptidase subgraph"", ""Amyloidogenic subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Calcium"", ""Calcium Signaling"", ""Humans"", ""Neurons"", ""Presenilins"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides"", ""Presenilins"", ""Calcium""]}",False
DIRECTLY_DECREASES,37118,4488,2011,22110360,False,False,False,"Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen- activated protein kinase kinase kinase family, is composed of an inhibitory N-terminal domain, a kinase domain, and a C-terminal regulatory domain (Ichijo et al., 1997). ASK1 can promote apoptosis in response to common pro-apoptotic stresses, such as oxidative stress (Song et al., 2002), death receptor ligands (Nishitoh et al., 1998), and endoplasmic reticulum stress (Nishitoh et al., 2002). ASK1 also phosphorylates and activates both p38 and JNK pathways (Ichijo et al., 1997). The mechanism of ASK1 activation is positively regulated by its binding proteins such as TNF receptor-ssociated factors 2/6 (Noguchi et al., 2005) and Daxx (Chang et al., 1998). On the other hand, several cellular proteins, including thioredoxin (Saitoh et al., 1998), Hsp90 (Zhang et al., 2005), and 14-3-3 (Zhang et al., 1999), have been reported to interact with ASK1 and inhibit ASK1 activity.",#59:5,PMC3213740,"{""full_journal_name"": ""Experimental neurobiology"", ""pub_date"": ""2011-11-23"", ""ref"": ""22110360"", ""pub_year"": 2011, ""last_author"": ""Chung KC"", ""type"": ""PubMed"", ""author_list"": [""Choi HK"", ""Chung KC""], ""title"": ""Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death."", ""doi"": ""10.5607/en.2011.20.1.35""}","{""Subgraph"": [""MAPK-JNK subgraph""]}",False
DIRECTLY_DECREASES,3323,5615,2012,22721728,False,False,False,"Furthermore, overexpression of miR-195 in N2a/APP decreased the level of Abeta, while inhibition of miR-195 resulted in an increase of Abeta. Thus, we demonstrated that miR-195 could downregulate the level of Abeta by inhibiting the translation of BACE1. We conclude that miR-195 might provide a therapeutic strategy for AD",#59:5,,"{""full_journal_name"": ""Brain research bulletin"", ""pub_date"": ""2012-11-23"", ""ref"": ""22721728"", ""pub_year"": 2012, ""last_author"": ""Duan DX"", ""type"": ""PubMed"", ""author_list"": [""Zhu HC"", ""Wang LM"", ""Wang M"", ""Song B"", ""Tan S"", ""Teng JF"", ""Duan DX""], ""title"": ""MicroRNA-195 downregulates Alzheimer's disease amyloid-\u03b2 production by targeting BACE1."", ""doi"": ""10.1016/j.brainresbull.2012.05.018""}","{""Subgraph"": [""Beta secretase subgraph"", ""miRNA subgraph""], ""mesh"": [""3' Untranslated Regions"", ""Aging, Premature"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Binding Sites"", ""Cell Line, Tumor"", ""Down-Regulation"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Neurologic Mutants"", ""MicroRNAs"", ""Mutagenesis, Site-Directed"", ""Neuroblastoma"", ""Protein Biosynthesis"", ""Protein Interaction Mapping"", ""Protein Processing, Post-Translational"", ""RNA Stability"", ""RNA, Messenger"", ""Recombinant Fusion Proteins""], ""substances"": [""3' Untranslated Regions"", ""Amyloid beta-Peptides"", ""MIRN195 microRNA, human"", ""MIRN195a microRNA, mouse"", ""MicroRNAs"", ""RNA, Messenger"", ""Recombinant Fusion Proteins"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human"", ""Bace1 protein, mouse""]}",False
DIRECTLY_DECREASES,4213,32340,2012,22046233,False,False,False,"We previously reported that genetic variants in SORCS1 increase the risk of AD, that over-expression of SorCS1 reduces gamma-secretase activity and ABeta¸ levels, and that SorCS1 suppression increases gamma-secretase processing of APP and ABeta¸ levels. We now explored the effect of variation in SORCS1 on memory.Variation in intron 1 in SORCS1 is associated with memory changes in AD",#59:5,PMC3202519,"{""full_journal_name"": ""PloS one"", ""pub_date"": ""2012-03-26"", ""ref"": ""22046233"", ""pub_year"": 2012, ""last_author"": ""Mayeux R"", ""type"": ""PubMed"", ""author_list"": [""Reitz C"", ""Lee JH"", ""Rogers RS"", ""Mayeux R""], ""title"": ""Impact of genetic variation in SORCS1 on memory retention."", ""doi"": ""10.1371/journal.pone.0024588""}","{""Subgraph"": [""Gamma secretase subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Case-Control Studies"", ""Hispanic or Latino"", ""Humans"", ""Memory"", ""Polymorphism, Single Nucleotide"", ""Receptors, Cell Surface""], ""substances"": [""Receptors, Cell Surface"", ""SORCS1 protein, human""]}",False
DIRECTLY_DECREASES,1381,3332,2019,30962309,False,False,False,"In patients with SLE, miR-155-5p expression is decreased in PBMCs compared with healthy controls (108).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,11573,12024,2017,27794524,False,False,False,"MN-166 (ibudilast) is a non-selective phosphodiesterase inhibitor that suppresses pro-inflammatory cytokines, promotes neurotrophic factors, and attenuates activated glial cell (Suzumura et al., 2003; Feng et al., 2004).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,7207,1535,2017,27794524,False,False,False,"However, when mitochondrial injury surpasses a certain threshold, energy deficiency will lead to axonal degeneration and cell death (Friese et al., 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,7207,4941,2017,27794524,False,False,False,"However, when mitochondrial injury surpasses a certain threshold, energy deficiency will lead to axonal degeneration and cell death (Friese et al., 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1850,41494,2017,27794524,False,False,False,"Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,35403,698,2015,26088141,False,False,False,"The data complements earlier findings on the ability of α7345–348A to function as a dominant negative blocker of G protein coupling in PC12 cells, and suggests that the GPBC directs nAChR association with Gαq and Gβγ.",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""PC12 Cells""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
DIRECTLY_DECREASES,11890,31687,2011,21882945,False,False,False,"Since this discovery, a number of high-affinity analogs, such as 17-AAG, and alternative synthetic scaffolds, including radicicol and PU-H71, have been reported (Figure 1) [85,88]. These compounds bind in either the N-terminal ATP-binding site (e.g., 17-AAG, radicicol and PU-H71) [89] or C-terminal dimerization domain (e.g., novobiocin and A4) [90,91], and they show great promise as both anticancer compounds and research tools for understanding Hsp90 biology",#69:73,PMC3190966,"{""full_journal_name"": ""Future medicinal chemistry"", ""pub_date"": ""2011-12-23"", ""ref"": ""21882945"", ""pub_year"": 2011, ""last_author"": ""Gestwicki JE"", ""type"": ""PubMed"", ""author_list"": [""Miyata Y"", ""Koren J"", ""Kiray J"", ""Dickey CA"", ""Gestwicki JE""], ""title"": ""Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies."", ""doi"": ""10.4155/fmc.11.88""}","{""Confidence"": [""Medium""], ""mesh"": [""Drug Evaluation, Preclinical"", ""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Humans"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""Protein Interaction Mapping"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""tau Proteins""]}",False
DIRECTLY_DECREASES,2174,21446,2012,22833681,False,False,False,"Acute treatment of rTg4510 mice with an O-GlcNAcase inhibitor transiently reduced tau phosphorylation at epitopes implicated in tau pathology. More importantly, long-term inhibitor treatment strongly increased tau O-GlcNAcylation, reduced the number of dystrophic neurons, and protected against the formation of pathological tau species without altering the phosphorylation of non-pathological tau.",#60:23,PMC3442535,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2012-12-04"", ""ref"": ""22833681"", ""pub_year"": 2012, ""last_author"": ""Boehm J"", ""type"": ""PubMed"", ""author_list"": [""Mondrag\u00f3n-Rodr\u00edguez S"", ""Trillaud-Doppia E"", ""Dudilot A"", ""Bourgeois C"", ""Lauzon M"", ""Leclerc N"", ""Boehm J""], ""title"": ""Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation."", ""doi"": ""10.1074/jbc.M112.401240""}","{""Confidence"": [""Medium""], ""Research_Model"": [""rTg4510 mice""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Disks Large Homolog 4 Protein"", ""Gene Expression Regulation"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Intracellular Signaling Peptides and Proteins"", ""Membrane Proteins"", ""Models, Biological"", ""Neurons"", ""Phosphorylation"", ""Protein Binding"", ""Proto-Oncogene Proteins c-fyn"", ""Rats"", ""Receptors, N-Methyl-D-Aspartate"", ""Synapses"", ""tau Proteins""], ""substances"": [""DLG4 protein, human"", ""Disks Large Homolog 4 Protein"", ""Dlg4 protein, rat"", ""Intracellular Signaling Peptides and Proteins"", ""Membrane Proteins"", ""Receptors, N-Methyl-D-Aspartate"", ""tau Proteins"", ""Proto-Oncogene Proteins c-fyn""]}",False
DIRECTLY_DECREASES,11660,4481,2015,24844691,False,False,False,"In the present study, we tested the potential of two selective HDAC6 inhibitors, tubastatin A and ACY-1215, to rescue cognitive deficits in a mouse model of AD. We found that both tubastatin A and ACY-1215 alleviated behavioral deficits, altered amyloid-β (Aβ) load, and reduced tau hyperphosphorylation in AD mice without obvious adverse effects. Our data suggested that tubastatin A and ACY-1215 not only promoted tubulin acetylation, but also reduced production and facilitated autophagic clearance of Aβ and hyperphosphorylated tau.",#60:23,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2015-03-30"", ""ref"": ""24844691"", ""pub_year"": 2015, ""last_author"": ""Qin C"", ""type"": ""PubMed"", ""author_list"": [""Zhang L"", ""Liu C"", ""Wu J"", ""Tao JJ"", ""Sui XL"", ""Yao ZG"", ""Xu YF"", ""Huang L"", ""Zhu H"", ""Sheng SL"", ""Qin C""], ""title"": ""Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice."", ""doi"": ""10.3233/JAD-140066""}","{""Confidence"": [""Medium""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Animals"", ""Brain"", ""Cognition Disorders"", ""Disease Models, Animal"", ""Exploratory Behavior"", ""Gene Expression Regulation"", ""Histone Deacetylase 6"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Hydroxamic Acids"", ""Indoles"", ""Maze Learning"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Peptide Fragments"", ""Phosphorylation"", ""Presenilin-1"", ""Pyrimidines"", ""Tubulin""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Histone Deacetylase Inhibitors"", ""Hydroxamic Acids"", ""Indoles"", ""PSEN1 protein, human"", ""Peptide Fragments"", ""Presenilin-1"", ""Pyrimidines"", ""Tubulin"", ""amyloid beta-protein (1-40)"", ""amyloid beta-protein (1-42)"", ""tubastatin A"", ""Hdac6 protein, mouse"", ""Histone Deacetylase 6"", ""Histone Deacetylases"", ""ricolinostat""]}",False
DIRECTLY_DECREASES,947,5581,2009,19323834,False,False,False,"Noradrenaline (NA) attenuated the LPS-induced reductions and increased SUMO-1 above basal levels. Over-expression of SUMO-1, Ubc9, or SENP1 reduced the activation of a NOS2 promoter, whereas activation of a 4 x NFkappaB binding-element reporter was only reduced by SUMO-1. ChIP studies revealed interactions of SUMO-1 and C/EBPbeta with C/EBP binding sites on the NOS2 promoter that were modulated by LPS and NA. SUMO-1 co-precipitated with C/EBPbeta confirmed by FRET analysis",#60:23,PMC2667488,"{""full_journal_name"": ""Journal of neuroinflammation"", ""pub_date"": ""2009-05-14"", ""ref"": ""19323834"", ""pub_year"": 2009, ""last_author"": ""Feinstein DL"", ""type"": ""PubMed"", ""author_list"": [""Akar CA"", ""Feinstein DL""], ""title"": ""Modulation of inducible nitric oxide synthase expression by sumoylation."", ""doi"": ""10.1186/1742-2094-6-12""}","{""Confidence"": [""Medium""], ""Method"": [""Chromatin Immunoprecipitation"", ""Fluorescence Resonance Energy Transfer""], ""mesh"": [""Aging"", ""Animals"", ""Astrocytes"", ""CCAAT-Enhancer-Binding Protein-beta"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Endopeptidases"", ""Gene Expression"", ""Inflammation"", ""Lipopolysaccharides"", ""Nitric Oxide Synthase Type II"", ""Norepinephrine"", ""Promoter Regions, Genetic"", ""RNA, Messenger"", ""Rats"", ""Rats, Sprague-Dawley"", ""SUMO-1 Protein"", ""Ubiquitin-Conjugating Enzymes""], ""substances"": [""CCAAT-Enhancer-Binding Protein-beta"", ""Lipopolysaccharides"", ""RNA, Messenger"", ""SUMO-1 Protein"", ""Nitric Oxide Synthase Type II"", ""Nos2 protein, rat"", ""Ubiquitin-Conjugating Enzymes"", ""Endopeptidases"", ""ubiquitin-conjugating enzyme UBC9"", ""Norepinephrine""]}",False
DIRECTLY_DECREASES,37132,33706,2013,23758787,False,False,False,"In an exceptional case, Pellino3-induced ubiquitination of TRAF6 at Lys124 suppresses the ability of TRAF6 to interact with and ubiquitinate IRF7, and thus inhibits type I IFN production in TLR3 signaling [202].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in cytokine receptor signaling""], ""SignalingPathway"": [""TLR3""]}",False
DIRECTLY_DECREASES,7180,6942,2017,27794524,False,False,False,"Whole brain MRS has successfully shown significant reduction in both NAA and NAA/creatine (NAA/Cr) ratio, in clinically isolated syndrome and RRMS, compared to healthy controls.",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,25152,26839,2013,23758787,False,False,False,"Activated GSK3β and ERK induce dual phosphorylation of C/EBPβ and thereby inhibit its activity [12,151,160].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in cytokine receptor signaling""]}",False
DIRECTLY_DECREASES,6903,365,2007,17213958,False,False,False,"Acetylcholinesterase (AChE) is thought to play an important role during apoptotic process. Our results showed that H2O2 induced AChE activity, a functional marker in apoptotic process, increases in neuronal-like PC12 cells. Glutathione, which is involved in cellular redox homeostasis, inhibited the increase of AChE activity, suggesting that reactive oxygen species (ROS) play a key role in this process. Further investigation showed that the elevation of AChE was observed after the degradation of Akt, release of cytochrome c from mitochondria into the cytosol, and activation of caspase family members. When nerve growth factor (NGF) was present, with the maintenance of Akt level, the elevation of AChE, the cytochrome c diffusion, as well as apoptotic process were markedly attenuated in H2O2-treated PC12 cells",#59:5,,"{""full_journal_name"": ""Acta biochimica et biophysica Sinica"", ""pub_date"": ""2007-02-21"", ""ref"": ""17213958"", ""pub_year"": 2007, ""last_author"": ""Zhang X"", ""type"": ""PubMed"", ""author_list"": [""Jiang H"", ""Zhang J"", ""Zhu H"", ""Li H"", ""Zhang X""], ""title"": ""Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Acetylcholine signaling subgraph"", ""Hydrogen peroxide subgraph""], ""mesh"": [""Acetylcholinesterase"", ""Animals"", ""Apoptosis"", ""Caspase 3"", ""Cytochromes c"", ""Enzyme Activation"", ""Glutathione"", ""Hydrogen Peroxide"", ""Nerve Growth Factor"", ""PC12 Cells"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Rats""], ""substances"": [""Cytochromes c"", ""Nerve Growth Factor"", ""Hydrogen Peroxide"", ""Proto-Oncogene Proteins c-akt"", ""Acetylcholinesterase"", ""Caspase 3"", ""Glutathione""]}",False
DIRECTLY_DECREASES,32340,29050,2008,18675468,False,False,False,Amyloidogenic APP processing may prevent a-secretase (a) cleavage of APP which would otherwise generate a secreted form of APP (sAPPa).,#59:5,PMC2566585,"{""full_journal_name"": ""Trends in neurosciences"", ""pub_date"": ""2008-11-25"", ""ref"": ""18675468"", ""pub_year"": 2008, ""last_author"": ""Mattson MP"", ""type"": ""PubMed"", ""author_list"": [""Bezprozvanny I"", ""Mattson MP""], ""title"": ""Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease."", ""doi"": ""10.1016/j.tins.2008.06.005""}","{""MeSHDisease"": [""Alzheimer Disease""], ""Subgraph"": [""ADAM Metallopeptidase subgraph"", ""Amyloidogenic subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Peptides"", ""Animals"", ""Calcium"", ""Calcium Signaling"", ""Humans"", ""Neurons"", ""Presenilins"", ""Signal Transduction"", ""Synapses""], ""substances"": [""Amyloid beta-Peptides"", ""Presenilins"", ""Calcium""]}",False
DIRECTLY_DECREASES,13104,32340,2013,22727043,False,False,False,"SORLA is proposed to act as a retention factor for APP in the TGN, preventing the release of precursor molecules into the processing pathways. Consequently, over-expression of SORLA in neurons prevents the targeting of APP from TGN to the cell surface and to endosomes and reduces the production of Abeta peptides [9-11]. The importance of SORLA for AD is further supported by low levels of receptor expression seen in patients suffering from the disease",#59:5,PMC3483162,"{""full_journal_name"": ""BMC systems biology"", ""pub_date"": ""2013-02-20"", ""ref"": ""22727043"", ""pub_year"": 2013, ""last_author"": ""Wolkenhauer O"", ""type"": ""PubMed"", ""author_list"": [""Lao A"", ""Schmidt V"", ""Schmitz Y"", ""Willnow TE"", ""Wolkenhauer O""], ""title"": ""Multi-compartmental modeling of SORLA's influence on amyloidogenic processing in Alzheimer's disease."", ""doi"": ""10.1186/1752-0509-6-74""}","{""Subgraph"": [""Low density lipoprotein subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Gene Expression Regulation"", ""Membrane Transport Proteins"", ""Models, Biological"", ""Protein Multimerization"", ""Protein Structure, Secondary"", ""Proteolysis"", ""Risk Factors"", ""Solubility""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Membrane Transport Proteins"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,39680,2512,2006,15946122,False,False,False,"the evidence that PPARγ stimulates the ubiquitination of APP supports the fact that the Abeta-lowering effect of PPARγ is due to the proteasome-mediated degradation of APP. Another issue in the present study is the finding that PPARγ, by decreasing Abeta secretion, protects the cells against H2O2-mediated necrosis",#59:5,PMC1276971,"{""full_journal_name"": ""The Biochemical journal"", ""pub_date"": ""2006-02-07"", ""ref"": ""15946122"", ""pub_year"": 2006, ""last_author"": ""Ricciarelli R"", ""type"": ""PubMed"", ""author_list"": [""d'Abramo C"", ""Massone S"", ""Zingg JM"", ""Pizzuti A"", ""Marambaud P"", ""Dalla Piccola B"", ""Azzi A"", ""Marinari UM"", ""Pronzato MA"", ""Ricciarelli R""], ""title"": ""Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death.""}","{""Subgraph"": [""Non-amyloidogenic subgraph"", ""Peroxisome proliferator activated receptor subgraph"", ""Ubiquitin degradation subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid beta-Protein Precursor"", ""Cell Line"", ""Down-Regulation"", ""Humans"", ""Hydrogen Peroxide"", ""Necrosis"", ""PPAR gamma"", ""Protein Processing, Post-Translational"", ""RNA Interference""], ""substances"": [""Amyloid beta-Protein Precursor"", ""PPAR gamma"", ""Hydrogen Peroxide""]}",False
DIRECTLY_DECREASES,3323,32340,2012,22721728,False,False,False,"Furthermore, overexpression of miR-195 in N2a/APP decreased the level of Abeta, while inhibition of miR-195 resulted in an increase of Abeta. Thus, we demonstrated that miR-195 could downregulate the level of Abeta by inhibiting the translation of BACE1. We conclude that miR-195 might provide a therapeutic strategy for AD",#59:5,,"{""full_journal_name"": ""Brain research bulletin"", ""pub_date"": ""2012-11-23"", ""ref"": ""22721728"", ""pub_year"": 2012, ""last_author"": ""Duan DX"", ""type"": ""PubMed"", ""author_list"": [""Zhu HC"", ""Wang LM"", ""Wang M"", ""Song B"", ""Tan S"", ""Teng JF"", ""Duan DX""], ""title"": ""MicroRNA-195 downregulates Alzheimer's disease amyloid-\u03b2 production by targeting BACE1."", ""doi"": ""10.1016/j.brainresbull.2012.05.018""}","{""Subgraph"": [""Beta secretase subgraph"", ""miRNA subgraph""], ""mesh"": [""3' Untranslated Regions"", ""Aging, Premature"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Binding Sites"", ""Cell Line, Tumor"", ""Down-Regulation"", ""HEK293 Cells"", ""Hippocampus"", ""Humans"", ""Mice"", ""Mice, Neurologic Mutants"", ""MicroRNAs"", ""Mutagenesis, Site-Directed"", ""Neuroblastoma"", ""Protein Biosynthesis"", ""Protein Interaction Mapping"", ""Protein Processing, Post-Translational"", ""RNA Stability"", ""RNA, Messenger"", ""Recombinant Fusion Proteins""], ""substances"": [""3' Untranslated Regions"", ""Amyloid beta-Peptides"", ""MIRN195 microRNA, human"", ""MIRN195a microRNA, mouse"", ""MicroRNAs"", ""RNA, Messenger"", ""Recombinant Fusion Proteins"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human"", ""Bace1 protein, mouse""]}",False
DIRECTLY_DECREASES,32290,7105,2019,30962309,False,False,False,"In humans, mRNA destabilization by deadenylation and subsequent exonucleolytic decay dominates the regulatory effect of miRNAs, whereas the contribution from direct translational repression is relatively small (35–39).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,37579,14470,2017,27794524,False,False,False,"If axonal Na+ rises above its nominal concentration, the Na+ /Ca2+ exchanger, normally exchanging axoplasmic Ca2+ for extracellular Na+ , will operate in a reverse Ca2+ importing mode.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11812,41494,2017,27794524,False,False,False,"Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,26780,12188,2017,27794524,False,False,False,"Second, mitochondrial injury may amplify oxidative stress through release of oxygen radicals generated as a result of impaired respiratory chain function, thus establishing a vicious cycle of tissue destruction (Murphy, 2009)",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,1850,40834,2017,27794524,False,False,False,"Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,35403,9358,2015,26088141,False,False,False,"The data complements earlier findings on the ability of α7345–348A to function as a dominant negative blocker of G protein coupling in PC12 cells, and suggests that the GPBC directs nAChR association with Gαq and Gβγ.",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""Medium""], ""MeSHAnatomy"": [""PC12 Cells""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
DIRECTLY_DECREASES,6781,31687,2011,21882945,False,False,False,"Since this discovery, a number of high-affinity analogs, such as 17-AAG, and alternative synthetic scaffolds, including radicicol and PU-H71, have been reported (Figure 1) [85,88]. These compounds bind in either the N-terminal ATP-binding site (e.g., 17-AAG, radicicol and PU-H71) [89] or C-terminal dimerization domain (e.g., novobiocin and A4) [90,91], and they show great promise as both anticancer compounds and research tools for understanding Hsp90 biology",#69:73,PMC3190966,"{""full_journal_name"": ""Future medicinal chemistry"", ""pub_date"": ""2011-12-23"", ""ref"": ""21882945"", ""pub_year"": 2011, ""last_author"": ""Gestwicki JE"", ""type"": ""PubMed"", ""author_list"": [""Miyata Y"", ""Koren J"", ""Kiray J"", ""Dickey CA"", ""Gestwicki JE""], ""title"": ""Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies."", ""doi"": ""10.4155/fmc.11.88""}","{""Confidence"": [""Medium""], ""mesh"": [""Drug Evaluation, Preclinical"", ""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Humans"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""Protein Interaction Mapping"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""HSP70 Heat-Shock Proteins"", ""HSP90 Heat-Shock Proteins"", ""Molecular Chaperones"", ""Neuroprotective Agents"", ""tau Proteins""]}",False
DIRECTLY_DECREASES,14317,2173,2014,23722080,False,False,False,"Primary cortical neurons exposed to the mitochondrial toxin NaN3 (0.1-3 mM) were submitted to oxidative stress with H2O2 (30-150 μM), to mimic conditions observed in neurodegenerative disorders. The effects of such treatment on a series of parameters useful in characterizing neuronal damage were investigated: (i) the basal release of glutamate, evaluated as (3)H-d-Aspartate efflux, was sharply, concentration-dependently, increased; (ii) the phosphorylation status of intracellular markers known to be involved in the neurodegenerative processes, in particular in Alzheimer disease: tau and GSK3β were increased, as well as the protein level of β-secretase (BACE1) and p35/25 evaluated by Western blotting, while (iii) the cell metabolic activity, measured with the MTT method, was reduced, in a concentration- and time-dependent manner. The latter effect, as well as tau hyperphosphorylation, was prevented both by a mixture of antioxidant drugs (100 μM ascorbic acid, 10 μM trolox, 100 μM glutathione) and by the anti-Alzheimer drug, memantine, 20 μM.",#60:23,,"{""full_journal_name"": ""Neurochemistry international"", ""pub_date"": ""2014-01-27"", ""ref"": ""23722080"", ""pub_year"": 2014, ""last_author"": ""Siniscalchi A"", ""type"": ""PubMed"", ""author_list"": [""Selvatici R"", ""Marani L"", ""Marino S"", ""Siniscalchi A""], ""title"": ""In vitro mitochondrial failure and oxidative stress mimic biochemical features of Alzheimer disease."", ""doi"": ""10.1016/j.neuint.2013.05.005""}","{""Anatomy"": [""cerebral cortex""], ""Confidence"": [""Medium""], ""Species"": [""10116""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Antioxidants"", ""Glycogen Synthase Kinase 3"", ""Glycogen Synthase Kinase 3 beta"", ""In Vitro Techniques"", ""Mitochondria"", ""Neuroprotective Agents"", ""Nitrogen"", ""Oxidative Stress"", ""Phosphorylation"", ""Rats"", ""Rats, Sprague-Dawley"", ""tau Proteins""], ""substances"": [""Antioxidants"", ""Neuroprotective Agents"", ""tau Proteins"", ""sodium nitride"", ""Glycogen Synthase Kinase 3 beta"", ""Gsk3b protein, rat"", ""Glycogen Synthase Kinase 3"", ""Nitrogen""]}",False
DIRECTLY_DECREASES,7030,19086,2016,26890116,False,False,False,Modification of the cap group of biphenylacrylohydroxamic acid-based HDAC inhibitors led to the identification of a new derivative (3) characterized by an indolyl-substituted 4-phenylcinnamic skeleton.,#60:23,,"{""full_journal_name"": ""European journal of medicinal chemistry"", ""pub_date"": ""2016-11-07"", ""ref"": ""26890116"", ""pub_year"": 2016, ""last_author"": ""Dallavalle S"", ""type"": ""PubMed"", ""author_list"": [""Cincinelli R"", ""Zwick V"", ""Musso L"", ""Zuco V"", ""De Cesare M"", ""Zunino F"", ""Simoes-Pires C"", ""Nurisso A"", ""Giannini G"", ""Cuendet M"", ""Dallavalle S""], ""title"": ""Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity."", ""doi"": ""10.1016/j.ejmech.2016.02.001""}","{""Confidence"": [""High""], ""mesh"": [""Antineoplastic Agents"", ""Apoptosis"", ""Biphenyl Compounds"", ""Colonic Neoplasms"", ""Drug Screening Assays, Antitumor"", ""HCT116 Cells"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Humans"", ""Hydroxamic Acids"", ""Molecular Docking Simulation"", ""Neoplasms"", ""Structure-Activity Relationship""], ""substances"": [""Antineoplastic Agents"", ""Biphenyl Compounds"", ""Histone Deacetylase Inhibitors"", ""Hydroxamic Acids"", ""Histone Deacetylases""]}",False
DIRECTLY_DECREASES,35212,5581,2009,19323834,False,False,False,"Noradrenaline (NA) attenuated the LPS-induced reductions and increased SUMO-1 above basal levels. Over-expression of SUMO-1, Ubc9, or SENP1 reduced the activation of a NOS2 promoter, whereas activation of a 4 x NFkappaB binding-element reporter was only reduced by SUMO-1. ChIP studies revealed interactions of SUMO-1 and C/EBPbeta with C/EBP binding sites on the NOS2 promoter that were modulated by LPS and NA. SUMO-1 co-precipitated with C/EBPbeta confirmed by FRET analysis",#60:23,PMC2667488,"{""full_journal_name"": ""Journal of neuroinflammation"", ""pub_date"": ""2009-05-14"", ""ref"": ""19323834"", ""pub_year"": 2009, ""last_author"": ""Feinstein DL"", ""type"": ""PubMed"", ""author_list"": [""Akar CA"", ""Feinstein DL""], ""title"": ""Modulation of inducible nitric oxide synthase expression by sumoylation."", ""doi"": ""10.1186/1742-2094-6-12""}","{""Confidence"": [""Medium""], ""Method"": [""Chromatin Immunoprecipitation"", ""Fluorescence Resonance Energy Transfer""], ""mesh"": [""Aging"", ""Animals"", ""Astrocytes"", ""CCAAT-Enhancer-Binding Protein-beta"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Endopeptidases"", ""Gene Expression"", ""Inflammation"", ""Lipopolysaccharides"", ""Nitric Oxide Synthase Type II"", ""Norepinephrine"", ""Promoter Regions, Genetic"", ""RNA, Messenger"", ""Rats"", ""Rats, Sprague-Dawley"", ""SUMO-1 Protein"", ""Ubiquitin-Conjugating Enzymes""], ""substances"": [""CCAAT-Enhancer-Binding Protein-beta"", ""Lipopolysaccharides"", ""RNA, Messenger"", ""SUMO-1 Protein"", ""Nitric Oxide Synthase Type II"", ""Nos2 protein, rat"", ""Ubiquitin-Conjugating Enzymes"", ""Endopeptidases"", ""ubiquitin-conjugating enzyme UBC9"", ""Norepinephrine""]}",False
DIRECTLY_DECREASES,41150,6743,2016,26582367,False,False,False,"As a control we scavenged the superoxide by addition of superoxide dismutase-1 (SOD1) or by addition of Trolox, a water-soluble analog of vitamin E, into the medium. Both scavengers neutralized the superoxide that was induced by neural debris (Fig. 5d).",#57:0,PMC4652165,"{""full_journal_name"": ""Scientific reports"", ""pub_date"": ""2016-09-12"", ""ref"": ""26582367"", ""pub_year"": 2016, ""last_author"": ""Neumann H"", ""type"": ""PubMed"", ""author_list"": [""Shahraz A"", ""Kopatz J"", ""Mathy R"", ""Kappler J"", ""Winter D"", ""Kapoor S"", ""Sch\u00fctza V"", ""Scheper T"", ""Gieselmann V"", ""Neumann H""], ""title"": ""Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages."", ""doi"": ""10.1038/srep16800""}","{""ChallengeType"": [""neural debris""], ""MeSHAnatomy"": [""Macrophages""], ""PublicationType"": [""Research""], ""Section"": [""Results""], ""TechnologyUsed"": [""Confocal Microscopy""], ""mesh"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Cell Line"", ""Chromatography, High Pressure Liquid"", ""Homeostasis"", ""Humans"", ""Lectins"", ""Lipopolysaccharides"", ""Macrophages"", ""Membrane Proteins"", ""Microspheres"", ""Molecular Weight"", ""Neuroprotective Agents"", ""Phagocytosis"", ""Polymerization"", ""Respiratory Burst"", ""Sialic Acids"", ""Tumor Necrosis Factor-alpha""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents"", ""Lectins"", ""Lipopolysaccharides"", ""Membrane Proteins"", ""Neuroprotective Agents"", ""SIGLEC11 protein, human"", ""Sialic Acids"", ""TNF protein, human"", ""Tumor Necrosis Factor-alpha"", ""polysialic acid""]}",False
DIRECTLY_DECREASES,4196,5034,2005,15817521,False,False,False,"the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARgamma) which acts to inhibit the expression of proinflammatory genes, this receptor appears a good candidate to mediate the observed anti-inflammatory effects",#59:5,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2005-09-13"", ""ref"": ""15817521"", ""pub_year"": 2005, ""last_author"": ""Landreth GE"", ""type"": ""PubMed"", ""author_list"": [""Heneka MT"", ""Sastre M"", ""Dumitrescu-Ozimek L"", ""Hanke A"", ""Dewachter I"", ""Kuiperi C"", ""O'Banion K"", ""Klockgether T"", ""Van Leuven F"", ""Landreth GE""], ""title"": ""Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Inflammatory response subgraph"", ""Peroxisome proliferator activated receptor subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloidosis"", ""Animals"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Aspartic Acid Endopeptidases"", ""Cyclooxygenase 2"", ""Disease Models, Animal"", ""Endopeptidases"", ""Glial Fibrillary Acidic Protein"", ""Hippocampus"", ""Ibuprofen"", ""Immunoenzyme Techniques"", ""Mice"", ""Mice, Transgenic"", ""Microglia"", ""Nitric Oxide Synthase"", ""Nitric Oxide Synthase Type II"", ""PPAR gamma"", ""Peptide Fragments"", ""Pioglitazone"", ""Prostaglandin-Endoperoxide Synthases"", ""RNA, Messenger"", ""Thiazolidinediones""], ""substances"": [""Amyloid beta-Peptides"", ""Anti-Inflammatory Agents, Non-Steroidal"", ""Glial Fibrillary Acidic Protein"", ""PPAR gamma"", ""Peptide Fragments"", ""RNA, Messenger"", ""Thiazolidinediones"", ""amyloid beta-protein (1-42)"", ""Nitric Oxide Synthase"", ""Nitric Oxide Synthase Type II"", ""Nos2 protein, mouse"", ""Cyclooxygenase 2"", ""Prostaglandin-Endoperoxide Synthases"", ""Amyloid Precursor Protein Secretases"", ""Endopeptidases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Ibuprofen"", ""Pioglitazone""]}",False
DIRECTLY_DECREASES,11298,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,29218,365,2007,17213958,False,False,False,"Acetylcholinesterase (AChE) is thought to play an important role during apoptotic process. Our results showed that H2O2 induced AChE activity, a functional marker in apoptotic process, increases in neuronal-like PC12 cells. Glutathione, which is involved in cellular redox homeostasis, inhibited the increase of AChE activity, suggesting that reactive oxygen species (ROS) play a key role in this process. Further investigation showed that the elevation of AChE was observed after the degradation of Akt, release of cytochrome c from mitochondria into the cytosol, and activation of caspase family members. When nerve growth factor (NGF) was present, with the maintenance of Akt level, the elevation of AChE, the cytochrome c diffusion, as well as apoptotic process were markedly attenuated in H2O2-treated PC12 cells",#59:5,,"{""full_journal_name"": ""Acta biochimica et biophysica Sinica"", ""pub_date"": ""2007-02-21"", ""ref"": ""17213958"", ""pub_year"": 2007, ""last_author"": ""Zhang X"", ""type"": ""PubMed"", ""author_list"": [""Jiang H"", ""Zhang J"", ""Zhu H"", ""Li H"", ""Zhang X""], ""title"": ""Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Acetylcholine signaling subgraph"", ""Caspase subgraph""], ""mesh"": [""Acetylcholinesterase"", ""Animals"", ""Apoptosis"", ""Caspase 3"", ""Cytochromes c"", ""Enzyme Activation"", ""Glutathione"", ""Hydrogen Peroxide"", ""Nerve Growth Factor"", ""PC12 Cells"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Rats""], ""substances"": [""Cytochromes c"", ""Nerve Growth Factor"", ""Hydrogen Peroxide"", ""Proto-Oncogene Proteins c-akt"", ""Acetylcholinesterase"", ""Caspase 3"", ""Glutathione""]}",False
DIRECTLY_DECREASES,37712,4488,2011,22110360,False,False,False,"Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen- activated protein kinase kinase kinase family, is composed of an inhibitory N-terminal domain, a kinase domain, and a C-terminal regulatory domain (Ichijo et al., 1997). ASK1 can promote apoptosis in response to common pro-apoptotic stresses, such as oxidative stress (Song et al., 2002), death receptor ligands (Nishitoh et al., 1998), and endoplasmic reticulum stress (Nishitoh et al., 2002). ASK1 also phosphorylates and activates both p38 and JNK pathways (Ichijo et al., 1997). The mechanism of ASK1 activation is positively regulated by its binding proteins such as TNF receptor-ssociated factors 2/6 (Noguchi et al., 2005) and Daxx (Chang et al., 1998). On the other hand, several cellular proteins, including thioredoxin (Saitoh et al., 1998), Hsp90 (Zhang et al., 2005), and 14-3-3 (Zhang et al., 1999), have been reported to interact with ASK1 and inhibit ASK1 activity.",#59:5,PMC3213740,"{""full_journal_name"": ""Experimental neurobiology"", ""pub_date"": ""2011-11-23"", ""ref"": ""22110360"", ""pub_year"": 2011, ""last_author"": ""Chung KC"", ""type"": ""PubMed"", ""author_list"": [""Choi HK"", ""Chung KC""], ""title"": ""Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death."", ""doi"": ""10.5607/en.2011.20.1.35""}","{""Condition"": [""Normal Healthy State""], ""Published"": [""CDR story""], ""Subgraph"": [""MAPK-JNK subgraph"", ""Unfolded protein response subgraph""]}",False
DIRECTLY_DECREASES,43598,31830,2011,21280075,False,False,False,"Sorting mechanisms that cause the amyloid precursor protein (APP) and the ÃƒÅ¸-secretases and gamma-secretases to colocalize in the same compartment play an important role in the regulation of ABeta¸ production in Alzheimer's disease (AD). We and others have reported that genetic variants in the Sortilin-related receptor (SORL1) increased the risk of AD, that SORL1 is involved in trafficking of APP, and that underexpression of SORL1 leads to overproduction of ABeta¸. Here we explored the role of one of its homologs, the sortilin-related VPS10 domain containing receptor 1 (SORCS1), in AD.SorCS1 influenced APP processing. While overexpression of SorCS1 reduced gamma-secretase activity and ABeta¸ levels, the suppression of SorCS1 increased gamma-secretase processing of APP and the levels of ABeta¸.",#59:5,PMC3086759,"{""full_journal_name"": ""Annals of neurology"", ""pub_date"": ""2011-03-16"", ""ref"": ""21280075"", ""pub_year"": 2011, ""last_author"": ""Mayeux R"", ""type"": ""PubMed"", ""author_list"": [""Reitz C"", ""Tokuhiro S"", ""Clark LN"", ""Conrad C"", ""Vonsattel JP"", ""Hazrati LN"", ""Palot\u00e1s A"", ""Lantigua R"", ""Medrano M"", ""Z Jim\u00e9nez-Vel\u00e1zquez I"", ""Vardarajan B"", ""Simkin I"", ""Haines JL"", ""Pericak-Vance MA"", ""Farrer LA"", ""Lee JH"", ""Rogaeva E"", ""George-Hyslop PS"", ""Mayeux R""], ""title"": ""SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk."", ""doi"": ""10.1002/ana.22308""}","{""Subgraph"": [""Gamma secretase subgraph"", ""Low density lipoprotein subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Brain"", ""Gene Expression"", ""Genetic Predisposition to Disease"", ""Genetic Variation"", ""Genotype"", ""Humans"", ""LDL-Receptor Related Proteins"", ""Membrane Transport Proteins"", ""Meta-Analysis as Topic"", ""Mutation"", ""Polymorphism, Single Nucleotide"", ""Receptors, Cell Surface"", ""Risk Factors"", ""White People""], ""substances"": [""Amyloid beta-Protein Precursor"", ""LDL-Receptor Related Proteins"", ""Membrane Transport Proteins"", ""Receptors, Cell Surface"", ""SORCS1 protein, human"", ""SORL1 protein, human"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,1806,32340,2008,18564425,False,False,False,"Activated microglia can reduce Abeta accumulation by increasing its phagocytosis or extracellular degradation. Microglia also release trophic factors such as the glia-derived neurotrophic factor (GDNF), which is neuroprotective",#59:5,PMC2442055,"{""full_journal_name"": ""Journal of neuroinflammation"", ""pub_date"": ""2008-08-21"", ""ref"": ""18564425"", ""pub_year"": 2008, ""last_author"": ""Gentleman SM"", ""type"": ""PubMed"", ""author_list"": [""Sastre M"", ""Walter J"", ""Gentleman SM""], ""title"": ""Interactions between APP secretases and inflammatory mediators."", ""doi"": ""10.1186/1742-2094-5-25""}","{""Subgraph"": [""Nerve growth factor subgraph""], ""mesh"": [""ADAM Proteins"", ""ADAM10 Protein"", ""ADAM17 Protein"", ""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Brain"", ""Humans"", ""Inflammation"", ""Membrane Proteins"", ""NF-kappa B"", ""PPAR gamma"", ""STAT1 Transcription Factor""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Membrane Proteins"", ""NF-kappa B"", ""PPAR gamma"", ""STAT1 Transcription Factor"", ""Amyloid Precursor Protein Secretases"", ""ADAM Proteins"", ""ADAM9 protein, human"", ""ADAM10 Protein"", ""ADAM10 protein, human"", ""ADAM17 Protein""]}",False
DIRECTLY_DECREASES,2071,30445,1997,8940412,False,False,False,"Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",#59:50,,"{""full_journal_name"": ""Endocrinology"", ""pub_date"": ""1997-01-23"", ""ref"": ""8940412"", ""pub_year"": 1997, ""last_author"": ""Chrousos GP"", ""type"": ""PubMed"", ""author_list"": [""Webster EL"", ""Lewis DB"", ""Torpy DJ"", ""Zachman EK"", ""Rice KC"", ""Chrousos GP""], ""title"": ""In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.""}","{""Anatomy"": [""cerebellum""], ""AssayType"": [""B""], ""Confidence"": [""Medium""], ""MeasurementRelation"": [""=""], ""MeasurementType"": [""Ki""], ""MeasurementUnits"": [""nM""], ""MeasurementValue"": [""1.3""], ""Species"": [""10116""], ""mesh"": [""Adrenocorticotropic Hormone"", ""Animals"", ""Binding, Competitive"", ""Carrageenan"", ""Cerebellum"", ""Corticotropin-Releasing Hormone"", ""Frontal Lobe"", ""Inflammation"", ""Injections, Subcutaneous"", ""Male"", ""Myocardium"", ""Pituitary Gland"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Sprague-Dawley"", ""Receptors, Corticotropin-Releasing Hormone"", ""Sheep""], ""substances"": [""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""antalarmin"", ""Carrageenan"", ""Adrenocorticotropic Hormone"", ""Corticotropin-Releasing Hormone""]}",False
DIRECTLY_DECREASES,2071,30445,1997,8940412,False,False,False,"Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",#59:50,,"{""full_journal_name"": ""Endocrinology"", ""pub_date"": ""1997-01-23"", ""ref"": ""8940412"", ""pub_year"": 1997, ""last_author"": ""Chrousos GP"", ""type"": ""PubMed"", ""author_list"": [""Webster EL"", ""Lewis DB"", ""Torpy DJ"", ""Zachman EK"", ""Rice KC"", ""Chrousos GP""], ""title"": ""In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.""}","{""Anatomy"": [""pituitary gland""], ""AssayType"": [""B""], ""Confidence"": [""Medium""], ""MeasurementRelation"": [""=""], ""MeasurementType"": [""Ki""], ""MeasurementUnits"": [""nM""], ""MeasurementValue"": [""1.9""], ""Species"": [""10116""], ""mesh"": [""Adrenocorticotropic Hormone"", ""Animals"", ""Binding, Competitive"", ""Carrageenan"", ""Cerebellum"", ""Corticotropin-Releasing Hormone"", ""Frontal Lobe"", ""Inflammation"", ""Injections, Subcutaneous"", ""Male"", ""Myocardium"", ""Pituitary Gland"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Sprague-Dawley"", ""Receptors, Corticotropin-Releasing Hormone"", ""Sheep""], ""substances"": [""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""antalarmin"", ""Carrageenan"", ""Adrenocorticotropic Hormone"", ""Corticotropin-Releasing Hormone""]}",False
DIRECTLY_DECREASES,37957,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,36001,43165,2017,28669544,False,False,False,"The accompanying cell death in these disorders may arise from a combination of a toxic gain of function and a loss of nuclear TDP-43, both of which are associated with the presence of cytoplasmic aggregates (Cohen et al., 2011; Gendron and Petrucelli, 2011).",#69:50,PMC5519492,"{""full_journal_name"": ""Neuron"", ""pub_date"": ""2017-09-14"", ""ref"": ""28669544"", ""pub_year"": 2017, ""last_author"": ""Rajendran L"", ""type"": ""PubMed"", ""author_list"": [""Paolicelli RC"", ""Jawaid A"", ""Henstridge CM"", ""Valeri A"", ""Merlini M"", ""Robinson JL"", ""Lee EB"", ""Rose J"", ""Appel S"", ""Lee VM"", ""Trojanowski JQ"", ""Spires-Jones T"", ""Schulz PE"", ""Rajendran L""], ""title"": ""TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss."", ""doi"": ""10.1016/j.neuron.2017.05.037""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Amyotrophic Lateral Sclerosis"", ""Frontotemporal Lobar Degeneration""], ""Species"": [""10090""], ""mesh"": [""Amyloid"", ""Amyotrophic Lateral Sclerosis"", ""Animals"", ""Brain"", ""Cognition"", ""DNA-Binding Proteins"", ""Mice, Transgenic"", ""Microglia"", ""Synapses""], ""substances"": [""Amyloid"", ""DNA-Binding Proteins"", ""TDP-43 protein, mouse""]}",False
DIRECTLY_DECREASES,7207,4941,2017,27794524,False,False,False,"However, when mitochondrial injury surpasses a certain threshold, energy deficiency will lead to axonal degeneration and cell death (Friese et al., 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11812,41494,2017,27794524,False,False,False,"Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,35403,698,2015,26088141,False,False,False,"Because α7345–348A- transfected cells did not show any responsiveness to SP, these findings suggest this receptor mutant is not functionally coupled to Gαq.",#57:62,PMC4536413,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2015-12-08"", ""ref"": ""26088141"", ""pub_year"": 2015, ""last_author"": ""Kabbani N"", ""type"": ""PubMed"", ""author_list"": [""King JR"", ""Nordman JC"", ""Bridges SP"", ""Lin MK"", ""Kabbani N""], ""title"": ""Identification and Characterization of a G Protein-binding Cluster in \u03b17 Nicotinic Acetylcholine Receptors."", ""doi"": ""10.1074/jbc.M115.647040""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Animals"", ""Binding Sites"", ""Brain"", ""GTP-Binding Proteins"", ""Mice"", ""Molecular Sequence Data"", ""PC12 Cells"", ""Rats"", ""Sequence Homology, Amino Acid"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor"", ""GTP-Binding Proteins""]}",False
DIRECTLY_DECREASES,44564,40328,2017,29191965,False,False,False,"Dephosphorylation of tau is achieved mainly by protein phosphatase (PP)2A, PP2B (calcineurin), and PP-1 (92).",#69:60,,"{""full_journal_name"": ""FASEB journal : official publication of the Federation of American Societies for Experimental Biology"", ""pub_date"": ""2017-12-11"", ""ref"": ""29191965"", ""pub_year"": 2017, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Pir GJ"", ""Choudhary B"", ""Mandelkow E""], ""title"": {""#text"": ""models of tauopathy."", ""i"": ""Caenorhabditis elegans""}, ""doi"": ""10.1096/fj.201701007""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Caenorhabditis elegans"", ""Disease Models, Animal"", ""Neurodegenerative Diseases"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,7024,44533,2014,24401760,False,False,False,"We show here that ITPKB protein level was increased 3-fold in the cerebral cortex of most patients with Alzheimer's disease compared with control subjects, and accumulated in dystrophic neurites associated to amyloid plaques. In mouse Neuro-2a neuroblastoma cells, Itpkb overexpression was associated with increased cell apoptosis and increased β-secretase 1 activity leading to overproduction of amyloid-β peptides. In this cellular model, an inhibitor of mitogen- activated kinase kinases 1/2 completely prevented overproduction of amyloid-β peptides. Transgenic overexpression of ITPKB in mouse forebrain neurons was not sufficient to induce amyloid plaque formation or tau hyperphosphorylation. However, in the 5X familial Alzheimer's disease mouse model, neuronal ITPKB overexpression significantly increased extracellular signal-regulated kinases 1/2 activation and β-secretase 1 activity, resulting in exacerbated Alzheimer's disease pathology as shown by increased astrogliosis, amyloid-β40 peptide production and tau hyperphosphorylation.",#60:23,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2014-04-11"", ""ref"": ""24401760"", ""pub_year"": 2014, ""last_author"": ""Brion JP"", ""type"": ""PubMed"", ""author_list"": [""Stygelbout V"", ""Leroy K"", ""Pouillon V"", ""Ando K"", ""D'Amico E"", ""Jia Y"", ""Luo HR"", ""Duyckaerts C"", ""Erneux C"", ""Schurmans S"", ""Brion JP""], ""title"": ""Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology."", ""doi"": ""10.1093/brain/awt344""}","{""Cell_Line"": [""N2a""], ""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Animals"", ""Apoptosis"", ""Brain"", ""Cell Line, Tumor"", ""Female"", ""Humans"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Middle Aged"", ""Neurites"", ""Neuroblastoma"", ""Phosphotransferases (Alcohol Group Acceptor)"", ""Plaque, Amyloid""], ""substances"": [""Phosphotransferases (Alcohol Group Acceptor)"", ""Inositol 1,4,5-trisphosphate 3-kinase""]}",False
DIRECTLY_DECREASES,1925,4481,2008,18558669,False,False,False,"Highly potent, substrate competitive HDAC6 selective inhibitors were identified (12ac:IC 50 = 65 nM and K i = 110 nM). Trithiocarbonate analogues with an aminoquinoline-substituted pyridinyl-thienoacetyl cap demonstrate a cytotoxicity profile and potency comparable to that of suberoylanilide hydroxamic acid (SAHA) as an approved cancer drug.",#60:23,,"{""full_journal_name"": ""Journal of medicinal chemistry"", ""pub_date"": ""2008-08-12"", ""ref"": ""18558669"", ""pub_year"": 2008, ""last_author"": ""Beckers T"", ""type"": ""PubMed"", ""author_list"": [""Dehmel F"", ""Weinbrenner S"", ""Julius H"", ""Ciossek T"", ""Maier T"", ""Stengel T"", ""Fettis K"", ""Burkhardt C"", ""Wieland H"", ""Beckers T""], ""title"": ""Trithiocarbonates as a novel class of HDAC inhibitors: SAR studies, isoenzyme selectivity, and pharmacological profiles."", ""doi"": ""10.1021/jm800093c""}","{""Confidence"": [""High""], ""IC50"": [""65 nM""], ""Ki"": [""110 nM""], ""mesh"": [""Acetylation"", ""Cell Cycle"", ""Cell Survival"", ""Enzyme Inhibitors"", ""Histone Deacetylase Inhibitors"", ""Histone Deacetylases"", ""Histones"", ""Humans"", ""Isoenzymes"", ""Kinetics"", ""Molecular Structure"", ""Structure-Activity Relationship"", ""Thiones""], ""substances"": [""Enzyme Inhibitors"", ""Histone Deacetylase Inhibitors"", ""Histones"", ""Isoenzymes"", ""Thiones"", ""Histone Deacetylases"", ""trithiocarbonic acid""]}",False
DIRECTLY_DECREASES,25638,5581,2009,19323834,False,False,False,"Noradrenaline (NA) attenuated the LPS-induced reductions and increased SUMO-1 above basal levels. Over-expression of SUMO-1, Ubc9, or SENP1 reduced the activation of a NOS2 promoter, whereas activation of a 4 x NFkappaB binding-element reporter was only reduced by SUMO-1. ChIP studies revealed interactions of SUMO-1 and C/EBPbeta with C/EBP binding sites on the NOS2 promoter that were modulated by LPS and NA. SUMO-1 co-precipitated with C/EBPbeta confirmed by FRET analysis",#60:23,PMC2667488,"{""full_journal_name"": ""Journal of neuroinflammation"", ""pub_date"": ""2009-05-14"", ""ref"": ""19323834"", ""pub_year"": 2009, ""last_author"": ""Feinstein DL"", ""type"": ""PubMed"", ""author_list"": [""Akar CA"", ""Feinstein DL""], ""title"": ""Modulation of inducible nitric oxide synthase expression by sumoylation."", ""doi"": ""10.1186/1742-2094-6-12""}","{""Confidence"": [""Medium""], ""Method"": [""Chromatin Immunoprecipitation"", ""Fluorescence Resonance Energy Transfer""], ""mesh"": [""Aging"", ""Animals"", ""Astrocytes"", ""CCAAT-Enhancer-Binding Protein-beta"", ""Cells, Cultured"", ""Cerebral Cortex"", ""Endopeptidases"", ""Gene Expression"", ""Inflammation"", ""Lipopolysaccharides"", ""Nitric Oxide Synthase Type II"", ""Norepinephrine"", ""Promoter Regions, Genetic"", ""RNA, Messenger"", ""Rats"", ""Rats, Sprague-Dawley"", ""SUMO-1 Protein"", ""Ubiquitin-Conjugating Enzymes""], ""substances"": [""CCAAT-Enhancer-Binding Protein-beta"", ""Lipopolysaccharides"", ""RNA, Messenger"", ""SUMO-1 Protein"", ""Nitric Oxide Synthase Type II"", ""Nos2 protein, rat"", ""Ubiquitin-Conjugating Enzymes"", ""Endopeptidases"", ""ubiquitin-conjugating enzyme UBC9"", ""Norepinephrine""]}",False
DIRECTLY_DECREASES,41782,37225,2017,28559417,False,False,False,"γ‐Secretase‐mediated degradation of the Trem2 CTF seems to be highly efficient in BMDMs, as seen by very low constitutive levels of CTF (Fig 3A).",#57:0,PMC5494459,"{""full_journal_name"": ""The EMBO journal"", ""pub_date"": ""2017-07-14"", ""ref"": ""28559417"", ""pub_year"": 2017, ""last_author"": ""Haass C"", ""type"": ""PubMed"", ""author_list"": [""Kleinberger G"", ""Brendel M"", ""Mracsko E"", ""Wefers B"", ""Groeneweg L"", ""Xiang X"", ""Focke C"", ""Deu\u00dfing M"", ""Su\u00e1rez-Calvet M"", ""Mazaheri F"", ""Parhizkar S"", ""Pettkus N"", ""Wurst W"", ""Feederle R"", ""Bartenstein P"", ""Mueggler T"", ""Arzberger T"", ""Knuesel I"", ""Rominger A"", ""Haass C""], ""title"": ""The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism."", ""doi"": ""10.15252/embj.201796516""}","{""Section"": [""Results""], ""mesh"": [""Animals"", ""Brain"", ""Disease Models, Animal"", ""Frontotemporal Dementia"", ""Gene Knock-In Techniques"", ""Glucose"", ""Humans"", ""Immunohistochemistry"", ""Magnetic Resonance Imaging"", ""Membrane Glycoproteins"", ""Mice"", ""Microglia"", ""Mutant Proteins"", ""Mutation, Missense"", ""Perfusion"", ""Positron-Emission Tomography"", ""Receptors, Immunologic""], ""substances"": [""Membrane Glycoproteins"", ""Mutant Proteins"", ""Receptors, Immunologic"", ""Trem2 protein, mouse"", ""Glucose""]}",False
DIRECTLY_DECREASES,26929,365,2007,17213958,False,False,False,"The overexpression of constitutively activated Akt, which is a downstream signalling element of the NGF receptor TrkA, delayed mitochondrial collapse and inhibited elevation of AChE activity. Thus, NGF prevented apoptosis and elevation of AChE activity by activating the Akt pathway and stabilizing the function of mitochondria",#59:5,,"{""full_journal_name"": ""Acta biochimica et biophysica Sinica"", ""pub_date"": ""2007-02-21"", ""ref"": ""17213958"", ""pub_year"": 2007, ""last_author"": ""Zhang X"", ""type"": ""PubMed"", ""author_list"": [""Jiang H"", ""Zhang J"", ""Zhu H"", ""Li H"", ""Zhang X""], ""title"": ""Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Akt subgraph"", ""Nerve growth factor subgraph""], ""mesh"": [""Acetylcholinesterase"", ""Animals"", ""Apoptosis"", ""Caspase 3"", ""Cytochromes c"", ""Enzyme Activation"", ""Glutathione"", ""Hydrogen Peroxide"", ""Nerve Growth Factor"", ""PC12 Cells"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Rats""], ""substances"": [""Cytochromes c"", ""Nerve Growth Factor"", ""Hydrogen Peroxide"", ""Proto-Oncogene Proteins c-akt"", ""Acetylcholinesterase"", ""Caspase 3"", ""Glutathione""]}",False
DIRECTLY_DECREASES,11512,7180,2017,27794524,False,False,False,"Several phase III clinical trials using IFNbeta1a and IFNbeta1b in SPMS did not show permanent disability delay, but did reduce relapses risk (SPECTRIMS Study Group, 2001; Cohen et al., 2002; Andersen et al., 2004; Panitch et al.,2004).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,29218,12037,2007,17213958,False,False,False,"Acetylcholinesterase (AChE) is thought to play an important role during apoptotic process. Our results showed that H2O2 induced AChE activity, a functional marker in apoptotic process, increases in neuronal-like PC12 cells. Glutathione, which is involved in cellular redox homeostasis, inhibited the increase of AChE activity, suggesting that reactive oxygen species (ROS) play a key role in this process. Further investigation showed that the elevation of AChE was observed after the degradation of Akt, release of cytochrome c from mitochondria into the cytosol, and activation of caspase family members. When nerve growth factor (NGF) was present, with the maintenance of Akt level, the elevation of AChE, the cytochrome c diffusion, as well as apoptotic process were markedly attenuated in H2O2-treated PC12 cells",#59:5,,"{""full_journal_name"": ""Acta biochimica et biophysica Sinica"", ""pub_date"": ""2007-02-21"", ""ref"": ""17213958"", ""pub_year"": 2007, ""last_author"": ""Zhang X"", ""type"": ""PubMed"", ""author_list"": [""Jiang H"", ""Zhang J"", ""Zhu H"", ""Li H"", ""Zhang X""], ""title"": ""Nerve growth factor prevents the apoptosis-associated increase in acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt.""}","{""Condition"": [""Normal Healthy State""], ""Subgraph"": [""Acetylcholine signaling subgraph"", ""Caspase subgraph""], ""mesh"": [""Acetylcholinesterase"", ""Animals"", ""Apoptosis"", ""Caspase 3"", ""Cytochromes c"", ""Enzyme Activation"", ""Glutathione"", ""Hydrogen Peroxide"", ""Nerve Growth Factor"", ""PC12 Cells"", ""Phosphorylation"", ""Proto-Oncogene Proteins c-akt"", ""Rats""], ""substances"": [""Cytochromes c"", ""Nerve Growth Factor"", ""Hydrogen Peroxide"", ""Proto-Oncogene Proteins c-akt"", ""Acetylcholinesterase"", ""Caspase 3"", ""Glutathione""]}",False
DIRECTLY_DECREASES,21142,4488,2011,22110360,False,False,False,"Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen- activated protein kinase kinase kinase family, is composed of an inhibitory N-terminal domain, a kinase domain, and a C-terminal regulatory domain (Ichijo et al., 1997). ASK1 can promote apoptosis in response to common pro-apoptotic stresses, such as oxidative stress (Song et al., 2002), death receptor ligands (Nishitoh et al., 1998), and endoplasmic reticulum stress (Nishitoh et al., 2002). ASK1 also phosphorylates and activates both p38 and JNK pathways (Ichijo et al., 1997). The mechanism of ASK1 activation is positively regulated by its binding proteins such as TNF receptor-ssociated factors 2/6 (Noguchi et al., 2005) and Daxx (Chang et al., 1998). On the other hand, several cellular proteins, including thioredoxin (Saitoh et al., 1998), Hsp90 (Zhang et al., 2005), and 14-3-3 (Zhang et al., 1999), have been reported to interact with ASK1 and inhibit ASK1 activity.",#59:5,PMC3213740,"{""full_journal_name"": ""Experimental neurobiology"", ""pub_date"": ""2011-11-23"", ""ref"": ""22110360"", ""pub_year"": 2011, ""last_author"": ""Chung KC"", ""type"": ""PubMed"", ""author_list"": [""Choi HK"", ""Chung KC""], ""title"": ""Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death."", ""doi"": ""10.5607/en.2011.20.1.35""}","{""Condition"": [""Normal Healthy State""], ""Published"": [""CDR story""], ""Subgraph"": [""Chaperone subgraph"", ""MAPK-JNK subgraph""]}",False
DIRECTLY_DECREASES,43598,32340,2011,21280075,False,False,False,"Sorting mechanisms that cause the amyloid precursor protein (APP) and the ÃƒÅ¸-secretases and gamma-secretases to colocalize in the same compartment play an important role in the regulation of ABeta¸ production in Alzheimer's disease (AD). We and others have reported that genetic variants in the Sortilin-related receptor (SORL1) increased the risk of AD, that SORL1 is involved in trafficking of APP, and that underexpression of SORL1 leads to overproduction of ABeta¸. Here we explored the role of one of its homologs, the sortilin-related VPS10 domain containing receptor 1 (SORCS1), in AD.SorCS1 influenced APP processing. While overexpression of SorCS1 reduced gamma-secretase activity and ABeta¸ levels, the suppression of SorCS1 increased gamma-secretase processing of APP and the levels of ABeta¸.",#59:5,PMC3086759,"{""full_journal_name"": ""Annals of neurology"", ""pub_date"": ""2011-03-16"", ""ref"": ""21280075"", ""pub_year"": 2011, ""last_author"": ""Mayeux R"", ""type"": ""PubMed"", ""author_list"": [""Reitz C"", ""Tokuhiro S"", ""Clark LN"", ""Conrad C"", ""Vonsattel JP"", ""Hazrati LN"", ""Palot\u00e1s A"", ""Lantigua R"", ""Medrano M"", ""Z Jim\u00e9nez-Vel\u00e1zquez I"", ""Vardarajan B"", ""Simkin I"", ""Haines JL"", ""Pericak-Vance MA"", ""Farrer LA"", ""Lee JH"", ""Rogaeva E"", ""George-Hyslop PS"", ""Mayeux R""], ""title"": ""SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk."", ""doi"": ""10.1002/ana.22308""}","{""Subgraph"": [""Low density lipoprotein subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Brain"", ""Gene Expression"", ""Genetic Predisposition to Disease"", ""Genetic Variation"", ""Genotype"", ""Humans"", ""LDL-Receptor Related Proteins"", ""Membrane Transport Proteins"", ""Meta-Analysis as Topic"", ""Mutation"", ""Polymorphism, Single Nucleotide"", ""Receptors, Cell Surface"", ""Risk Factors"", ""White People""], ""substances"": [""Amyloid beta-Protein Precursor"", ""LDL-Receptor Related Proteins"", ""Membrane Transport Proteins"", ""Receptors, Cell Surface"", ""SORCS1 protein, human"", ""SORL1 protein, human"", ""Amyloid Precursor Protein Secretases""]}",False
DIRECTLY_DECREASES,42328,32340,2011,20637285,False,False,False,"In the brain, megalin is expressed in brain capillaries, ependymal cells and choroid plexus, where it participates in the clearance of brain amyloid beta-peptide (Abeta) complex.Additionally, given that FE65 mediates the interaction between the low density lipoprotein receptor-related protein-1 and the amyloid precursor protein (APP) to modulate the rate of APP internalization from the cell surface, we hypothesize that megalin could also interact with APP in neurons.",#59:5,,"{""full_journal_name"": ""Molecular and cellular neurosciences"", ""pub_date"": ""2011-01-21"", ""ref"": ""20637285"", ""pub_year"": 2011, ""last_author"": ""Carro E"", ""type"": ""PubMed"", ""author_list"": [""Alvira-Botero X"", ""P\u00e9rez-Gonzalez R"", ""Spuch C"", ""Vargas T"", ""Antequera D"", ""Garz\u00f3n M"", ""Bermejo-Pareja F"", ""Carro E""], ""title"": ""Megalin interacts with APP and the intracellular adapter protein FE65 in neurons."", ""doi"": ""10.1016/j.mcn.2010.07.005""}","{""MeSHAnatomy"": [""Brain""], ""Subgraph"": [""Low density lipoprotein subgraph"", ""Non-amyloidogenic subgraph""], ""mesh"": [""Amyloid beta-Protein Precursor"", ""Animals"", ""Brain"", ""Low Density Lipoprotein Receptor-Related Protein-2"", ""Mice"", ""Nerve Tissue Proteins"", ""Neurons"", ""Nuclear Proteins""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Apbb1 protein, mouse"", ""Low Density Lipoprotein Receptor-Related Protein-2"", ""Nerve Tissue Proteins"", ""Nuclear Proteins""]}",False
DIRECTLY_DECREASES,2071,24136,1997,8940412,False,False,False,"Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",#59:50,,"{""full_journal_name"": ""Endocrinology"", ""pub_date"": ""1997-01-23"", ""ref"": ""8940412"", ""pub_year"": 1997, ""last_author"": ""Chrousos GP"", ""type"": ""PubMed"", ""author_list"": [""Webster EL"", ""Lewis DB"", ""Torpy DJ"", ""Zachman EK"", ""Rice KC"", ""Chrousos GP""], ""title"": ""In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.""}","{""Anatomy"": [""frontal cortex""], ""AssayType"": [""B""], ""Confidence"": [""Medium""], ""MeasurementRelation"": [""=""], ""MeasurementType"": [""Ki""], ""MeasurementUnits"": [""nM""], ""MeasurementValue"": [""1.4""], ""Species"": [""10116""], ""mesh"": [""Adrenocorticotropic Hormone"", ""Animals"", ""Binding, Competitive"", ""Carrageenan"", ""Cerebellum"", ""Corticotropin-Releasing Hormone"", ""Frontal Lobe"", ""Inflammation"", ""Injections, Subcutaneous"", ""Male"", ""Myocardium"", ""Pituitary Gland"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Sprague-Dawley"", ""Receptors, Corticotropin-Releasing Hormone"", ""Sheep""], ""substances"": [""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""antalarmin"", ""Carrageenan"", ""Adrenocorticotropic Hormone"", ""Corticotropin-Releasing Hormone""]}",False
DIRECTLY_DECREASES,2071,24136,1997,8940412,False,False,False,"Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",#59:50,,"{""full_journal_name"": ""Endocrinology"", ""pub_date"": ""1997-01-23"", ""ref"": ""8940412"", ""pub_year"": 1997, ""last_author"": ""Chrousos GP"", ""type"": ""PubMed"", ""author_list"": [""Webster EL"", ""Lewis DB"", ""Torpy DJ"", ""Zachman EK"", ""Rice KC"", ""Chrousos GP""], ""title"": ""In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.""}","{""Anatomy"": [""cerebellum""], ""AssayType"": [""B""], ""Confidence"": [""Medium""], ""MeasurementRelation"": [""=""], ""MeasurementType"": [""Ki""], ""MeasurementUnits"": [""nM""], ""MeasurementValue"": [""1.3""], ""Species"": [""10116""], ""mesh"": [""Adrenocorticotropic Hormone"", ""Animals"", ""Binding, Competitive"", ""Carrageenan"", ""Cerebellum"", ""Corticotropin-Releasing Hormone"", ""Frontal Lobe"", ""Inflammation"", ""Injections, Subcutaneous"", ""Male"", ""Myocardium"", ""Pituitary Gland"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Sprague-Dawley"", ""Receptors, Corticotropin-Releasing Hormone"", ""Sheep""], ""substances"": [""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""antalarmin"", ""Carrageenan"", ""Adrenocorticotropic Hormone"", ""Corticotropin-Releasing Hormone""]}",False
DIRECTLY_DECREASES,6889,3330,2019,30962309,False,False,False,"In SLE urine, miR-155-5p levels are significantly higher, treatment with calcitriol reduces miR-155-5p levels, and miR-155-5p levels correlate with proteinuria and disease activity, whereas the amount of miR-146a-5p correlates with the estimated glomerular filtration rate in SLE patients (108).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,14251,40917,2017,27794524,False,False,False,"Masitinib is a selective tyrosine kinase inhibitor controlling mast cell degranulation, NO-mediated damage, and dendritic cell activity (Dubreuil et al., 2009).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11812,40834,2017,27794524,False,False,False,"Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,11812,40834,2017,27794524,False,False,False,"Blocking these ion channels with amiloride or glibenclamide, respectively could be a new approach, as they provided neuroprotection in EAE and decreased neuronal and oligodendrocyte damage (Friese et al., 2007; Schattling et al., 2012).",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""MeSHDisease"": [""Encephalomyelitis, Autoimmune, Experimental""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,5339,16835,2017,26979166,False,False,False,"For instance, activation of a7 nAChRs leads to stimulation of adenylate cyclase-1 and thus to increases in cAMP levels[61]. This in turn stimulates protein kinase A (PKA), which may result in further signaling events such as CREB activation [61] and GSK3 inhibition [62]",#58:34,PMC4894934,"{""full_journal_name"": ""Cellular and molecular life sciences : CMLS"", ""pub_date"": ""2017-02-15"", ""ref"": ""26979166"", ""pub_year"": 2017, ""last_author"": ""Feuerbach D"", ""type"": ""PubMed"", ""author_list"": [""Kalkman HO"", ""Feuerbach D""], ""title"": ""Modulatory effects of \u03b17 nAChRs on the immune system and its relevance for CNS disorders."", ""doi"": ""10.1007/s00018-016-2175-4""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Central Nervous System Diseases"", ""Drug Discovery"", ""Humans"", ""Immune System"", ""Signal Transduction"", ""alpha7 Nicotinic Acetylcholine Receptor""], ""substances"": [""alpha7 Nicotinic Acetylcholine Receptor""]}",False
DIRECTLY_DECREASES,36311,40328,2017,29191965,False,False,False,"Dephosphorylation of tau is achieved mainly by protein phosphatase (PP)2A, PP2B (calcineurin), and PP-1 (92).",#69:60,,"{""full_journal_name"": ""FASEB journal : official publication of the Federation of American Societies for Experimental Biology"", ""pub_date"": ""2017-12-11"", ""ref"": ""29191965"", ""pub_year"": 2017, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Pir GJ"", ""Choudhary B"", ""Mandelkow E""], ""title"": {""#text"": ""models of tauopathy."", ""i"": ""Caenorhabditis elegans""}, ""doi"": ""10.1096/fj.201701007""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Caenorhabditis elegans"", ""Disease Models, Animal"", ""Neurodegenerative Diseases"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,7024,38396,2014,24401760,False,False,False,"We show here that ITPKB protein level was increased 3-fold in the cerebral cortex of most patients with Alzheimer's disease compared with control subjects, and accumulated in dystrophic neurites associated to amyloid plaques. In mouse Neuro-2a neuroblastoma cells, Itpkb overexpression was associated with increased cell apoptosis and increased β-secretase 1 activity leading to overproduction of amyloid-β peptides. In this cellular model, an inhibitor of mitogen- activated kinase kinases 1/2 completely prevented overproduction of amyloid-β peptides. Transgenic overexpression of ITPKB in mouse forebrain neurons was not sufficient to induce amyloid plaque formation or tau hyperphosphorylation. However, in the 5X familial Alzheimer's disease mouse model, neuronal ITPKB overexpression significantly increased extracellular signal-regulated kinases 1/2 activation and β-secretase 1 activity, resulting in exacerbated Alzheimer's disease pathology as shown by increased astrogliosis, amyloid-β40 peptide production and tau hyperphosphorylation.",#60:23,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2014-04-11"", ""ref"": ""24401760"", ""pub_year"": 2014, ""last_author"": ""Brion JP"", ""type"": ""PubMed"", ""author_list"": [""Stygelbout V"", ""Leroy K"", ""Pouillon V"", ""Ando K"", ""D'Amico E"", ""Jia Y"", ""Luo HR"", ""Duyckaerts C"", ""Erneux C"", ""Schurmans S"", ""Brion JP""], ""title"": ""Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology."", ""doi"": ""10.1093/brain/awt344""}","{""Cell_Line"": [""N2a""], ""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Animals"", ""Apoptosis"", ""Brain"", ""Cell Line, Tumor"", ""Female"", ""Humans"", ""Male"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Middle Aged"", ""Neurites"", ""Neuroblastoma"", ""Phosphotransferases (Alcohol Group Acceptor)"", ""Plaque, Amyloid""], ""substances"": [""Phosphotransferases (Alcohol Group Acceptor)"", ""Inositol 1,4,5-trisphosphate 3-kinase""]}",False
DIRECTLY_DECREASES,11888,150,2018,27550730,False,False,False,"Here we report the discovery of a new first-in-class small-molecule (CM-414) that acts as a dual inhibitor of PDE5 and HDACs. We have used this compound as a chemical probe to validate this systems therapeutics strategy, where an increase in the activation of cAMP/cGMP-responsive element-binding protein (CREB) induced by PDE5 inhibition, combined with moderate HDAC class I inhibition, leads to efficient histone acetylation. This molecule rescued the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice. Chronic treatment of Tg2576 mice with CM-414 diminished brain Aβ and tau phosphorylation (pTau) levels, increased the inactive form of GSK3β, reverted the decrease in dendritic spine density on hippocampal neurons, and reversed their cognitive deficits, at least in part by inducing the expression of genes related to synaptic transmission.",#60:23,PMC5399234,"{""full_journal_name"": ""Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology"", ""pub_date"": ""2018-01-05"", ""ref"": ""27550730"", ""pub_year"": 2018, ""last_author"": ""Garcia-Osta A"", ""type"": ""PubMed"", ""author_list"": [""Cuadrado-Tejedor M"", ""Garcia-Barroso C"", ""S\u00e1nchez-Arias JA"", ""Rabal O"", ""P\u00e9rez-Gonz\u00e1lez M"", ""Mederos S"", ""Ugarte A"", ""Franco R"", ""Segura V"", ""Perea G"", ""Oyarzabal J"", ""Garcia-Osta A""], ""title"": ""A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice."", ""doi"": ""10.1038/npp.2016.163""}","{""Confidence"": [""Medium""], ""Species"": [""10090""], ""mesh"": [""Alzheimer Disease"", ""Animals"", ""Behavior, Animal"", ""Disease Models, Animal"", ""Female"", ""Hippocampus"", ""Histone Deacetylase Inhibitors"", ""Mice"", ""Mice, Transgenic"", ""Motor Activity"", ""Neuronal Plasticity"", ""Phosphodiesterase 5 Inhibitors"", ""Primary Cell Culture"", ""Pyrazoles"", ""Pyrimidinones""], ""substances"": [""CM-414"", ""Histone Deacetylase Inhibitors"", ""Phosphodiesterase 5 Inhibitors"", ""Pyrazoles"", ""Pyrimidinones""]}",False
DIRECTLY_DECREASES,37439,32534,2019,29334120,False,False,False,"We recently found that overexpression of TDP-43 enhances tau exon 10 inclusion and tau mRNA instability. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion.",#60:23,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2019-01-07"", ""ref"": ""29334120"", ""pub_year"": 2019, ""last_author"": ""Liu F"", ""type"": ""PubMed"", ""author_list"": [""Gu J"", ""Wang W"", ""Miao S"", ""Chen F"", ""Wu F"", ""Hu W"", ""Iqbal K"", ""Gong CX"", ""Liu F""], ""title"": ""Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion."", ""doi"": ""10.1002/1873-3468.12976""}","{""Confidence"": [""High""], ""mesh"": [""Alternative Splicing"", ""DNA-Binding Proteins"", ""Exons"", ""HEK293 Cells"", ""HeLa Cells"", ""Humans"", ""Marine Toxins"", ""Okadaic Acid"", ""Oxazoles"", ""Phosphorylation"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2"", ""Serine"", ""Up-Regulation"", ""tau Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Marine Toxins"", ""Oxazoles"", ""TARDBP protein, human"", ""tau Proteins"", ""Okadaic Acid"", ""Serine"", ""calyculin A"", ""Protein Phosphatase 1"", ""Protein Phosphatase 2""]}",False
DIRECTLY_DECREASES,21479,33326,2009,19401603,False,False,False,Pin1 is indicated to facilitate Tau dephosphorylation via PP2A by binding to the phospho-Thr-231-Pro or phospho-Thr-212-Pro site,#60:23,PMC2719320,"{""full_journal_name"": ""The Journal of biological chemistry"", ""pub_date"": ""2009-10-20"", ""ref"": ""19401603"", ""pub_year"": 2009, ""last_author"": ""Hisanaga SI"", ""type"": ""PubMed"", ""author_list"": [""Yotsumoto K"", ""Saito T"", ""Asada A"", ""Oikawa T"", ""Kimura T"", ""Uchida C"", ""Ishiguro K"", ""Uchida T"", ""Hasegawa M"", ""Hisanaga SI""], ""title"": ""Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau."", ""doi"": ""10.1074/jbc.M109.003277""}","{""Confidence"": [""Medium""], ""mesh"": [""Amino Acid Substitution"", ""Animals"", ""Base Sequence"", ""Brain"", ""DNA Primers"", ""Humans"", ""In Vitro Techniques"", ""Kinetics"", ""Mice"", ""Mice, Knockout"", ""Microtubules"", ""Models, Neurological"", ""Mutation"", ""NIMA-Interacting Peptidylprolyl Isomerase"", ""Peptide Mapping"", ""Peptidylprolyl Isomerase"", ""Phosphorylation"", ""Protein Conformation"", ""Rats"", ""Recombinant Proteins"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""DNA Primers"", ""MAPT protein, human"", ""NIMA-Interacting Peptidylprolyl Isomerase"", ""Recombinant Proteins"", ""tau Proteins"", ""PIN1 protein, human"", ""Peptidylprolyl Isomerase"", ""Pin1 protein, mouse""]}",False
DIRECTLY_DECREASES,21493,35154,2013,23758787,False,False,False,"CYLD, a tumor suppressor and a target gene of NF-κB, negatively regulates NF-κB and JNK activation by removing K63-linked polyubiquitin chains from TRAF2 and TRAF6 as well as several other signaling proteins [214,215].",#57:0,PMC3697994,"{""full_journal_name"": ""Journal of molecular signaling"", ""pub_date"": ""2013-07-03"", ""ref"": ""23758787"", ""pub_year"": 2013, ""last_author"": ""Xie P"", ""type"": ""PubMed"", ""author_list"": [""Xie P""], ""title"": ""TRAF molecules in cell signaling and in human diseases."", ""doi"": ""10.1186/1750-2187-8-7""}","{""PublicationType"": [""Review""], ""Section"": [""TRAFs in cytokine receptor signaling""]}",False
DIRECTLY_DECREASES,3900,32340,2009,19355846,False,False,False,Lower-expression of PS1 and over-expression of IDE or NEP may be helpful in potentially lowering brain Abeta levels in subjects with AD,#59:5,,"{""full_journal_name"": ""Current Alzheimer research"", ""pub_date"": ""2009-06-22"", ""ref"": ""19355846"", ""pub_year"": 2009, ""last_author"": ""Wang Y"", ""type"": ""PubMed"", ""author_list"": [""Tian J"", ""Shi J"", ""Zhang L"", ""Yin J"", ""Hu Q"", ""Xu Y"", ""Sheng S"", ""Wang P"", ""Ren Y"", ""Wang R"", ""Wang Y""], ""title"": ""GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.""}","{""Subgraph"": [""Non-amyloidogenic subgraph""], ""mesh"": [""Alzheimer Disease"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Analysis of Variance"", ""Animals"", ""Aspartic Acid Endopeptidases"", ""Disease Models, Animal"", ""Donepezil"", ""Drug Therapy, Combination"", ""Drugs, Chinese Herbal"", ""Ginsenosides"", ""Hippocampus"", ""Humans"", ""Indans"", ""Insulysin"", ""Male"", ""Memory"", ""Mice"", ""Mice, Inbred C57BL"", ""Mice, Transgenic"", ""Mutation"", ""Neprilysin"", ""Neuropsychological Tests"", ""Piperidines"", ""Presenilin-1"", ""Space Perception"", ""Time Factors""], ""substances"": [""Amyloid beta-Peptides"", ""Amyloid beta-Protein Precursor"", ""Drugs, Chinese Herbal"", ""Ginsenosides"", ""Indans"", ""Piperidines"", ""Presenilin-1"", ""Donepezil"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""Bace1 protein, mouse"", ""Neprilysin"", ""Insulysin""]}",False
DIRECTLY_DECREASES,15000,11853,2017,27794524,False,False,False,"In multiple sclerosis, activated microglia damage oligodendrocytes through different mechanisms including: secretion of pro-inflammatory cytokines such as IL-1, IL-6, TNF-alpha, and IFN-gamma, phagocytic activity, and presentation of antigens via MHC Class II to CD4+ T cells (Correale, 2014).",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,37118,4488,2011,22110360,False,False,False,"Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen- activated protein kinase kinase kinase family, is composed of an inhibitory N-terminal domain, a kinase domain, and a C-terminal regulatory domain (Ichijo et al., 1997). ASK1 can promote apoptosis in response to common pro-apoptotic stresses, such as oxidative stress (Song et al., 2002), death receptor ligands (Nishitoh et al., 1998), and endoplasmic reticulum stress (Nishitoh et al., 2002). ASK1 also phosphorylates and activates both p38 and JNK pathways (Ichijo et al., 1997). The mechanism of ASK1 activation is positively regulated by its binding proteins such as TNF receptor-ssociated factors 2/6 (Noguchi et al., 2005) and Daxx (Chang et al., 1998). On the other hand, several cellular proteins, including thioredoxin (Saitoh et al., 1998), Hsp90 (Zhang et al., 2005), and 14-3-3 (Zhang et al., 1999), have been reported to interact with ASK1 and inhibit ASK1 activity.",#59:5,PMC3213740,"{""full_journal_name"": ""Experimental neurobiology"", ""pub_date"": ""2011-11-23"", ""ref"": ""22110360"", ""pub_year"": 2011, ""last_author"": ""Chung KC"", ""type"": ""PubMed"", ""author_list"": [""Choi HK"", ""Chung KC""], ""title"": ""Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death."", ""doi"": ""10.5607/en.2011.20.1.35""}","{""Condition"": [""Normal Healthy State""], ""Published"": [""CDR story""], ""Subgraph"": [""Chaperone subgraph"", ""MAPK-JNK subgraph""]}",False
DIRECTLY_DECREASES,12434,32340,2012,22232000,False,False,False,"Clusterin, a multifunctional lipoprotein is expressed in a number of tissues but expression is particularly high in the brain, where it binds to amyloid-ÃƒÅ¸ (ABeta¸), possibly facilitating ABeta¸ transport into the bloodstream.Its concentration in peripheral blood was identified as a potential biomarker for Alzheimer's disease (AD).",#59:5,,"{""full_journal_name"": ""Journal of Alzheimer's disease : JAD"", ""pub_date"": ""2012-05-24"", ""ref"": ""22232000"", ""pub_year"": 2012, ""last_author"": ""Love S"", ""type"": ""PubMed"", ""author_list"": [""Baig S"", ""Palmer LE"", ""Owen MJ"", ""Williams J"", ""Kehoe PG"", ""Love S""], ""title"": ""Clusterin mRNA and protein in Alzheimer's disease."", ""doi"": ""10.3233/JAD-2011-110473""}","{""MeSHAnatomy"": [""Brain""], ""Subgraph"": [""Amyloidogenic subgraph"", ""Endosomal lysosomal subgraph""], ""mesh"": [""Aged"", ""Aged, 80 and over"", ""Alzheimer Disease"", ""Arabidopsis Proteins"", ""Brain"", ""Clusterin"", ""Female"", ""Humans"", ""Intramolecular Transferases"", ""Male"", ""RNA, Messenger""], ""substances"": [""Arabidopsis Proteins"", ""Clusterin"", ""RNA, Messenger"", ""Intramolecular Transferases"", ""marneral synthase, Arabidopsis""]}",False
DIRECTLY_DECREASES,14335,38200,2012,21800078,False,False,False,"The study also revealed that the nuclear receptor peroxisome proliferators activated receptor γ (PPARγ) played an important role in the CLA-induced intracellular BACE1 decrease, as well as the extracellular sAPPalpha increase through knockdown of PPARγ transcription using siRNA. We hypothesize that CLA acts as an agonist or ligand, which binds with PPARγ and leads to the increase in APP cleavage via alpha-secretase-mediated pathway and the decrease in the deposition of Abeta.",#59:5,,"{""full_journal_name"": ""Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"", ""pub_date"": ""2012-03-30"", ""ref"": ""21800078"", ""pub_year"": 2012, ""last_author"": ""Zhong L"", ""type"": ""PubMed"", ""author_list"": [""Li YC"", ""Chen Q"", ""Wan XZ"", ""Yang XL"", ""Liu X"", ""Zhong L""], ""title"": ""Effects of conjugated linoleic acid on cleavage of amyloid precursor protein via PPAR\u03b3."", ""doi"": ""10.1007/s10072-011-0711-4""}","{""Subgraph"": [""Beta secretase subgraph"", ""Non-amyloidogenic subgraph"", ""Peroxisome proliferator activated receptor subgraph""], ""mesh"": [""ADAM Proteins"", ""ADAM10 Protein"", ""Amyloid Precursor Protein Secretases"", ""Amyloid beta-Protein Precursor"", ""Analysis of Variance"", ""Aspartic Acid Endopeptidases"", ""Cell Line, Tumor"", ""Cell Survival"", ""Dose-Response Relationship, Drug"", ""Enzyme-Linked Immunosorbent Assay"", ""Gene Expression Regulation, Neoplastic"", ""Humans"", ""Linoleic Acid"", ""Membrane Proteins"", ""Neuroblastoma"", ""PPAR gamma"", ""RNA, Messenger""], ""substances"": [""Amyloid beta-Protein Precursor"", ""Membrane Proteins"", ""PPAR gamma"", ""RNA, Messenger"", ""Linoleic Acid"", ""Amyloid Precursor Protein Secretases"", ""Aspartic Acid Endopeptidases"", ""BACE1 protein, human"", ""ADAM Proteins"", ""ADAM10 Protein"", ""ADAM10 protein, human""]}",False
DIRECTLY_DECREASES,2071,30445,1997,8940412,False,False,False,"Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",#59:50,,"{""full_journal_name"": ""Endocrinology"", ""pub_date"": ""1997-01-23"", ""ref"": ""8940412"", ""pub_year"": 1997, ""last_author"": ""Chrousos GP"", ""type"": ""PubMed"", ""author_list"": [""Webster EL"", ""Lewis DB"", ""Torpy DJ"", ""Zachman EK"", ""Rice KC"", ""Chrousos GP""], ""title"": ""In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.""}","{""Anatomy"": [""frontal cortex""], ""AssayType"": [""B""], ""Confidence"": [""Medium""], ""MeasurementRelation"": [""=""], ""MeasurementType"": [""Ki""], ""MeasurementUnits"": [""nM""], ""MeasurementValue"": [""1.4""], ""Species"": [""10116""], ""mesh"": [""Adrenocorticotropic Hormone"", ""Animals"", ""Binding, Competitive"", ""Carrageenan"", ""Cerebellum"", ""Corticotropin-Releasing Hormone"", ""Frontal Lobe"", ""Inflammation"", ""Injections, Subcutaneous"", ""Male"", ""Myocardium"", ""Pituitary Gland"", ""Pyrimidines"", ""Pyrroles"", ""Rats"", ""Rats, Sprague-Dawley"", ""Receptors, Corticotropin-Releasing Hormone"", ""Sheep""], ""substances"": [""Pyrimidines"", ""Pyrroles"", ""Receptors, Corticotropin-Releasing Hormone"", ""antalarmin"", ""Carrageenan"", ""Adrenocorticotropic Hormone"", ""Corticotropin-Releasing Hormone""]}",False
DIRECTLY_DECREASES,1289,3339,2019,30962309,False,False,False,"In human epithelial cells, overexpression of miR-214-3p downregulates caspase-1, and the miRNA is downregulated in cataract lens anterior capsular tissues (59).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,32290,2678,2019,30962309,False,False,False,"In humans, mRNA destabilization by deadenylation and subsequent exonucleolytic decay dominates the regulatory effect of miRNAs, whereas the contribution from direct translational repression is relatively small (35–39).",#69:46,,"{""full_journal_name"": ""Journal of immunology (Baltimore, Md. : 1950)"", ""pub_date"": ""2019-12-27"", ""ref"": ""30962309"", ""pub_year"": 2019, ""last_author"": ""Zettl UK"", ""type"": ""PubMed"", ""author_list"": [""Boxberger N"", ""Hecker M"", ""Zettl UK""], ""title"": ""Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases."", ""doi"": ""10.4049/jimmunol.1801416""}","{""Confidence"": [""High""], ""Species"": [""9606""], ""mesh"": [""Autoimmune Diseases"", ""Caspase 1"", ""Caspase 8"", ""Humans"", ""Inflammasomes"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""Receptors, Interleukin"", ""Signal Transduction"", ""Toll-Like Receptors""], ""substances"": [""Inflammasomes"", ""MIRN155 microRNA, human"", ""MIRN223 microRNA, human"", ""MicroRNAs"", ""NLR Family, Pyrin Domain-Containing 3 Protein"", ""NLRP3 protein, human"", ""Receptors, Interleukin"", ""Toll-Like Receptors"", ""CASP8 protein, human"", ""Caspase 8"", ""Caspase 1""]}",False
DIRECTLY_DECREASES,37579,11567,2017,27794524,False,False,False,"If axonal Na+ rises above its nominal concentration, the Na+ /Ca2+ exchanger, normally exchanging axoplasmic Ca2+ for extracellular Na+ , will operate in a reverse Ca2+ importing mode.",#64:59,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,34508,40328,2016,26631930,False,False,False,"Protein phosphatase 1 (PP1), PP2A, PP2B, PP2C and PP5 have all been implicated in the dephosphorylation of tau",#59:49,,"{""full_journal_name"": ""Nature reviews. Neuroscience"", ""pub_date"": ""2016-04-20"", ""ref"": ""26631930"", ""pub_year"": 2016, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Wang Y"", ""Mandelkow E""], ""title"": ""Tau in physiology and pathology."", ""doi"": ""10.1038/nrn.2015.1""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Humans"", ""Phosphorylation"", ""Protein Processing, Post-Translational"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
DIRECTLY_DECREASES,26780,12188,2017,27794524,False,False,False,"Second, mitochondrial injury may amplify oxidative stress through release of oxygen radicals generated as a result of impaired respiratory chain function, thus establishing a vicious cycle of tissue destruction (Murphy, 2009)",#61:20,,"{""full_journal_name"": ""Brain : a journal of neurology"", ""pub_date"": ""2017-05-29"", ""ref"": ""27794524"", ""pub_year"": 2017, ""last_author"": ""Fiol MP"", ""type"": ""PubMed"", ""author_list"": [""Correale J"", ""Gait\u00e1n MI"", ""Ysrraelit MC"", ""Fiol MP""], ""title"": ""Progressive multiple sclerosis: from pathogenic mechanisms to treatment."", ""doi"": ""10.1093/brain/aww258""}","{""Confidence"": [""High""], ""mesh"": [""Disease Progression"", ""Humans"", ""Magnetic Resonance Imaging"", ""Multiple Sclerosis""]}",False
DIRECTLY_DECREASES,31595,41416,2013,23384725,False,False,False,Addition of a reducing agent such as DTT to RRM1 10 min after the start of oxidation treatment prevented protein aggregation.,#70:9,,"{""full_journal_name"": ""FEBS letters"", ""pub_date"": ""2013-04-30"", ""ref"": ""23384725"", ""pub_year"": 2013, ""last_author"": ""Huang TH"", ""type"": ""PubMed"", ""author_list"": [""Chang CK"", ""Chiang MH"", ""Toh EK"", ""Chang CF"", ""Huang TH""], ""title"": ""Molecular mechanism of oxidation-induced TDP-43 RRM1 aggregation and loss of function."", ""doi"": ""10.1016/j.febslet.2013.01.038""}","{""Confidence"": [""High""], ""mesh"": [""Amino Acid Sequence"", ""Conserved Sequence"", ""Cysteine"", ""DNA-Binding Proteins"", ""Humans"", ""Models, Molecular"", ""Molecular Sequence Data"", ""Neurodegenerative Diseases"", ""Oxidation-Reduction"", ""Protein Denaturation"", ""Protein Structure, Secondary"", ""Protein Structure, Tertiary"", ""Recombinant Proteins""], ""substances"": [""DNA-Binding Proteins"", ""Recombinant Proteins"", ""Cysteine""]}",False
DIRECTLY_DECREASES,40891,40328,2017,29191965,False,False,False,"Dephosphorylation of tau is achieved mainly by protein phosphatase (PP)2A, PP2B (calcineurin), and PP-1 (92).",#69:60,,"{""full_journal_name"": ""FASEB journal : official publication of the Federation of American Societies for Experimental Biology"", ""pub_date"": ""2017-12-11"", ""ref"": ""29191965"", ""pub_year"": 2017, ""last_author"": ""Mandelkow E"", ""type"": ""PubMed"", ""author_list"": [""Pir GJ"", ""Choudhary B"", ""Mandelkow E""], ""title"": {""#text"": ""models of tauopathy."", ""i"": ""Caenorhabditis elegans""}, ""doi"": ""10.1096/fj.201701007""}","{""Confidence"": [""High""], ""mesh"": [""Animals"", ""Caenorhabditis elegans"", ""Disease Models, Animal"", ""Neurodegenerative Diseases"", ""Tauopathies"", ""tau Proteins""], ""substances"": [""tau Proteins""]}",False
